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MECHANISTIC STUDIES ON D-ARGININE DEHYDROGENASE AND FUNCTIONAL
ANNOTATION OF A NOVEL NADH:QUINONE OXIDOREDUCTASE (PA1024)
by

JACOB BALL

Under the Direction of Giovanni Gadda, PhD

ABSTRACT
Pseudomonas aeruginosa D-arginine dehydrogenase (PaDADH) is an FAD-dependent
enzyme that catalyzes the oxidative deamination of D-arginine to generate the corresponding αketo acid and ammonia. The enzyme is similar to D-amino acid oxidase, except that PaDADH is
a strict dehydrogenase with no oxygen reactivity. The enzyme exhibits broad substrate
specificity and can oxidize 17 of the 20 common amino acids. The best substrates for the enzyme
are D-arginine and D-lysine based on the second order rate constant kcat/Km values.
The 3D structure of the DADH-iminoarginine complex suggests that E87 engages in an
electrostatic interaction with the positively charged guanidinium group of D-arginine. The 3D
structure also displays a hydrogen bonding network of water molecules that connects H48 to the
substrate α-amine, suggesting it may serve as catalytic base. E87 and H48 were mutated to

produce E87L and H48F variants, and pH effect kinetic approaches with zwitterionic and
cationic substrates were employed. The data, in combination with previous results on Y53 and
Y249 variants, suggests that there is no catalytic base, since the catalytic pKa is present in all
variants. The results are also consistent with E87 required to be deprotonated to bind cationic
substrates.
In the second part of this dissertation, a presumed nitronate monooxygenase from P.
aeruginosa, PA1024, is characterized. PA1024 is determined to not possess NMO activity and
instead catalyze the two-electron reduction of quinones via the oxidation of NADH. The enzyme
has a strict preference for NADH over NADPH. The functional annotation and bioinformatics
identifies a novel class of FMN-dependent NADH:quinone oxidoreductases (NQO) with a TIMbarrel fold. The pH effects reveal that PA1024 has two regimes of activity at low and high pH
dictated by the deprotonation of an enzymatic residue with pKa ~7. In addition, the 3D X-ray
structure of PA1024 in complex with the reaction product NAD + is solved. The structure reveals
the structural basis for the strict NADH specificity, which relies on a steric constraint imposed by
a nearby P78 and Q80. The structure also reveals a conformational gating mechanism of Q80 and
an unusual interrupted helix structural pattern to bind the pyrophosphate of NAD +.
INDEX WORDS: flavin, oxidoreductase, NADH, quinones, D-arginine dehydrogenase, pH
effects, enzyme kinetics
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1
1.1
1.1.1

INTRODUCTION

Substrate specificity of flavoenzymes that oxidize D-amino acids
Abstract
The oxidation of D-amino acids is relevant to neurodegenerative diseases, detoxification,

and nutrition in microorganisms and mammals. It is also important for the resolution of racemic
amino acid mixtures and the preparation of chiral building blocks for the pharmaceutical and
food industry. Considerable biochemical and structural knowledge has been accrued in recent
years on the enzymes that carry out the oxidation of the Cα-N bond of D-amino acids. These
enzymes contain FAD as a required cofactor, share similar overall three-dimensional folds and
highly conserved active sites, but differ in their specificity for substrates with neutral, anionic, or
cationic side-chains. Here, we summarize the current biochemical and structural knowledge
regarding substrate specificity on D-amino acid oxidase, D-aspartate oxidase, and D-arginine
dehydrogenase, for which a wealth of biochemical and structural studies is available.
1.1.2

Introduction
The oxidation of D-amino acids is important from both fundamental and applied

standpoints.1 The reaction is relevant to neurodegenerative diseases, detoxification, nutrition, and
other biological processes in microorganisms and mammals. It is also important for the
resolution of racemic amino acid mixtures, the preparation of chiral building blocks for the
pharmaceutical industry, and the food industry. In this review article, we present a brief
overview of the importance of D-amino acids regarding biochemical processes and industrial
applications, and summarize the current biochemical as well as structural knowledge on the
flavoenzymes that oxidize α-D-amino acids with emphasis on substrate specificity. The enzymes
covered within the scope of this review include D-amino acid oxidase (DAAO), D-arginine

2

dehydrogenase (DADH), and D-aspartate oxidase (DASPO), for which a wealth of biochemical
and structural studies is available. These enzymes are divided into three categories, depending on
their preference for D-amino acid substrates with neutral, cationic, or anionic side-chains.
Mutant variants of the enzymes that had an impact on substrate specificity are also discussed. We
conclude with some general principles about structure and specificity for the oxidation of α-Damino acids by flavoenzymes. The mechanistic aspects of the enzymes that oxidize the C α-N
bond of D-amino acids have been recently reviewed by Fitzpatrick and are not covered here. 2
1.1.3

Importance of D-amino acids
Due to a lack of detection methods for D-amino acids for most of the 20 th century, with

only isolated cases of detection mostly in invertebrates3-5, studies investigating L-amino acids
have eclipsed those of D-amino acids. Analysis of D-amino acids changed with the advent of
improved analytical techniques in the 1990s, such as gas chromatography, high performance
liquid chromatography, and the use of chiral columns, which allow separation of D/L-racemic
mixtures and the detection of trace amounts of D-amino acids.4, 6 In bacteria, D-Ala and D-Glu
have been detected as important components of the bacterial peptidoglycan and contribute to the
overall strength of the cell wall.5 In humans, D-Ser has been detected at high concentrations in
the brain and serves as the endogenous agonist of N-methyl-D-Asp (NMDA) receptors. 7 D-Asp
has been detected in the β-amyloid peptides of patients with Alzheimer’s disease 8, the crystallin
peptides of patients with cataracts 9, and the αA-crystallin peptides of the elastic fibers in sundamaged skin.10 Thus, the emergence of knowledge on D-amino acids is fairly recent and
remains underappreciated in many fields of biochemistry.
D-amino acid derivatives are increasingly attractive chiral building blocks for drug
discovery.11 Many natural and synthetic antibiotics contain D-amino acid groups, such as
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penicillins and cephalosporins.12 The inherent resistance to protease cleavage demonstrated by
antibiotic peptides containing D-amino acids greatly reduces the rate of their inactivation.
Several drugs containing D-amino acids have surfaced in recent years including Nafarelin, which
is used in the treatment of estrogen-dependent conditions such as endometriosis. 13 D-cycloserine
has been reported to have antibacterial properties through its inhibition of bacterial DAAOs. 13
Furthermore, recent findings suggest that human DAAO may play a significant role in the
pathogenesis of schizophrenia due to its metabolic action on the neuromodulator D-Ser. 14
Because many routine commercial methods to synthesize amino acids result in a racemic
mixture, L-amino acids must often be purified from D-amino acids. Several enzymatic systems
that use D-amino acid oxidizing enzymes have been designed to resolve racemic amino acid
mixtures.12 D-amino acid detection is of paramount importance in the food industry, where
spontaneous racemization due to heat and processing conditions can generate D-amino acids that
contaminate food preparations.15,

16

Enzymes that oxidize D-amino acids have been shown to

accomplish rapid D-amino acid detection in mixtures, with a low cost and accuracy comparable
to classical analytical techniques, such as high-performance liquid chromatography that are more
expensive and time-consuming.17
1.1.4

Flavoenzymes and Cα-N bond oxidation
Enzymes that are known to oxidize the Cα-N bond of D-amino acids with high

stereospecificity for the D-isomer are flavoenzymes. Flavoenzymes are versatile catalysts that
utilize a covalently, or more often, non-covalently bound FMN or FAD as a cofactor (Figure
1.1).18 The reactive portion of FMN or FAD is the 7,8-dimethylisoalloxazine ring (Figure 1.1),
which is a fusion of xylene, pyrazine and pyrimidine rings, allowing for multifunctional
capabilities.19 The general reaction of D-amino acid oxidation by flavoenzymes entails the
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oxidation of the bond between the C α atom and the amine N atom to generate the corresponding
imino acid (Scheme 1.1). Non-enzymatic
enzymatic hydrolysis of the imino acid product yields the α-keto
acid and ammonia.
mmonia. The reduced flavin cofactor donates electrons to an acceptor to regenerate the
oxidized flavin. As illustrated in Scheme 1.1,, oxidases utilize oxygen as electron acceptor,
whereas dehydrogenases utilize electron acceptors other than oxygen. Although
Althoug the hydrolysis
reaction occurs non-enzymatically
enzymatically in solution, recent studies have reported an imine deiminase
enzyme from the Rid protein family that can accelerate the breakdown of the imino acid to the
corresponding α-keto acid.20, 21

Figure 1.1 Structure of FMN, FAD, and 7,8
7,8-dimethylisoalloxazine.
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Scheme 1.1 General scheme of the reaction catalyzed by A) D-amino acid oxidases and B) Darginine dehydrogenase.
EAox: oxidized electron acceptor; EAred: reduced electron acceptor. The D-amino acid substrate
in the DAAO reaction loses the amino group proton prior to forming the ES complex. 2
The oxidation of D-amino acids is found in key life processes, such as regulatory
processes, neurotransmission,22-24 cell-signaling,25 and metabolism.26 As a result, imbalance in
the regulation or function of these enzymes is proposed to cause neurodegenerative diseases and
even cell death.22, 25 The oxidation of the Cα-N bond of D-amino acids by flavoenzymes can be
harnessed for the preparation of α-keto acids and chirally-active pharmaceutical precursors. 27
Among the several flavoenzymes reported that oxidize the C α-N bond of D-amino acids, a wealth
of biochemical information is available for D-amino acid oxidase from pig kidney (pDAAO),
Rhodoturula gracilis (RgDAAO), and human (hDAAO), as well as Pseudomonas aeruginosa Darginine dehydrogenase (PaDADH), and DASPO (Table 1.1). X-Ray crystallographic data are
available for all the enzymes except DASPO, for which we have built here a 3D model of the
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enzyme from beef kidney (bDASPO) using SWISS-MODEL and the coordinates of pDAAO
(PDB code: 1KIF), which share 43% identity in the amino acid sequence. These enzymes show
similar overall three-dimensional structures (Figure 1.2), highly conserved active sites (Figure
1.3), contain a non-covalently bound FAD, adopt a Rossmann fold to bind the cofactor, 28 but
show different substrate specificity (Table 1.2).
Table 1.1 Select flavoenzymes that oxidize the Cα-N group of D-amino acids.
Enzyme

Source

Cofactor

EC number

PDB

FAD

Electron
acceptor
Oxygen

D-amino acid
oxidase

Pig kidney

1.4.3.3

1KIF

D-amino acid
oxidase

Rhodoturula
gracilis

FAD

Oxygen

1.4.3.3

1C0I

D-amino acid
oxidase

Human

FAD

Oxygen

1.4.3.3

2DU8

D-arginine
dehydrogenase

Pseudomonas
aeruginosa

FAD

Unknown
(PMS in vitro)

1.4.99.6

3NYC

Various

FAD

Oxygen

1.4.3.1

Unavailable

D-aspartate oxidase
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Table 1.2 Preferred and select biologically relevant D-amino acid substrates for pDAAO,
RgDAAO, hDAAO PaDADH, and bDASPO.
Substrate
kcat/Km, M-1 s-1
kcat, s-1
Km, mM
a
pDAAO
D-Pro
9,200
87.2
9.5
D-Ala
5,500
12.7
2.3
D-Met
4,800
143
30
D-Phe
4,500
55.9
12.3
D-Trp
D-Phe
D-Met
D-Ala
CephC

RgDAAOb
530,000
358,000
265,000
129,000
18,000

160
105
106
103
91

0.3
0.3
0.4
0.8
5.0

D-Cys
D-Tyr
D-DOPA
D-Ala
D-Ser

hDAAOc
14,600
13,500
6,750
4,000
400

8.6
14.8
40.5
5.2
3

0.6
1.1
6.0
1.3
7.5

PaDADHd
3,400,000
530,000
27600
14800
6900

204
141
23
154
75

0.06
0.26
0.8
10
11

D-Arg
D-Lys
D-Tyr
D-Met
D-Phe

bDASPOe
NMDA
20600
30.9
1.5
D-Asp
6090
22.5
3.7
D-Glu
213
1.2
5.6
Enzyme activity was measured varying concentrations of the desired amino acid and 21% O 2
(oxidase) or 1 mM PMS (dehydrogenase) at 25 oC and apH 8.5, bpH 8.5, cpH 8.5 (except D-Tyr pH 8.3), dpH 8.7 and epH 7.2
a
standard errors were not reported.29
b
standard errors reported to be <33%.17
c
standard errors reported to be <22%.30-32
d
standard errors reported to be <15%.33
e
standard errors were not reported.34
CephC – Cephalosporin C; D-DOPA – D-3,4-dihydroxyphenylalanine
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Figure 1.2 Three-dimensional
dimensional structure of: (A) pDAAO (PDB 1KIF); (B) RgDAAO
DAAO (PDB
1C0I); (C) hDAAO
DAAO (PDB 2DU8); (D) PaDADH (PDB 3NYC); and (E) three-dimensional
dimensional model
of bDASPO (model template: 1KIF).
Each panel is shown with the same orientation of the subunit for ease of comparison.
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Figure 1.3 Active site of: (A) pDAAO in complex with benzoate (BEZ); (B) RgDAAO in
complex with 2-amino benzoate (2-ABEZ); (C) hDAAO in complex with benzoate (BEZ); (D)
PaDADH in complex with iminoarginine (IAR); and (E) model of the active site of bDASPO.
The FAD carbons are shown in yellow. Some residues and/or water molecules have been omitted
for clarity. FAD is shown with the same orientation in each panel for ease of comparison. The
residues circled in red indicate the residue that chiefly defines the substrate specificity.
1.1.5

D-amino acid oxidase: an enzyme with preference for neutral substrates
Pioneering studies by the groups of Massey and Yagi established DAAO as the archetype

of the flavin-dependent oxidase/dehydrogenase enzymes.35-48 DAAO is found in various animals
and microorganisms. The enzyme catalyzes the oxidative deamination of D-amino acids to imino
acids with concomitant flavin reduction. Subsequent reoxidation of the flavin by molecular
oxygen produces hydrogen peroxide (Scheme 1.1A). Two protons are released during the
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reaction; the first proton is released from the amino acid amino group prior to binding to the ES
complex and the second proton is released from the amino acid α-hydrogen. 49 Apart from being
one of the initial discoveries in the flavin field by Krebs, 50 DAAO has spurred a myriad of
studies on several topics, including the versatility of the flavin cofactor, substrate specificity,
biotechnological applications, and physiological role of the enzyme. Interest in this enzyme has
never dwindled in part because of the controversy surrounding the accepted catalytic mechanism
of amino acid oxidation, i.e., hydride transfer versus carbanion, along with the discovery of the
enzyme in humans.2, 4, 51-53 DAAO serves a regulatory role in humans via the degradation of the
neurotransmitter D-Ser, a co-agonist of the NMDA receptor, as hypofunction of the NMDA
receptor is hypothesized to contribute to schizophrenia.54 In bacteria and fungi DAAO functions
in a catabolic role to convert D-amino acids into carbon and nitrogen sources. 54
Pig kidney D-amino acid oxidase
The pDAAO contains one FAD cofactor for each 40 kDa-subunit (Figure 1.2A).51, 55 The
enzyme has been detected in multiple oligomeric states in solution depending on the protein
concentration.4 The different oligomeric states can alter certain aspects of the kinetics, such as
product release and inhibitor binding.36 pDAAO is most active with hydrophobic substrates, such
as D-Pro, D-Ala, D-Met, and D-Phe (Table 1.2).

56

The bulky D-Tyr and D-Trp are slowly

oxidized as well.56 The enzyme does not react with the anionic amino acids D-Asp and D-Glu
and displays marginal activity against the cationic amino acids D-Arg and D-Lys. 56 (Figure
1.3A).51 Thiazolidine-2-carboxylic acid is also a substrate for the enzyme with catalytic turnover
numbers similar to D-Pro.57 A hydrophobic cage comprised of L51, I215, Y224, and Y228 that
surrounds the substrate side-chain explains why charged substrates display poor reactivity with
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pDAAO (Figure 1.3A).51 The volume of the active site cavity is 160 Å3, permitting substrates
with side-chains of 4-6 C atoms to bind optimally.51,

56

However, the structure of the

iminotryptophan complex revealed some degree of plasticity of the active site in pDAAO,
enabling it to expand the volume for bulky amino acids.52 Stabilization of the substrate αcarboxylate is provided by interactions with Y228 and R283, whereas the α-amino group is
within hydrogen bond distance to the hydroxyl group of Y224 and a buried water molecule
(Wat352) (Figure 1.3A).
Mutagenesis of Y224 to phenylalanine indicated that the hydroxyl group does not play a
role in the substrate specificity of pDAAO since the kcat/Km values with D-Ala, D-Pro, D-Met,
and D-Phe were largely unchanged as compared to the wild-type enzyme. 29 In contrast, the
kcat/Km value for the Y228F variant was roughly 20-fold lower for D-Ala and D-Phe, 10-fold
lower for D-Pro, and 6-fold lower for D-Met than in the wild-type enzyme, suggesting the
hydroxyl of Y228 affects the substrate specificity of pDAAO.29 A recent study that investigated
Y224A and Y228A variants reported a significant reduction in specific activity against all
substrates, demonstrating the importance of the phenyl ring of Y224 and Y228 in pDAAO for
substrate specificity and catalytic function.58 Replacement of H307 with leucine provided
evidence that this residue is involved in proper orientation of FAD for binding to the enzyme as
the dissociation constant for FAD was 28-fold greater in the H307L variant as compared to the
wild-type enzyme.59 Conversion of pDAAO into an R-stereoselective amine oxidase was
recently accomplished by a double variant of I230A/R283G. 60

12

Rhodotorula gracilis D-amino acid oxidase
The RgDAAO is a homodimer of 80 kDa with one molecule of FAD bound per subunit
(Figure 1.2B). The enzyme is most active with D-Trp, but can also process small neutral amino
acids, such as D-Ala, as shown in Table 1.2.61, 62 RgDAAO exhibits 14,800- and 370-fold lower
kcat/Km values with D-Asp and D-Arg as compared to D-Trp, respectively.63 The amino acid
sequence identity between pDAAO and RgDAAO is 30% and their overall topology is highly
similar (Figure 1.2A-B), yet RgDAAO possesses a more open active site architecture than
pDAAO (Figure 1.3A-B). An active site volume of ~230 Å3 is estimated with Caver Analyst 1.0
(J. Ball and G. Gadda; unpublished results), providing a rationale for RgDAAO exhibiting a
preference for bulky substrates like D-Phe and D-Trp. (Figure 1.3B). The α-carboxylate of the
amino acid substrate forms an electrostatic interaction with R285 and a hydrogen bond with the
side-chains of Y223 and Y238 (Figure 1.3B). The α-amino group of the ligand establishes a
hydrogen bond with the side chain of S335 and a water molecule (Wat72), which is fixated in
space through hydrogen bond interactions with N54 and Q339.64 RgDAAO is highly sought after
for biotechnological applications due to its overall higher catalytic efficiency than pDAAO, high
thermal and operational stability65, and its ability to oxidize Cephalosporin C as part of a twostep process to produce the antibiotic precursor 7-aminocephalosporic acid. 66
Considerable efforts have been undertaken to produce RgDAAO variants with altered
substrate specificities due to its biotechnological potential. M213 is especially important because
it resides ~3 Å from the β-carbon of D-F3-Ala bound to the enzyme and presumably interacts
with the side-chain of the substrate.67 M213 of RgDAAO was mutated to arginine and the
resulting M213R variant acquired activity with D-Asp as substrate, 68 with a kcat/Km value for DAsp similar to the value reported with bDASPO (Table 1.2); however, the kcat/Km of M213R for
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D-Ala was 220-fold lower in comparison to the wild-type enzyme.68 The M213G variant was
shown to oxidize unnatural aromatic amino acids such as D-2-naphthylglycine, which is a
component of Nafarelin.17. Mutations at R285 severely depleted the enzymatic activity of the
enzyme, consistent with this residue being essential to the general reactivity with amino acids as
it binds the α-amino group of the substrate.63, 69 Y238 was later mutated to generate the Y238F
and Y238S variants, which demonstrated enhanced catalytic efficiency with D-Phe and D-Tyr
without compromising D-Ala activity.17 A directed evolution study that employed an error-prone
PCR approach identified three RgDAAO variants, i.e., L118H, T60A/Q144R/K152E, and
Q144R/G199D/Y223C/H329R, which were active on all D-amino acids with significantly
improved catalytic efficiency with D-Ala, D-Arg, and D-Asp than past mutagenic efforts.
Intriguingly, most of the mutations identified by error-prone PCR that increased the catalytic
activity of RgDAAO were not in the active site but they were clustered on the surface of the
enzyme, but not far away from the substrate entrance.70 It was concluded that these surface
residues synergistically enhance the catalytic turnover and substrate affinity by modulating the
protein dynamics and/or stability.70
Human D-amino acid oxidase
The hDAAO is a homodimer of 80 kDa that binds one FAD per subunit (Figure 1.2C).32,
71

hDAAO shares 85% amino acid sequence identity with pDAAO. The activation of hDAAO by

pLG72, which elevates the biodegradation of the D-Ser, a potent activator of the NMDA
receptor, has been associated with the pathophysiology of schizophrenia. 72 A distinctive feature
of hDAAO is that it demonstrates the weakest binding affinity of the FAD cofactor, with a Kd
value of 8 M, among known DAAOs.32 A hydrophobic stretch (V47AAGL51) in hDAAO, which
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is fully conserved in pDAAO, was shown to be in a different conformation than the pig enzyme,
and this difference was proposed to be responsible for the weaker binding of FAD in the human
enzyme.31 D-Cys is the best substrate for the enzyme as indicated by a kcat/Km value of 14,600 Ms (Table 1.2),

1 -1

30

and it was proposed that D-Cys might be the physiological substrate of the

enzyme in some tissues.30 Due to the high levels of D-Ser in the brain it was also proposed that
D-Ser might be the physiological substrate for hDAAO in the brain, although the enzyme has a
low kcat/Km value of 400 M-1s-1, which would suggest otherwise.73 D-Glu and NMDA are not
substrates for hDAAO, whereas D-Asp exhibits a low kcat/Km value of 4 M-1s-1.30 As shown in
Figure 1.3C, the side-chain of the D-amino acid extends into a fairly hydrophobic pocket, which
explains the specificity for neutral substrates.74, 75 The active site volume is ~220 Å3, making it
larger than pDAAO and explaining the higher kinetic efficiency with D-Tyr than pDAAO.75 The
α-carboxylate group of the ligand interacts with the guanidino group of R283 and the hydroxyl
group of Y228, while the α-amino group participates in hydrogen bond interactions to the flavin
O4 atom and the main-chain amide oxygen atom of G313 (Figure 1.3C).74-76
Most of the mutations of hDAAO have focused on variants related to disease states. The
R199W variant has been associated with familial amyotrophic lateral sclerosis, and biochemical
investigations have shown that this mutation promotes protein instability and decreases kinetic
efficiency with D-Ser.77 A W209R variant of the enzyme, which is also deposited in the single
nucleotide polymorphisms database, exhibited greater D-Ser activity and higher affinity for
FAD.77 It was proposed that the increased production of hydrogen peroxide by the W209R
variant as a result of increased D-Ser oxidation might be the feature affecting cell viability. 77
Two variants associated with an increased risk of schizophrenia, D31H and R279A, showed an
increased kinetic efficiency for D-Ser and tighter binding of the FAD cofactor. 78 A recent study
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reported that a Y55A variant, which is located on a loop on the border between the active site
and the hydrophobic substrate binding pocket, increased the specific activity of hDAAO and
pDAAO towards D-His, D-Met, D-Phe, D-Tyr, and D-Trp by facilitating solvent and substrate
access.58

1.1.6

D-arginine dehydrogenase: an enzyme with preference for cationic substrates
PaDADH is a 42 kDa monomer that binds one FAD molecule (Figure 1.2D).33 PaDADH

catalyzes the same chemical reaction as DAAO, except it employs an electron acceptor other
than molecular oxygen to reoxidize the flavin (Scheme 1.1B). Phenazine methosulfate is used in
vitro as the physiological electron acceptor remains unknown.79 The enzyme functions as the
first step in a novel two-enzyme coupled system in P. aeruginosa that racemizes D-Arg to LArg.26 The second enzyme is an NAD(P)H-dependent L-arginine dehydrogenase that combines
ammonia and the α-keto acid to produce L-Arg. The three-dimensional structures of PaDADH in
both a ligand-free and product-bound conformation, and that of the enzyme with an N5iminoleucine adduct, are available.33, 80
PaDADH has a broad substrate specificity with the ability to oxidize all of the 19 common
D-amino acids except D-Asp and D-Glu.33 The cationic amino acids, D-Arg and D-Lys, are the
best substrates for the enzyme as judged by the high kcat/Km values shown in Table 1.2 (105-106
M-1s-1).33 The position of iminoarginine bound to PaDADH suggests that the side-chain of the
D-Arg substrate forms an electrostatic interaction with E87. The presence of E87 rationalizes the
lack of reactivity with D-Asp and D-Glu. Similar to pDAAO, a hydrophobic cage formed by the
side-chains of Y53, M240, V242 and Y249 (Figure 1.3D) engages in favorable van der Waals
and π-π interactions with aliphatic and aromatic side-chains of the substrate, consequently D-Met
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and D-Tyr are oxidized in the 104 M-1s-1 range. The active site volume of PaDADH, which is
calculated to be ~320 Å with Caver Analyst 1.0 (unpublished results; J. Ball and G. Gadda), is
large enough to provide the necessary space to accommodate bulky substrates, such as D-Arg, DTyr and D-Trp. Contrary to the single arginine used to bind the α-carboxylate of the substrate in
DAAOs, PaDADH employs two arginine residues, R222 and R305, to bind the substrate αcarboxylate (Figure 1.3D).
Mutagenic work on PaDADH established the importance of E87 to be unprotonated for
optimal binding of cationic substrates.81 Although the E87L variant did not lose the ability to
oxidize D-Arg, the kcat/Km value was down 20-fold compared to the wild-type enzyme.81 An
H48F variant decreased the kcat/Km value with D-Arg only by 2-fold, indicating this residue does
not significantly affect substrate specificity.81 Overall, the mutagenic work suggests there is no
catalytic base operative in the mechanism, and the catalytic pKa seen, irrespective of the
substrate or variant, belongs to the substrate α-amino group. 81, 82 A base not being required for
the chemical step of catalysis was also proposed for DAAO.63, 67 A recent and extensive review
on PaDADH can be found here.83

1.1.7

D-aspartate oxidase: an enzyme with preference for anionic substrates
DASPO is a specialized enzyme of 39 kDa that oxidizes the anionic amino acids D-Asp

and D-Glu.84,

85

The enzyme catalyzes the oxidative deamination of D-Asp to generate 2-

ketoglutarate, ammonia, and hydrogen peroxide. In the brain, D-Asp functions as a
neurotransmitter.86 DASPO has been biochemically and kinetically characterized from various
mammalian sources, including human brain, beef kidney, pig kidney, mouse, and octopus. 85, 87-90
DASPO has also been characterized from the yeast Cryptococcus humicola.91 Purified bDASPO
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forms a homotetramer while purified pig kidney DASPO is monomeric. 85, 88 The enzyme from
all sources has a higher catalytic efficiency with D-Asp as compared to D-Glu. The major
difference between human brain, beef kidney, pig kidney, and mouse DASPO to octopus
DASPO is that the latter exhibits a lower activity against NMDA than the former enzymes. 88, 90
Increasing evidence has linked DASPO to schizophrenia in mammals, where enhanced activity
of DASPO in the post-mortem dorsolateral prefrontal cortex of patients with schizophrenia
contributes to dysfunctional NMDA transmission. 92-94 DASPO is proposed to play a role in the
assimilation and detoxification of D-Asp in yeast. 95
The three-dimensional structure of DASPO has yet to be solved, but a structural model of
bDASPO using SWISS-MODEL with the pDAAO (PDB: 1KIF; 43% sequence identity) as
template is shown in Figure 1.2E and Figure 1.3E. The position of R216 in the model suggests
it might form an electrostatic interaction with the side-chain of D-Asp (Figure 1.3E). It appears
the α-amino group may interact with S308 or Y223 (Figure 1.3E). Biochemical studies on R237
from mouse DASPO, which corresponds to R278 of bDASPO, suggests it serves to bind the αcarboxylate group of D-Asp, and does not significantly affect the strict specificity for anionic
amino acids.96 Lower levels of turnover and higher Km values were detected with D-Glu,
indicating an active site framework that is finely tuned for the one-carbon shorter D-Asp. 34
Mutations on DASPO have focused on R216 and S308, which are conserved between
bDASPO and mouse DASPO. An R216L variant of mouse DASPO acquired the ability to
oxidize D-Phe and D-His, but at the cost of appreciably lower activity against D-Asp and NMDA
than the wild-type enzyme.96 Replacement of S308 with glycine doubled the specific activity
(U/mg) of mouse DASPO against D-Asp and nearly tripled the specific activity against
NMDA.97 H56 of yeast DASPO has been shown to be important for the substrate specificity of
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the enzyme as the H56A and H56N variants of the enzyme lost the ability to oxidize D-Asp, but
gained the ability to oxidize neutral substrates, such as D-Met, D-Phe, and D-Gln. 98
1.1.8

Active site lid
pDAAO (I215-225N), hDAAO (T216-228Y), and PaDADH (R33-56P) contain a flexible

loop region which acts as an “active site lid” (Figure 1.4).33,

51, 55, 99

The iminotryptophan

complex of pDAAO demonstrated the flexibly of active site loop in pDAAO (Figure 1.4A). It
has been proposed by Mattevi and coworkers that when in the closed conformation this loop
primes pDAAO for the hydride transfer by desolvation of the active site.52 The active site lid is
also thought to regulate substrate entry and exit. 51 Specific inhibitors of hDAAO have been
shown to stabilize the open conformation of the lid (Figure 1.4B).99 A similar active site lid is
absent in RgDAAO, which may contribute to differences in substrate specificity and the reason
FAD reduction is rate-limiting for RgDAAO instead of product release, contrary to pDAAO and
hDAAO.64 Nonetheless, RgDAAO does have a residue Y238 that corresponds to Y224 of
pDAAO and is proposed to exert a similar role in capping the active site.100 Structural models of
a newly characterized DAAO from Rubrobacter xylanophilus (RxDAAO), which shows a strict
specificity for D-Val, indicate there is a L215 in the corresponding spatial position of Y224 in
pDAAO, and it was proposed this residue might contribute to the unique substrate specificity of
RxDAAO.101 The flexible loop region comprised in PaDADH has been observed in both an open
and

closed

conformations,

representing the

ligand-free

enzyme

and

product-bound

conformations, respectively.33 Y53 of PaDADH, which corresponds to Y224 of pDAAO, in the
ligand-free enzyme points away from the active site, but in the product-bound conformation it
swings inward to shield the active site from bulk solvent (Figure 1.4C).33
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Deletion of the active site lid loop in both pDAAO and hDAAO results in variants
deficient in activity or inactive towards most substrates.58 Mutagenesis of the I215-N225 loop
region of pDAAO to the corresponding region of human brain DASPO (R216-G220) granted
pDAAO the ability to oxidize D-Asp.102 Molecular dynamics studies on PaDADH indicated the
loop is highly flexible and the loop variants S45A and A46G, which are two residues that reside
on the “hinge” region of the loop (Figure 1.4C), suggested these mutations modulate the
dynamics of the gate to a more open conformation and this negatively affects the ability of
PaDADH to capture and oxidize D-amino acid substrates. 103 The functional character of this
loop and its flexibility are major determinants for the substrate specificity of flavoenzymes
oxidizing the Cα-N bond of D-amino acids.
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Figure 1.4 Active site loops of: (A) pDAAO (PDBs 1KIF and 1DDO) (B) hDAAO
DAAO (PDBs 2DU8
and 4QFD) and (C) PaDADH
DADH (PDB 3NYE).
ITRP – iminotryptophan; IAR – iminoarginine. Each open conformation is shown in orange.
Each closed conformation is shown in green. FAD carbons shown in yellow. ITRP and IAR
I
carbons are shown in cyan. Benzoate was removed from panel A and 33-(7-hydroxy
hydroxy-2-oxo-4phenyl-2H-chromen-6-yl)propanoic
yl)propanoic acid and benzoate were removed from panel B for clarity.
1.1.9

General principles about structure and specificity
The active site in the flavoenzymes that oxidize D
D-amino
amino acids is generally located at the

interface of the flavin- and substrate
substrate-binding
binding domains with conservation of key active site
residues that enable the amino acid main
main-chain
chain to bind and the hydride transfer possible (Figure
(
1.3).
). The topology of the flavin
flavin-binding
binding domain is similar while subtle modifications in the
substrate side-chain
chain pocket render differential specificity for D
D-amino
amino acid substrates. The α-
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carbon of the amino acid substrate must be within striking distance (<5 Å) of the N5 of the flavin
in order to transfer a hydride equivalent. The ideal hydride transfer distance is achieved by
tethering both the N and C terminus of the amino acid to the protein through a combination of
electrostatic interactions and hydrogen bonds. Salt-bridge stabilization of the carboxylate group
is made possible by an arginine residue(s). A tyrosine, serine, or water molecule is typically
positioned to form hydrogen bond interactions with the α-amino group of the substrate. The
cationic substrates are captured by E87 in PaDADH; the anionic substrates are captured by R216
in bDASPO; pDAAO, hDAAO, and RgDAAO capture neutral substrates with I215, L215, and
M213, respectively. M213 of RgDAAO could possibly be engaging in favorable sulfur-π
interactions with the aromatic rings of D-Trp and D-Phe. An alanine is behind the N5 atom of the
FAD in all the enzymes and may modulate the flavin redox potential. Another major factor is the
active site cavity volume, which physically limits the size of substrates that can fit into the active
site. A flexible loop that functions as an active site lid is present in most of the enzymes and
plays a role to allow these enzymes to adjust the active site for a diverse range of amino acids.
Lastly, the absence of a strong base in the proximity of the substrate α-C prevents reactions with
α-hydroxy acids, which typically have much higher pKa values than the α-amino group on amino
acids.2

1.1.10 Closing thoughts and future directions
A single enzyme is not sufficient to oxidize at equal rates all the various D-amino acids,
which differ in charge, size, and shape. Nature has designed different architectures for substratebinding sites. The opposite charge of anionic and cationic D-amino acids requires distinctive
binding pockets for the side-chain. The varying size and shape of D-amino acids necessitates
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characteristic active site volumes. Movements of flexible loops contribute to the active site
plasticity, which broadens the substrate scope of the enzymes. Many of the factors governing the
substrate specificity of enzymes that oxidize D-amino acids have been elucidated, yet most of the
focus has been on active site residues and utilized a rational design approach. Mutagenesis of
distal surface residues offers intriguing possibilities in altering the substrate specificity and
would open new paradigms in the relationship between enzyme structure and substrate
specificity. Future directions could focus on how the dynamic behavior and molecular motions of
enzymes that oxidize D-amino acid influence the kinetics in order to develop a more complete
understanding of their structure-function relationships. This information will help elaborate how
a relatively rigid protein structure is fine-tuned by its internal motions to optimize catalysis for
neutral, charged, as well as hydrophobic D-amino acid substrates. Another important aspect
centers on engineering oxidases from dehydrogenases, i.e., DADH, to aid the industrial
utilization of the enzymes that oxidize D-amino acids. A question that deserves attention is the
physiological fate of the other product of reaction formed in the oxidation of D-amino acids, i.e.,
hydrogen peroxide or other reduced electron acceptors. Do these molecules play an active role in
regulatory processes and neurotransmission, cell-signaling, and metabolism? The recent decades
have witnessed incredible advances in our understanding of the structure-function of the
enzymes that oxidize D-amino acids. The future offers intriguing questions whose answers will
take synthetic biology a step closer to the de novo design of targeted catalytic activities for the
oxidation of specific D-amino acids for industrial and biotechnological use.
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1.2
1.2.1

Quinone detoxification by flavoenzymes
Quinones
Quinones are six-membered cyclic, unsaturated compounds that contain two carbonyl

groups, resulting in a fully conjugated cyclic dione. The carbonyl groups can be adjacent or
separated by a vinylene group. The simplest single ring form of a quinone, 1,4-benzoquinone, is
shown in Figure 1.5. The simplest double ring form of a quinone, 1,4-naphthoquinone, is also
shown in Figure 1.5. These two classes of 1,4-quinones will be studied as substrates in this
dissertation.

Figure 1.5 1,4-benzoquinone and 1,4-naphthoquinone
Quinones are pervasive in nature and participate in a wide variety of reactions, most
notably in the electron transport chain in the form of Coenzyme Q10. As shown in Scheme 1.2,
quinones can accept one or two electrons to generate the semiquinone or hydroquinone,
respectively.
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Scheme 1.2 One- and two- electron enzymatic reduction of quinones.
Modified from Piper and Millson.1
1.2.2

Two-electron reduction of quinones
The two-electron reduction of quinones is interpreted as a detoxification mechanism

employed by organisms to reduce potential oxidative stress. 2, 3 Quinones can be reduced by a
single electron by enzymes such as cytochrome p450 reductase to yield a semiquinone radical;
however, the semiquinone radical can initiate chain reactions to produce reactive oxygenated
species (ROS). Therefore, the prevention of the deleterious one-electron reduction is
accomplished by directly reducing by two-electrons to the hydroquinone form. The
hydroquinone can be further detoxified through conjugation mechanisms by the organism.
Flavoenzymes can accomplish the two-electron reduction by first receiving two electrons
from NADH to form the reduced flavin, and then transferring those two electrons to the quinone.
The most well studied flavin-dependent two-electron NADH:quinone oxidoreductase (NQO) is
NQO1. This enzyme is found in various sources, including humans, where they have proposed
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roles in quinone detoxification and alleviation of oxidative stress. 4 All of the flavin-dependent
two-electron NQOs characterized to date are a flavodoxin-like fold.4 This dissertation will detail
the characterization of a novel FMN-dependent two-electron NADH:quinone oxidoreductase
from Pseudomonas aeruginosa with a TIM-barrel fold.
1.2.3
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1.3

Specific Goals
The first specific goal of this dissertation is to investigate ionizable groups in the active site

of PaDADH through site directed mutagenesis in combination with kinetic approaches. H48 is
hypothesized to serve as a catalytic base with the aid of two water molecules connected by the
hydrogen-bonding network. E87 is hypothesized to be important for binding cationic substrates,
a.k.a. amino acid substrates bearing positively-charged side chains. Methods to be employed
include a) site-directed mutagenesis of E87 and H48, which are implicated to play roles in
catalysis and/or substrate binding and b) pH effects on the kinetic parameters of the variant
enzymes with multiple substrates of zwitterionic and cationic nature. The broader impact of this
study will determine the identity of the catalytic base, or determine that there is no base
functioning in the mechanism. This study will also establish the importance or insignificance of
E87 and H48 for binding substrates through kinetic approaches. The factors controlling substrate
specificity in PaDADH can provide valuable information to investigators interested in protein
engineering efforts, particularly those focused on a single biosensor capable of detecting all types
of amino acids.
The second specific goal of this dissertation is to characterize the gene product of pa1024
to improve the gene prediction of thousands of misannotated genes. Many of the genes annotated
as Nitronate monooxygenases (NMOs) are likely not NMOs, specifically pa1024. Based on the
genomic context of PA1024, the enzyme most likely is involved in β-oxidation, not nitronate
detoxification. PA1024 may serve as a mechanism to regenerate NAD + for use by a 3-hydroxyacyl Coa dehydrogenase present in the operon. Methods to be employed include testing of the
potential substrates/non-substrates for the enzyme. A comprehensive spectral and kinetic
characterization of PA1024 will be pursued. Refinement of the bioinformatic analysis of PA1024
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will be carried out to more accurately assess the patterns or motifs in the amino acid sequence
critical to the specific reaction catalyzed by the enzyme. This study will characterize the enzyme
through pH and kinetic solvent viscosity approaches and X-ray crystallography, which will
provide valuable insights on the function of ionizable groups in the mechanism, rate-limiting
steps operative in the mechanism, and substrate binding modes. Finally, this study will aim to
establish a new class of enzymes and remedy the annotations of more than one thousand
hypothetical proteins in the database.
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2

AMINE OXIDATION BY D-ARGININE DEHYDROGENASE IN Pseudomonas
aeruginosa

(This chapter has been published verbatim in Ouedraogo D., Ball J., Iyer A., Reis R.A.G.,
Vodovoz M., and Gadda G. (2017) Arch Biochem Biophys, 632, 192-201; the author contributed
the substrate specificity and steady-state kinetic mechanism sections in addition to help with
editing the final manuscript.)
2.1

Abstract
PaDADH is a flavin-dependent oxidoreductase with a noncovalently linked FAD that

exhibits broad substrate specificity towards D-amino acids. Various biochemical studies have
established the structure and the mechanistic properties of the enzyme. The enzyme effectively
catalyzes the oxidation of positively charged and hydrophobic D-amino acids to their respective
imino acids. It is a true dehydrogenase, since it displays no reactivity towards oxygen. As
established through solvent and multiple kinetic isotope studies, PaDADH catalyzes the
asynchronous CH and NH bond cleavage via a hydride transfer mechanism. The Steady-state
kinetic studies with D-arginine and D-histidine are consistent with the enzyme following a pingpong bi-bi mechanism. As shown by a combination of crystallography, kinetic and
computational data the shape and flexibility of the active site, in particular loop L1 in PaDADH,
plays a significant role in its ability to oxidize a diverse range of D-amino acids.
2.2

Introduction
In 1848 Louis Pasteur made the groundbreaking discovery of molecular chirality1.

Pasteur was also one of the first to observe enantioselectivity in a biochemical process, which is
now a well-established concept1-3. Numerous investigations were launched concerning D-amino
acids and their roles in nature4, 5. Later in 1935, Hans Krebs discovered D-amino acid oxidase
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(DAAO) through the observation that D-amino acids undergo selective deamination by
homogenates derived from pig kidney6.
D-amino acid oxidase is a ubiquitous flavin-dependent enzyme found in various species
of bacteria, fungi, and mammals and remains the most extensively studied enzyme that oxidizes
D-amino acids, with more than 30 structures deposited in the Protein Data Bank 7. D-amino acid
oxidase from pig kidney (pDAAO) remains the most studied orthologue of the D-amino acid
oxidase structural family, which also contains D-amino acid oxidases from other organisms,
sarcosine oxidases, glycine oxidase and dimethylglycine oxidase8-11.The enzyme has become a
model for stereospecific flavin-dependent oxidoreductases that oxidize D-amino acids into their
corresponding imino acids. Flavin-dependent enzymes that also oxidize D-amino acids include
D-glutamate oxidase, D-amino acid dehydrogenase, and D-arginine dehydrogenase, among
others12-16.
The function of DAAO in microorganisms is to utilize D-amino acids as a nutrient
source, although the functions of the enzyme in eukaryotes are still under investigation 8,

17

.

DAAO has been reported to function in maintaining critical concentrations of D-serine that acts
as a neuromodulator in mammals18-20. To gain an in-depth understanding of D-amino acid
oxidizing enzymes, the readers are referred to recent reviews on DAAO and D-aspartate
oxidase7, 19, 21, 22.
The present review highlights the mechanistic and structural findings on D-arginine
dehydrogenase from Pseudomonas aeruginosa which is a member of the DAAO structural
family. D-arginine dehydrogenase is an FAD-dependent enzyme that catalyzes the oxidative
deamination of D-amino acids to their respective imino acids, which nonenzymatically hydrolyze
to α-keto acids and ammonia23, 24. The enzyme plays a pivotal role in utilizing D-arginine as a
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primary source of carbon and nitrogen16. PaDADH oxidizes the CN bond between the αC and
the amine group of the D-amino acid converting it to an imino acid 25. The enzyme does not
display any reactivity towards molecular oxygen, which could potentially be a preventative
mechanism to avoid production of harmful reactive oxygen species in host cells.
2.3

D-amino acids and their metabolism
D-amino acids occur in free-form naturally in soil, plants, and are utilized by

microorganisms commonly found in soil i.e., P. aeruginosa26. Racemization of amino acids
depends on various abiotic factors like temperature, ionizing radiation, metal ions and pH,
including several biotic factors like enzymes4. Environmental pressures and increased D-amino
acid content in soil and waterways have forced bacteria to evolve in order to not only metabolize,
but utilize and synthesize D-amino acids4.
Higher organisms lack extensive machinery in place to degrade D-amino acids. Indeed,
high levels of D-isomers are not tolerated and have a toxic effect on plants and fungi growth 27, 28.
In humans, D-amino acids have specialized roles such as D-Serine and D-aspartate which are
agonists for N-methyl-D-aspartate receptors and D-aspartate is also associated with ageing in
tissues18, 29-32. D-amino acids in most eukaryotes are racemized via a one-enzyme racemase, most
of which are PLP-dependent19, 32, 33.
In bacteria, however, several cases of the utilization of D-amino acids in peptidoglycan
layers have been reported34. Bacteria, in most cases, have the required machinery in place to
metabolize and utilize D-amino acids34. D-alanine and D-glutamate are among the D-amino
acids that are most prevalent in bacteria, making alanine and glutamate racemases essential in
microorganisms35. Tsukada in 1966 demonstrated that Pseudomonas fluorescens had two distinct
D-amino acid dehydrogenases expressed in D-tryptophan treated cells. Both enzymes use FAD
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as a cofactor and do not use molecular oxygen as an electron acceptor. One of the D-amino acid
dehydrogenases specifically reacted with Dichlorophenolindophenol as an electron acceptor,
while the other with methylene blue and were named D-amino acid:2,6-dichloroindophenol
oxidoreductase and D-amino acid :methylene blue oxidoreductase, respectively15.
Li & Lu in 2009 discovered a novel two-enzyme system that functions to convert Darginine to L-arginine in P. aeruginosa. Further analysis of the two gene products revealed that
the two-enzyme system is composed of an FAD-dependent D-arginine dehydrogenase and an
NAD(P)H-dependent L-arginine dehydrogenase as described in Scheme 2.123. Although Haas &
associates in 1988 did provide evidence for an arginine racemase in P. aeruginosa by
demonstrating utilization of D-arginine by Arginine auxotrophs, they were not able to
demonstrate arginine racemase activity in vitro24. The two enzymes are products of the dauBAR
operon, which can be induced by D-arginine and D-Lysine. The gene products DauA and DauB
provide a unique coupled anabolic and catabolic system that enables PAO1 to utilize D-arginine
as the only source of carbon and nitrogen. Li & Lu also reported that the DauBAR operon is
conserved among several other bacterial species16, 23, 36.

Scheme 2.1 D-Arginine racemization with the two-enzyme racemic system in Pseudomonas
aeruginosa.
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2.4
2.4.1

Structural features of PaDADH
Overall fold of PaDADH
The three-dimensional structure of PaDADH was determined by X-ray crystallography at

high resolution without added D-amino acids (~ 1.06 Å, PDB ID: 3NYC) 36. However, extra
density for a low occupancy iminoarginine was found in the active site. Ligand-free and bound
forms were obtained, the latter of which was probably due to the product of the enzymatic
reaction being trapped during the expression of the enzyme by E. coli.36 The PaDADH crystal
structures were also determined for crystals grown in presence of D-arginine and D-histidine
thereby yielding a PaDADH/iminoarginine (PDB ID 3NYE)36 and PaDADH/iminohistidine
(PDB ID 3NYF)36 complexes. Additionally, a covalent N5 flavin adduct was obtained at atomicresolution in the enzyme co-crystallized with D-leucine instead of the expected iminoleucine
(PDB ID 3SM8)37. Table 2.1 summarizes the crystal structures of PaDADH available in the
PDB. The four structures of hexahistidine-tagged PaDADH are highly similar, with RMS
deviations of less than 0.14 Å for 381 αC atoms, and display a non-covalently bound FAD as the
cofactor36. All 375 residues of PaDADH were well defined in the electron density map and
organized in two domains. The FAD-binding domain is formed by a central six-stranded β-sheet
surrounded by three-stranded antiparallel β-sheets with two α-helices on one side and five αhelices on the other side (Figure 1A). The substrate binding domain is composed of eightstranded β-sheets and two short antiparallel β-strands that constitute a sandwich surrounded by
four α-helices and four loops (L1 to L4)36 (Figure 2.1A).
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Table 2.1 Crystal structures of PaDADH deposited in PDB
PDB ID
3NYC
3NYE
3NYF
3SM8

Resolution (Å)
1.06
1.30
1.30
1.07

Redox state of flavin
Mixed*
Reduced
Reduced
Reduced

Ligand
Iminoarginine
Iminoarginine
Iminohistidine
D-leucine
leucine N5 flavin adduct

*Ligand-free and product-bound
bound conformations for PaDADH.
DADH. The crystal structures of
PaDADH
DADH exhibit all the same space group P212121.

Figure 2.1 Overall structure and active site of PaDADH
DADH in complex with iminoarginine.
(A) The PaDADH
DADH structure is shown in cartoon diagram and surface representation. Carbon
atoms are colored blue for the FAD
FAD-binding domain and gray for the substrate--binding domain.
Iminoarginine and FAD stick representations are illustrated in green and yellow, respectively.
Loops that contribute to the active site are highlighted in magenta. (B) Close up view of the
active site showing the substrate interactions of the active site residues and FAD with the
iminoarginine product. Protein side chains are displayed in sticks.
2.4.2

FAD-binding domain
The crystal structures of PaDADH
DADH show a noncovalently bound FAD as the cofactor36.

The flavin adopts an elongated conformation with the isoalloxaz
isoalloxazine
ine moiety located at the
interface of the substrate-binding
binding domain and the FAD
FAD-binding
binding domain. The adenosine portion
of the FAD moiety is buried deep within the FAD
FAD-binding domain36 (Figure 2.1A).
2.
The major
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interactions involved in the flavin
flavin-apoprotein complex are shown in Figure 2. The ribose ring
moiety has hydrogen bond interactions with the main
main-chain
chain of R33 and A171, water molecules
and the side chain of E32. The pyrimidine portion of the isoalloxazine moiety interacts through
hydrogen bonds with backbone aatoms
toms of the I335, Q336, His48 and a water molecule while the
benzene portion forms van der Waals contacts with R44, R222, W301, G303 and R305 (Figure
(
2.1B)36. Crystallographic data of PaDADH
DADH demonstrate that the isoalloxazine moiety of the
FAD is in a non-planar conformation with a ring puckering angle of 15° along the N5 – N10
axis, defining two planes containing the benzene and pyrimidine moieties 36. The bent
conformation is in agreement with other flavin
flavin-dependent
dependent enzymes structures containing flavin
in the reduced state38, 39.

Figure 2.2 Interactions of FAD with apoprotein.
Apoprotein carbons in PaDADH
DADH are in grey and FAD moiety carbons are in yellow. The red
spheres represent water molecules.
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2.4.3

Substrate binding-domain
The substrate-binding domain of PaDADH is formed by a small entrance that extends at

the bottom near the isoalloxazine moiety of the FAD, adopting a triangular cross section shape
with ~10 Å deep from the αC of G54 to the FAD O2 atom 36. The carboxylate group of the
iminoarginine product occupies the same plane as the isoalloxazine moiety of the FAD, while its
side chain is almost perpendicular to the FAD (Figure 2.1B)36. The side chain atoms of Y53,
R222, Y249, R305 and main-chain of G332 form polar interactions with the iminoproduct
carboxylate group (Figure 2.1B)36. The side chain of the iminoarginine product has hydrophobic
interactions with V242 and Y53 side chain, hydrogen bond interaction with T50 and ionic
interaction with E87 side chain36(Figure 2.1B). Two water molecules are located near the imino
group of the product and form a hydrogen bond network extending to the side chain of H48 36.
The entrance of the active site is controlled by a flexible loop L1, which is formed by residues
33-56. The loop L1 has two different peptidyl regions including residues 45-47 and residues 5056 adopting two conformations depending on whether the substrate is present or not in the active
site36.
2.4.4

Structural Comparison of PaDADH with D-amino Acid Oxidase (DAAO)
Previous crystallographic analysis showed that PaDADH has a high three-dimensional

structural similarity compared to DAAO36. The crystal structure of PaDADH (PDB ID 3NYE)
and pDAAO (PDB ID 1DDO) were used for an in-depth comparison of the overall structure and
the active site36,

40, 41

. pDAAO and PaDADH share 17.2 % sequence identity with a RMS

deviation value of 2.4 Å for 270 αC atoms

36

. PaDADH and DAAO were chosen since both

enzymes catalyze the same chemical reaction except that DAAO utilizes molecular oxygen as its
electron acceptor. As shown in Figure 3A, the overall structure of PaDADH is similar to
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pDAAO. The isoalloxazine moiety of the FAD is located at the interface between the FADbinding domain and the substrate-binding domain in both enzymes 36. The main difference
between the two structures is observed in the FAD-binding domain as indicated in Figure 3A
where three antiparallel β-sheets in PaDADH are replaced by an α-helix in DAAO36. The
substrate binding-domain in both PaDADH and pDAAO is characterized by the presence of a
large β-sheets36 (Figure 2.3A).

Figure 2.3 Comparison of the three-dimensional structure of pDAAO (light-blue, PDB ID
1DDO) with PaDADH (gray, PDB ID 3NYE).
(A) represents the overall structure of the two enzymes and (B) represents the active sites of the
enzymes. For clarity, Y53 from PaDADH was omitted. Iminoacid carbons in PaDADH are in
green, iminotryptophan carbons in pDAAO are in magenta and FAD moiety carbons are in
yellow and orange in PaDADH and pDAAO, respectively.
The active site of PaDADH in complex with iminoarginine and pDAAO in complex with
imonotryptophan showed that the ligands in both enzymes bind at the re face of the isoalloxazine
ring of the FAD moiety36, 40 (Figure 2.3B). The carboxylate groups of the iminoproducts in both
enzymes lie almost on the same plane and parallel to the isoalloxazine moiety (Figure 2.3B). On
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the contrary, the side chains of the iminoproducts are quasi-perpendicular to the isoalloxazine
moiety of the FAD (Figure 2.3B). In pDAAO only one arginine side chain residue, R283,
interacts with the iminoproduct carboxylate group whereas in PaDADH two arginine residues,
R222 and R305, participate in the interaction (Figure 2.3B)36. pDAAO has polar interactions
with the iminotryptophan product formed by the side chain residues of Y224, Y228, and the
main chain oxygen atom of G313, which are similar to the interaction in PaDADH formed by
the side chains of Y53,Y249 and main chain oxygen of G332 (Figure 2.3B). The side chains of
the A49, L51, I215, I230 and Y224 in pDAAO form a hydrophobic cage interacts with the
iminotryptophan product. PaDADH has a similar hydrophobic cage, but a key difference being
the presence of E87 and T50 in PaDADH in place of I230 and L51 in pDAAO, respectively36, 40
(Figure 2.3B).
2.5

Substrate specificity of PaDADH
PaDADH exhibits broad substrate scope, being most active with large basic and

hydrophobic substrates, and demonstrates the highest activity with D-arginine and D-lysine 42
(Table 2.2). PaDADH is strictly stereospecific and L-amino acids are not substrates 36. PaDADH
cannot oxidize the anionic amino acids aspartate and glutamate. The anionic amino acids are
oxidized by specific D-aspartate and D-glutamate oxidases12, 21. The portion of the PaDADH
active site that binds the main chain follows intuition for the most part by providing a protein
positive charge(s) from R222 and R305 to bind the carboxylate of the substrate, and hydrogenbonds from Y53 and the main chain O atom of G332 to bind the amino group. The portion of the
active site that binds the side chain of the substrate is fine-tuned to bind arginine with E87
positioned to form an electrostatic interaction at a distance of 2.5 Å with the guanidinium headgroup of arginine (Figure 1B)36. The relatively large active site volume and the presence of a
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hydrophobic cage comprised of residues Y53, Y254, M240, and V242 grants PaDADH the
ability to oxidize large hydrophobic amino acids as well 43. The large active site of PaDADH and
lack of a handle on glycine is likely the reason glycine cannot find an optimal configuration to be
oxidized and smaller hydrophobic substrates are oxidized slowly by PaDADH36. Based on
crystallographic and computational evidence PaDADH is proposed to be further modulated by a
flexible loop to enhance the substrate scope by providing active site plasticity36.
Table 2.2 Steady-state kinetic parameters for PaDADH with various D-amino acids.
Substrate
kcat/Km, M-1 s-1
kcat, s-1
Km, mM
D-arginine
(3.4 ± 0.3) x 106
204 ± 3
0.06 ± 0.01
D-lysine
(5.3 ± 0.2) x 105
141 ± 3
0.26 ± 0.01
D-tyrosine
27600 ± 3800
23 ± 1
0.8 ± 0.1
D-methionine
14800 ± 600
154 ± 3
10 ± 1
D-phenylalanine
6900 ± 300
75 ± 3
11 ± 1
D-histidine
3140 ± 30
35 ± 1
11 ± 1
D-leucine
515 ± 60
6.4 ± 0.3
12 ± 1
D-proline
420 ± 10
-a
D-tryptophan
245 ± 3
D-isoleucine
195 ± 3
D-glutamine
186 ± 3
D-valine
47 ± 1
D-alanine
41 ± 1
D-asparagine
16 ± 1
D-serine
3.8 ± 0.1
D-threonine
0.75 ± 0.01
D-glutamate
D-aspartate
L-arginine
glycine
D-cysteine
ndb
nd
nd
Enzyme activity was measured varying concentrations of the desired amino acid and 1 Mm PMS
in 20 mM Tris-HCl, pH 8.7, at 25 oC. bCannot be saturated with substrate thereby kcat and Km
values are not reported. cNot determined. PMS was reduced nonenzymatically by cysteine.
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2.5.1

E87 dictates substrate specificity
D-Arginine and D-lysine are the best substrates for PaDADH as gauged by their large

kcat/Km values in the 106 M-1 s-1 range36. The kinetic parameter kcat/Km defines the ability of the
enzyme for capturing the substrate to form the enzyme-substrate complex that proceeds to
catalysis. D-Arginine exhibits the largest kcat/Km value at pH 8.7 of 3.4 x 106 M-1 s-1, about 7-fold
higher than the next closest kcat/Km value belonging to D-lysine36. The bi-dentate electrostatic
interaction that arginine engages with E87 is likely more energetically favorable than the monodentate interaction involved with D-lysine and may account for the differences in kinetic
parameters. Replacement of E87 with leucine resulted in a 20-fold decrease in the kcat/Km value
with D-arginine, yet the value is still in the 105 M-1 s-1 range, hence the contributions of the
hydrophobic cage and other H-bonds to bind the D-arginine side-chain, such as T50 shown in
Figure 4, may be underestimated42.
The kcat/Km value with D-histidine as a substrate may suffer simply because it cannot
interact with E87 due to distance requirements42. In the crystal structure of the iminohistidine
complex as shown in Figure 4, the iminohistidine product is present in two distinct
conformations, one of which does not point towards E87 and may partially explain the 1000-fold
lower kcat/Km values with D-histidine as compared to D-arginine36. Further evidence of a distinct
binding behavior for D-histidine comes from the inverse solvent viscosity effect on the kcat/Km
value, Such a solvent effect is not seen with D-arginine as a substrate 36.
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Figure 2.4 Overlay of the crystal structures of PaDADH
DADH in complex with iminoarginine and
iminohistidine.
PaDADH
DADH residues line the interior of the substrate binding pocket. (Some residues were omitted
for clarity). Iminoarginine and iminohistidine bind in two distinct conformations. The surface of
the substrate binding pocket is in blue and the surface of the FAD binding domain is in white.
Iminoacid carbons are in green, FAD carbons are in yellow, and side chain carbons are in grey.
The arrow indicates the entrance to the active site.
2.5.2

A hydrophobic cage and a flexible loop extends substrate scope
In addition to exceptional kinetic parameters for amino acids bearing positively charged

side chains, PaDADH
DADH can efficiently oxidize the bu
bulky
lky aromatic substrates tyrosine and
phenylalanine, and the sulfur-containing
containing methionine ((Table 2.2)36. The ability of PaDADH to
accommodate hydrophobic amino acid substrates is rooted in the presence of a hydrophobic cage
as mentioned above (Figure 2.3B
3B). The D-phenylalanine and D-tyrosine
tyrosine substrates most likely
form π-ππ stacking interactions with either or both of Y53 and Y249 36. D-Tyrosine
Tyrosine can also
potentially form hydrogen bonds with one or both of the Y53 and Y249 residues. D-Methionine
D
is also a good substrate, making
ing it likely that the sulfur of methionine engages in favorable
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sulfur-π interactions with the aromatic rings of Y53 and Y24942,

44

. The flexible loop L1 of

PaDADH is present in two alternate conformations and is proposed to act as a gate to control
substrate entry/exit and substrate accommodation36. A similar loop is found in pDAAO
composed of residues 216-22840. Loop L1 in PaDADH may help lock small substrates in place
by closing tightly, whereas in the case of large substrates like D-tyrosine and D-tryptophan the
loop may protrude outward36.
2.5.3

Substrate specificity comparison to D-amino acid Oxidases
The specificity of PaDADH for large and basic substrates is in contrast to the pDAAO

and human DAAO enzymes which show a preference for smaller hydrophobic substrates i.e., Dalanine, and likewise possess small active site volumes of 160 and 220 Å 3, respectively7. The
substrate specificity of the yeast enzymes, RgDAAO and TvDAAO, demonstrate a preference for
amino acids bearing large and bulky hydrophobic side-chains such as valine, phenylalanine and
tryptophan45. Naturally, the key factors that determine the specificity of each of the enzymes
seem to lie within the interactions of the substrate side-chain with the active site residues and the
relative sizes of the active site pockets.
2.6

Steady-state kinetic mechanism of PaDADH
The steady-state kinetic mechanism of PaDADH is consistent with the minimal ping-

pong bi-bi kinetic mechanism depicted in Scheme 246. Evidence for a ping-pong mechanism
stems from the occurrence of parallel lines in the double reciprocal plots of the enzymatic rates
versus varied concentrations of D-arginine or D-histidine at different fixed concentrations of
PMS as electron acceptor. The artificial electron acceptor PMS was utilized because the
physiological oxidizing substrate is unknown. As shown in Scheme 2, the irreversible release of
the iminoacid product (k5) must occur before the second substrate, PMS, binds to enzyme (k7)46.
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In agreement with a ping-pong mechanism, the binding of PMS was not significantly altered
when either D-arginine or D-histidine was used as the reducing substrate, yielding a Km of
around 10 µM in both cases. Flavin reduction (k3) was demonstrated to be irreversible with Dhistidine as substrate using rapid kinetics approaches46. This conclusion can be extended to the
faster substrate D-arginine, since it was shown that 85% of the reduction of the flavin occurs
within the dead time of the instrument (2.2 ms)46. The reoxidation of the flavin (k9) is also
presumed to be irreversible after examination of the reduction potentials of PMS/PMSH 2 >
FAD/FADH2, with values of +80 and -200 mV respectively47. However, it is worth noting that
the reduction potentials could potentially be far different when buried within the enzyme
environment.

Scheme 2.2 Steady-state kinetic mechanism of PaDADH.
PaDADHox, oxidized D-arginine dehydrogenase; S, amino acid substrate; PaDADHred, reduced
D-arginine dehydrogenase; P, iminoacid product; PMS, phenazine methosulfate. k5 and k11 are
shown as irreversible because products are assumed to be close to zero during the determination
of the initial rates of reaction; k4 is shown although it is close to zero based on stopped-flow
data46.
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2.6.1

Product release
The release of the iminoacid product (k5) is partially rate determining for overall turnover

with D-arginine as substrate. Evidence for this conclusion comes from the effect of increasing
solvent viscosity on the normalized rate constant for overall turnover when the enzyme is
saturated with substrates21. Product release is the only diffusion-controlled step present in the
proposed steady-state kinetic mechanism of PaDADH46. The kcat value for D-arginine exhibits a
linear dependence on increasing viscosity yielding a positive slope of 0.14, consistent with
product release being partially rate-determining, or about 14% responsible for the rate 46.
Furthermore, the kred value for D-arginine is not measurable using stopped-flow reaction
techniques due to the reduction occurring within the dead-time of the instrument, consistent with
an estimated value for flavin reduction > 800 s-1 48. Thus, another step other than product release
may also be contributing to the overall rate of turnover with D-arginine but has yet to be
elucidated. In the case of D-histidine, increasing solvent viscosity elicited no effect on kcat,
indicating product release was not limiting for turnover48. Comparison of the kred value of 60 s-1
with D-histidine and its corresponding kcat of 35 s-1 implies that flavin reduction is at least
partially rate-limiting with D-histidine as substrate46. Yet this also implies there is another step
that occurs prior to product release and after substrate binding, such as an internal isomerization
of the enzyme, that contributes to the overall turnover with D-histidine as well.
2.6.2

Substrate inhibition via a dead-end complex
At sufficiently high concentrations of D-arginine ( > 0.5 mM) during steady-state

turnover, substrate inhibition of PaDADH occurs46. The excess D-arginine binds to the free
reduced enzyme to form a dead-end complex PaDADHred-D-Arg as shown in Scheme 2. The
accumulation of the dead-end complex leads to a lower overall rate of turnover. Substrate
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inhibition due to the formation of dead-end complexes between the reduced enzyme and
substrate has been observed in other flavoproteins such as nitroalkane oxidase, flavocytochrome
b2, thymidylate synthase, aldehyde oxidase, and cellobiose dehydrogenase 49-53.
2.7
2.7.1

Catalytic mechanism
Mechanism CN bond cleavage
The reductive-half reaction of PaDADH was investigated to gain insight on the

mechanism of CN bond cleavage. During flavin reduction with either D-leucine or Dhistidine, C4a or flavin N5 adducts were not observed, which is consistent with a hydride
transfer mechanism (Scheme 3). pH-profile and computational studies showed that the hydride

transfer in PaDADH is triggered by the abstraction of the substrate -NH3+ group proton
(Scheme 2.3). Moreover, substrate, solvent and multiple kinetic isotope effects studies on wildtype PaDADH were consistent with the NH and CH bond cleavage of the substrate occurring
asynchronously with irreversible flavin reduction (refs). In order to investigate on the status of

the base that abstracts the substrate -NH3+ group proton (Scheme 2.3), Y53F and Y249F
variant enzymes were generated through site-directed mutagenesis. Indeed, the crystal structure
of PaDADH showed that the hydroxyl groups of Y53 and Y249 residues are at a distance ≤ 4 Å
from the substrate amino group consistent with the Y53 and Y249 residues to act as a base 25, 36.
The pH-profile studies on the reductive-half reaction of the Y53F and Y249F variant enzymes,
and subsequent steady-state kinetic studies on E87L and H48F enzymes, established that Y53,

Y249, E87 or H48 residues were not the base25, 42. Thus, it was proposed that the -NH3+ group
of the substrate loses its proton to the solvent to trigger amine oxidation in PaDADH25, 42, 48.
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Scheme 2.3 Hydride transfer mechanism in PaDADH.
B- is a catalytic base, currently assumed to be a solvent molecule.
Similar to the wild-type PaDADH, no flavin intermediates were observed in the Y53F
and Y249F variants, consistent with a hydride transfer mechanism. On the contrary, flavin
reduction was reversible in both the Y53F and Y249F variants. Moreover, the solvent and
multiple kinetic isotope effect studies on the Y53F and Y249F variants demonstrate a
synchronous CH and NH bond cleavage, consistent with a hydride transfer, and an alteration in
the relative timing of the two bond cleavages as compared to the wild-type enzyme 25. Based on
this observation, it was concluded that the two tyrosine residues are involved in the stabilization
of the transition state in PaDADH to facilitate the hydride transfer from the substrate αC to the
N5 atom of the isoalloxazine moiety of the FAD25.
2.7.2

Restricted proton transfer
The pH-profile studies on the substrate affinity value, Kd, and computational studies

indicate that PaDADH prefers to bind the protonated form of the substrate (i.e., -NH3+)48. As
shown in Scheme 4, after formation of the ESH + complex the substrate then loses a proton to
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form the ES complex that proceeds to catalysis. A prominent hollow observed in the kcat pHprofiles with D-lysine as a substrate with the wild-type PaDADH provides evidence that the
equilibration of the proton within the enzyme-substrate complex (i.e., k16/k15) is slower than other
relevant kinetic steps42 (Scheme 2.4). Moreover, a requirement for the hollow is usually
observed with sticky substrates, which have a very high capacity to proceed to catalysis (i.e., k3)
after the formation of the enzyme-substrate complex in comparison to its dissociation (i.e., k2) to
free enzyme and substrate54-56.

Scheme 2.4 Reductive half-reaction of PaDADH accounting for a slow proton equilibrium in the
Michaelis complex.
S is the D-amino acid substrate. P is the iminoacid product.
The pH-profiles on the variant enzymes H48F and E87L provide further evidence that the
hollow is related to a sub-optimal binding of the substrate in the active site of the enzyme 42. The
E87 residue stabilizes D-arginine by engaging in an ionic interaction with the substrate guanido
group, thereby replacement of the E87 side chain to leucine impaired the optimal binding of the
substrate, resulting in a slow proton release to the solvent 42. It was shown that the hollowed pHprofile of the H48F variant, which is not in direct contact with the substrate, is likely due to the
disruption of the H-bond network between the water molecules, H48 residue and the amino
group of the substrate (Figure 2.5)36, 42. The H-bond network is important to optimize substrate
binding and to prevent a slow proton release from the enzyme-substrate complex 42 (Figure 2.5).
As shown in the crystal structure, E87 residue has an ionic interaction with the substrate guanido
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group, while H48 residue interacts indirectly with the substrate via two water molecules (Figure
(
2.5)36. Thus, it was concluded that both H48 and E87 residues pa
participate
rticipate in the optimal
orientation of the substrate to prevent a slow proton exchange between the ESH + complex and
the solvent42 (Figure 2.5).

Figure 2.5 PaDADH loop L1 with S45, A46 and H48 residues.
The isoalloxazine moiety of the FAD is in yellow, and the iminoarginine product is in green.
Loop L1 is in magenta with H48 interacting with the iminoarginine product through two water
molecules.
2.8

Role of loop L1 dynamics
ynamics in PaDADH
The crystallographic data showed that PaDADH
DADH has an active site loop L1 with
wit two

flexible segments that span the FAD
FAD-binding domain and the substrate-binding
binding domain36. Loop
L1 was also shown to occupy two distinct conformations corresponding to an open, competent
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substrate binding conformation, and a catalytic ligand-bound closed conformation36 (Figure 2.6).
Y53 residue in loop L1, located at the entrance of active site
site, was proposed to act as a gate to
control the access to the active site36. In the FAD-binding
binding domain the side chains of S45 and A46
residues in loop L1, which do not interact directly with the substrate, adopt two alternate
conformations depending on whether the ligand is present in the active site or not (Figure
(
2.6)36.
Thus, the alternating conformations of S45 and A46, known as the S45/A46 switch was also
considered to participate in the catalytic function of PaDADH36.

Figure 2.6 Open-closed
closed conformations of loop L1.
The open conformation is shown in blue and the closed conformation in magenta. The carbons in
the isoalloxazine ring of the FAD are shown in yellow.
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2.8.1

S45/A46 switch and the Y53 gate
In the open conformation, as shown by the crystal structure, both the side chains of S45

and A46 located at the FAD-binding domain point away from the isoalloxazine moiety, while the
side chain of Y53 points away from the active site pocket toward the bulk solvent (Figure 2.6)36.
In the closed conformation, S45 and A46 side chains move closer to the isoalloxazine moiety and
the side chain of Y53 gate swings back into the active site pocket to interact with the carboxylate
group of the iminoarginine product

36

. S45 and A46 residues were mutated individually to

alanine and glycine, respectively, to investigate the dynamics of loop L1
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. The molecular

dynamics data indicate that in both S45A and A46G variants the Y53 gate has a higher
probability to be in the open conformation as compared to the wild-type, where the gate has
almost equal probability to be in the open and closed conformations during the simulation time 57.
Thus, it was concluded that the conformations of the S45/A46 switch and the Y53 gate are
coupled57. Moreover, the intensity of the fluorescence spectroscopy showed an increase of ~ 2fold in the S45A and A46G variant enzymes compared to the wild-type when the flavin was
excited at its lower energy peak in the enzyme bound-flavin57. The emission peak of the flavin
fluorescence of the enzyme-bound flavin was red-shifted from 513 nm in the wild-type to 522
nm in both the variant enzymes (Figure 2.7). It was concluded that the active site in the S45A
and the A46G variant is more exposed to the solvent due to the higher probability of Y53 gate to
stay in the open conformation with respect to wild-type PaDADH57.
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Figure 2.7 Probability distribution of the S45A, A46G variant enzymes and the wild-type.
S45A variant is colored in blue, A46G variant in read and the wild-type in black. The inset
represents the flavin fluorescence of the variants and the wild-type enzyme.
2.8.2

Dynamics of loop L1 in substrate capture and catalysis
The dynamics of loop L1 participate in the optimal orientation of the enzyme-substrate

complex, as evidenced by molecular dynamics simulations and steady-state kinetic approaches 57.
The pH-independent kcat/Km values were lowered by 11- to 13-fold in the S45A and A46G
variants compared to the wild-type42, 57. Based on the decreased kcat/Km values observed in the
S45A and A46G variants, it was proposed that the likelihood of substrate capture in the variants
is impaired due to the higher probability of the Y53 gate to be in the open conformation as
compared to the wild-type enzyme57. A hollow was observed in the kcat pH-profiles for both the
S45A and A46G variants, consistent with a restricted proton transfer from the enzyme-substrate
complex to the solvent57. To gain insight on the effect of loop L1 dynamics on the rate of flavin
reduction, the reductive half-reaction of both variants was investigated. No conclusions could be
gained on the status of flavin reduction since both variants could not be saturated with the slow
substrate D-leucine57.
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The movement of side chain residues in mobile loops has been shown to participate in the
catalytic function of several enzymes58. In RgDAAO, Y238 was proposed to act as a gate that
may control substrate entrance and product exit from the active site, and the corresponding
residue in pDAAO, Y224, was proposed to contribute to the active site plasticity responsible for
the binding of various substrates40, 59. Y215 in lactate oxidase and E89 in phosphoenolpyruvate
carboxykinase, which are not in direct contact with the substrate, help to optimize substrate
binding60, 61. Residues on flexible loop portions located at the entrance of enzymes not only act
as gates but have been shown to shield the active site from the solvent upon binding of the
substrate58, 62-64.
2.9

Open questions
Although the mechanistic and structural features of PaDADH have been established, the

physiological electron acceptor of the enzyme has yet to be identified. In vitro, PMS has been
used as an artificial electron acceptor. Based on the abundance of quinones in nature and their
participation in many electron transport systems, quinones could possibly act as potential
physiological electron acceptors. Oxygen reactivity could be useful in exploiting the enzyme
function in industrial use to separate racemic mixtures. Engineering flavoprotein dehydrogenases
to react with molecular oxygen to this day remains a challenging endeavor. Previous studies have
established that there is no catalytic base in PaDADH and the proton is simply transferred from
the substrate amino group to the solvent in the active site of the enzyme. Investigation into
identifying if there is a catalytic base functioning in PaDADH is still under work. PaDADH is
part of a novel two-enzyme racemic system involved in D- to L-arginine racemization, since
most of the racemization is catalyzed by a single enzyme. The presence of two enzymes instead
of one could potentially serve as a regulatory mechanism. Further investigation of PaDADH and
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engineering variants that display oxygen reactivity can be utilized for enzymatic synthesis of
various α-keto acids and the separation of racemic amino acid mixtures which are of potential
interest to the industry.
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3

IMPORTANCE OF GLUTAMATE 87 AND THE SUBSTRATE α-AMINE IN THE
REACTION CATALYZED BY D-ARGININE DEHYDROGENASE

(This chapter has been published verbatim in Ball J., Bui Q.V., Gannavaram S., and Gadda G.
(2015), Arch Biochem Biophys, 568, 56-63; the author contributed the pH effects with Darginine and D-Lys, and the pH effects with the H48F variant.)
3.1

Abstract
Pseudomonas aeruginosa D-arginine dehydrogenase (PaDADH) catalyzes the oxidation

of D-arginine to iminoarginine, which is non-enzymatically hydrolyzed to 2-ketoarginine and
ammonia. Here, site-directed mutagenesis and pH effects were used to investigate binding and
catalysis of zwitterionic and cationic substrates for the enzyme. An unprotonated group with
apparent pKa value ≥7.9 is required for binding D-arginine or D-lysine, but not D-methionine or
D-leucine. This group is E87, as suggested by its replacement with leucine. An unprotonated
group with pKa of 9.5, which persists in the H48F and E87L variants, is required for amine
oxidation with all substrates. Since Y53 and Y249 were previously ruled out, the pKa is assigned
to the substrate α-NH3+ group, which previous QM/MM and Kd pH-profile demonstrated to be
protonated for preferred binding to the enzyme. Lack of pH effects on the Dkred with D-leucine
established 9.5 as the intrinsic pKa, and D-leucine as a non-sticky substrate. D-Arginine, D-lysine
and D-methionine and their corresponding iminoproducts were significantly stickier than Dleucine, as indicated by apparent pKa values <9.5 in both kcat/Km and kcat. Restricted proton
movements in catalysis were established from hollowed kcat pH profiles in wild-type PaDADH
with D-lysine and in the H48F and E87L enzymes with D-arginine.
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3.2

Introduction
Pseudomonas aeruginosa D-arginine dehydrogenase (PaDADH) catalyzes the flavin-

mediated, oxidative deamination of D-arginine to iminoarginine, followed by the non-enzymatic
hydrolysis in solution of the imino product to give 2-ketoarginine and ammonia (Scheme 3.1).[1]

Scheme 3.1 Oxidation of D-Arginine by PaDADH.
All the standard D-amino acids except D-glutamate, D-aspartate, and glycine are
oxidized by the enzyme,[1, 2] with D-arginine and D-lysine displaying the highest rate constants
for substrate capture, kcat/Km, of 105-106 M-1s-1.[2] PaDADH is one of the few known enzymes
that can oxidize cationic D-amino acids with great efficiency, sharing strikingly similar substrate
specificity to D-amino acid oxidase (DAAO) from Arthrobacter protophormiae.[3] Acidic Damino acids are oxidized by the highly selective D-aspartate oxidases.[4, 5] L-Amino acids are
not substrates for PaDADH.[2] PaDADH is a strict dehydrogenase because during turnover it
reacts with an electron acceptor other than molecular oxygen, presumably ubiquinone in vivo.[6]
The enzyme follows a Ping-Pong Bi-Bi steady-state kinetic mechanism, as demonstrated with Darginine or D-histidine as substrate and phenazine methosulfate (PMS) as electron acceptor.[6]
In the reductive half-reaction the enzyme-bound flavin (PaDADHox) is reduced to hydroquinone
with concomitant oxidation of the amino acid to the imino acid (PaDADHox-P), as shown in
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Scheme 3.2. In the oxidative half-reaction, the reduced flavin is oxidized (in vitro) by PMS
(Scheme 3.3).

Scheme 3.2 Reductive half-reaction of PaDADH.

Scheme 3.3 Oxidative half-reaction of PaDADH.
Flavin reduction is irreversible with D-histidine or D-leucine as substrate, as established by a
zero intercept value in a plot of the observed rate constant for flavin reduction as a function of
substrate concentration.[6] With D-arginine, however, the reaction is too fast and cannot be
studied in a stopped-flow spectrophotometer due to >80% of the flavin being completely reduced
within the mixing time of the instrument (i.e., 2.2 ms), as previously reported.[6] Amine
oxidation has been studied with D-leucine, which is amenable to mechanistic investigation using
a stopped-flow spectrophotometer, with pH, substrate and solvent kinetic isotope effects, as well
as computational studies.[7] Free energy calculations and the pH profile for Kd are consistent
with the enzyme binding preferentially the zwitterionic form of D-leucine.[7] After isomerization
of the enzyme-substrate complex, amine deprotonation triggers the oxidation reaction, with
cleavages of the NH and CH bonds of D-leucine occurring asynchronously, as suggested by
multiple deuterium kinetic isotope effects on the rate constant for flavin reduction.[7] In this
respect PaDADH is similar to proline dehydrogenase,[8] but different from other flavindependent amine oxidases, such as DAAO or monomeric sarcosine oxidase, for which amine
oxidation occurs from the anionic substrate.[9]
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The three-dimensional structures of PaDADH in complex with iminoarginine or
iminohistidine, or in the unliganded form, have been previously solved at high resolution (1.061.3 Å), along with an atomic-resolution structure of a 4-methyl-2-pentanone-FAD adduct in the
enzyme co-crystallized with D-leucine.[2, 10] The structure of the enzyme in complex with
iminoarginine underlines the importance of the side chain carboxylate of E87 for binding the
cation of the iminoarginine side chain, as shown in Figure 3.1.[10]
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Figure 3.1 Interactions of iminoarginine with active site residues of PaDADH.
Carbon atoms are colored green for each of the PaDADH
DADH active site residues and magenta for
iminoarginine. FAD is represented by its isoalloxazine ring with the C atoms colored yellow. HH
bond and ionic interactions are shown as dashed lines. Two water molecules in the binding site
are shown as red spheres.. For clarity, panels A and B focus on different interactions. Note that
the side chain of M240 is present in two alternate conformations.
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Two tyrosine residues, i.e., Y53 and Y249, with the aid of M240 and V242 arrange into a
hydrophobic pocket that surrounds the central part of the iminoarginine side chain. The imine of
the imino-product is connected to H48 through two intervening water molecules (Figure 3.1B).
The imino-product Cα atom is close to the flavin N(5) atom, presumably indicating where the Cα
atom of the amino acid substrate resides during catalysis. The structure of the enzyme in
complex with iminohistidine demonstrates that the imidazole of the ligand is present in two
alternate conformations, with H-bonding interactions with the side chains of H48, T50, and
either E87 or Q336. A mobile loop, composed of residues 50-56, is present in two alternate
conformations in the unliganded and product-bound enzyme structures.[2] This flexible loop
forms an active site lid and is proposed to play an important role for substrate specificity and
recognition, allowing the enzyme to accommodate bulky substrates like phenylalanine or
tryptophan.[2]
In this study, we have used mechanistic approaches to investigate further the reaction of
amine oxidation catalyzed by PaDADH. Effects of pH were determined on the steady-state
kinetic parameters with selected substrates and on the kinetic isotope effects associated with
flavin reduction using D-leucine. Mutagenesis of specific residues hypothesized to be important
for catalysis or binding has been carried out to facilitate in the assignment of the observed pKa
values. The results shed light on the ionization states of groups that are relevant to amine
oxidation and provide further mechanistic insight on the catalytic mechanism for amine
oxidation by PaDADH.
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3.3
3.3.1

Experimental Procedures
Materials
D-Methionine and D-leucine were purchased from Sigma-Aldrich (St. Louis, MO). D-

Arginine and D-lysine were obtained from Alfa-Aesar (Ward Hill, MA). D-Leucine d10 was
obtained from CDN Isotopes (Pointe-Claire, Canada). PaDADH-wt was prepared as described
previously.[2, 6] All other reagents used were of the highest purity commercially available.
3.3.2

Steady-state kinetics
The steady-state kinetic parameters for D-arginine, D-lysine, or D-methionine were

measured polarographically on a computer-interfaced O2 electrode by using the method of initial
rates. The enzyme does not react with O2, hence as electron acceptor we used PMS, which
spontaneously reacts in its reduced form with molecular oxygen.[11] The reaction was initiated
by the addition of the enzyme, with final concentrations ranging from 5 nM to 2 μM depending
on pH and the substrate used, yielding a reaction volume of 1 mL. Substrate concentrations
ranged from 0.01-100 mM for D-arginine, 0.25-250 mM for D-lysine, 1-186 mM for Dmethionine, and 0.5-50 mM for D-leucine, ensuring that the Km values determined were within
the range of substrate concentrations used at any given pH. The same concentrations of Darginine were used as substrate for the H48F and E87L enzyme variants. The assays were carried
out at 25 o C in 20 mM sodium pyrophosphate (pH 8.5-10.0), 20 mM sodium phosphate (pH 6.08.5) or 20 mM piperazine (pH 4.75-6.0). The same buffers, substrate concentrations, and enzyme
concentrations were used for the assays performed at 6 oC. Substrate solutions were prepared in
buffer and the pH values were adjusted prior to addition to the reaction mixtures. The
concentration of PMS was kept fixed at 1 mM to ensure full saturation of the enzyme. Data for
D-leucine with the wild-type were taken from Yuan et al.[7]
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3.3.3

Kinetic isotope effects
The reductive half-reaction of PaDADH with D-leucine was monitored using an SF-

61DX2 Hi-Tech KinetAsyst high performance stopped-flow spectrophotometer thermostated at
25 oC. The observed first-order rate constants for flavin reduction (kobs) were determined at
varying concentrations of D-leucine or D-leucine d10 between 0.5 and 50 mM under pseudo firstorder conditions using the buffer system described above at pH 7.0, 8.5, and 10.0. Multiple
measurements typically differed by ≤5%.
3.3.4

Mutagenesis
Mutagenesis to prepare the H48F or E87L variants of the enzyme was performed

following the QuikChange protocol using the cloned wild-type gene pET20b(+)/PA3863 as
template. The forward primer for H48F was 5’-GCTCCGCCGCGTTCTACACGGTGGCCTA3’, while that for E87L was 5’-AGCCCGCGTCCGCTGATGGTGGTCGACTTC-3’ The
underlined portions represent the mutated sites. Oligonucleotide primers were purchased from
Sigma Genosys (The Woodlands, TX). Plasmids were purified using kits from Qiagen, Inc
(Valencia, CA). Sequencing was performed by the GSU Biology Core Facility using an Applied
Biosystems Big Dye Kit on an Applied Biosystems model ABI377 DNA sequencer. The
expression and purification of H48F and E87L mutant enzymes followed the same protocol as
the wild-type enzyme.[2, 6]
3.3.5

Data analysis
Kinetic data were analyzed with KaleidaGraph software (Synergy Software, Reading,

PA) and the Kinetic Studio Software Suite (Hi-Tech Scientific, Bradford on Avon, U.K.).
Stopped-flow traces were fit to eq 1, which describes a single exponential process where kobs
represents the observed first-order rate constant for flavin reduction at any given concentration of
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substrate, t is time, A is the absorbance at 446 nm at any given time, B is the amplitude of the
absorbance change, and C is the absorbance at infinite time, which in this case is the non-zero
absorbance of the fully reduced enzyme. Kinetic parameters for the reductive half-reactions were
determined by using eq 2, where kobs is the observed first-order rate constant for the reduction of
the enzyme-bound flavin at any given concentration of substrate (S), kred is the limiting firstorder rate constant for flavin reduction at saturating concentrations of substrate, and

Kd is the

app

apparent dissociation constant for binding of the substrate to the enzyme.
The apparent steady-state kinetic parameters at varying substrate concentrations were
determined by using the Michaelis-Menten equation for a single substrate. Previous results
demonstrated a Ping Pong Bi–Bi steady-state kinetic mechanism for PaDADH for both the fast
substrate arginine and the slow substrate histidine, with a Km value for PMS of ~10 µM.[6]
Consequently, and after considering the results of the pH effect obtained in this study, when the
steady-state kinetic parameters were determined at a fixed concentration of 1 mM PMS they
approximate well the true kcat, Km, and kcat/Km values for the amino acid substrate.
The pH profiles of the kcat values for D-arginine and kcat and kcat/Km values for Dmethionine were fit to eq 3, which describes a curve that increases at increasing pH with slope of
+1 and a limiting value (C) at high pH. The pH profiles of the kcat/Km values for D-arginine and
D-lysine were fit to eq 4, which describes a curve that increases at increasing pH with slope of
+2, a limiting value (C) at high pH and two indistinguishable pKa values. The pH profiles of the
kcat values for D-lysine with the wild-type enzyme and D-arginine with the H48F and E87L
enzymes were fit to eq 5, which describes a curve that increases with increasing pH to a limiting
value (C) to yield three pH dependent terms containing a hollow that is defined by β = 1 + k3/k2
and Kα = (k1/k7 )(1+k8/k5)K1. Here, pKe is the intrinsic pKa value for kcat, β reflects the stickiness
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of the substrate (k3/k2), and Kα describes the relative rates of the kinetic steps involved in the
equilibration of ESH+ complex. [12]
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Standard errors were obtained from KaleidaGraph's "General curve fit", which uses the
Levenburg-Marquardt algorithm.[13]
3.4
3.4.1

Results
Steady-state kinetics with D-leucine at variable concentration of PMS
The steady-state kinetic parameters for D-leucine as substrate for PaDADH were

measured at two concentrations of PMS (0.1 and 1 mM) at pH 6.0 and 10.0, in order to ensure
full saturation of PMS was achieved across the pH range used. As shown in Table 3.1, the
kinetic parameters were indistinguishable at both pH values, consistent with the enzyme being
fully saturated at 1 mM PMS. In agreement with these results, previous data with D-arginine and
D-histidine at pH 8.7 established a Km < 10 µM for PMS.[6] Since the enzyme follows a Ping
Pong Bi–Bi steady-state kinetic mechanism,[6] it is concluded that 1 mM PMS saturates the
enzyme irrespective of the substrate used within the pH range used in this study.
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Table 3.1 Apparent steady-state kinetic parameters at saturating PMS
[PMS] (mM)
0.1
1.0
0.1
1.0

pH
kcat (s-1)
Km (mM) kcat/Km (M-1s-1)
6.0 0.061 (±0.002) 1.8 (±0.2)
33 (±3)
6.0 0.059 (±0.002) 1.6 (±0.1)
36 (±3)
10.0 55 (±1)
4.6 (±0.3) 12,000 (±1,000)
10.0 53 (±1)
4.4 (±0.3) 12,000 (±1,000)

(R2)a
0.994
0.995
0.998
0.997

Experimental conditions: 20 mM sodium pyrophosphate in H2O at 25 oC. Data were acquired at
varying concentrations of D-leucine and fixed PMS concentrations of 0.1 and 1.0 mM yielding
overlapping saturation curves.
a
Coefficient of determination, which in the algorithm used in KaleidaGraph is:
R = 1−∑

(

)

, where χ is defined as Chi Square, σ is the weight, y is the actual value,

and y is the mean of actual values.
3.4.2

kcat/Km and kcat pH-profiles with cationic substrates
The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were

determined with D-arginine or D-lysine as substrate to establish relevant ionizations of groups
involved in binding or catalysis with substrates carrying a positive charge on the side chain. As
shown in Figure 3.2, the kcat pH-profile with D-arginine increased to a limiting value at high pH,
defining the requirement for an unprotonated group for catalysis. With D-lysine as substrate a
similar pattern was seen at low pH, with an unprotonated group required for catalysis having a
pKa similar to that seen with D-arginine, although the enzyme could not be saturated with Dlysine below pH 6.0 (Figure 3.2). Despite similar kcat values with the two substrates up to pH
7.5, turnover with D-lysine was significantly faster than with D-arginine at high pH, and the
curve demonstrated a hollow that yielded three pKa values. Both D-lysine and D-arginine had
kcat/Km pH-profiles increasing to limiting values with increasing pH (Figure 3.2). However, the
ascending limbs clearly showed the presence of two unprotonated groups rather than the single
one seen in the kcat pH-profiles. The apparent pKa values and the pH-independent, limiting values
of kcat/Km and kcat determined with D-arginine and D-lysine are summarized in Table 3.2.
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Figure 3.2 pH-profiles of kcat (A) and kcat/Km (B) with D-arginine (▲), D-lysine (∇), and Darginine (●) at 6 o C.
PaDADH activity was measured at varying concentrations of D-arginine or D-lysine and 1 mM
PMS at 25 oC, unless otherwise stated. Curves represent fits of the data to eqs 3-5.
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Table 3.2 pH Effects on kcat/Km and kcat of PaDADH
kcat/Km
pKa2

pKa1
pKa
cationic substrates
D-arginine
7.2b,c 7.2b,c 2,600,000 (±500,000)
6.3b,d
b,c
b,c
D-lysine
7.9
7.9
580,000 (±150,000) ~6.2e,f,g,h
o
b
b,c
D-arginine 6 C 6.9
6.9
140,000 (±40,000)
6.0b,d
zwitterionic substrates
D-methionine
7.7b,d –
36,000 (±6,000)
6.9b,d
i
d,j
j
D-leucine
~9.5
–
~11,000
~9.5d,j
a
pH-independent limiting value at high pH.
b
(±0.1).
c
Determined by using eq 4.
d
Determined by using eq 3.
e
Inferred by visual inspection of Figure 2A.
f
(±0.3).
g
Determined by using eq 5.
h
βpKα
i
From Yuan et al.[7]
j
Approximate value, due to plateau being not well defined.
3.4.3

(kcat/Km)Ha(M-1s-1)

pKα

kcat
pKe

–
8.7f,g
–

–
9.2f,g
–

160 (±20)
~550j

–
–

–
–

190 (±20)
~100j

(kcat)Ha(s-1)

kcat/Km and kcat pH-profiles with D-arginine at 6 oC
Previous studies on creatine kinase by Cook et al. demonstrated that altering temperature

may induce hollowed pH profiles of steady-state kinetic parameters.[14] In an effort to evaluate
if this could be the case for PaDADH with D-arginine, the pH profiles of the steady-state kinetic
parameters were determined at 6 oC. As shown in Figure 2A, no hollow was detected for the pH
profile of the kcat, which qualitatively looked similar to that obtained at 25 oC. Table 3.2
summarizes the apparent pKa values and the pH-independent, limiting values of kcat/Km and kcat
determined with D-arginine at 6 oC.
3.4.4

kcat/Km and kcat pH-profiles with zwitterionic substrates
The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were

determined with D-methionine or D-leucine as substrate to establish relevant ionizations of
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groups involved in binding or catalysis with substrates not carrying a positive charge on the side
chain. With both D-methionine and D-leucine, the pH-profiles of the kcat and kcat/Km values
increased with increasing pH, reaching limiting values at high pH, and demonstrating the
requirement for a single unprotonated group for catalysis (Figure 3.3).

Figure 3.3 pH-profiles of kcat and kcat/Km with D-methionine (●) and D-leucine (○).
PaDADH activity was measured at varying concentrations of d-methionine or d-leucine and
1 mM PMS at 25 °C. Curves represent fits of the data to Eq. 3.
3.4.5

kcat/Km and kcat pH-profiles with H48F variant

The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were
determined with D-arginine in the H48F variant to investigate if H48 acts as a catalytic base in
amine oxidation. The kcat/Km pH profiles of the H48F enzyme resembled that obtained with the
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wild-type enzyme; however, the kcat pH profile did not exhibit a pronounced hollow describing
three pKa values (Figure 3.4), as for the case of D-lysine with wild-type PaDADH. Thus, H48
was not responsible for the pKa values seen in the wild-type enzyme. Table 3.3 summarizes the
apparent pKa values and the pH-independent, limiting values of kcat/Km and kcat.
Table 3.3 pH Effects on kcat/Km and kcat of PaDADH Variants with D-Arginine as Substrate.
kcat/Km
kcat
pKa1 pKa2
(kcat/Km)Ha(M-1s-1)
βpKα
pKα
pKe (kcat)Ha(s-1)
PaDADH Variant
H48F
7.1b,c 7.1b,c 1,100,000 (±240,000)
6.1b,d 8.9b,d 9.4d,e ~150f
E87L
8.2g,h –
150,000 (±50,000)
~5.5i
9.0b,d 9.7d,h ~150f
a
pH-independent limiting value at high pH.
b
(±0.1).
c
Determined by using eq 4.
d
Determined by using eq 5.
e
(±0.3).
f
Approximate value, due to plateau being not well defined.
g
Determined by using eq 3.
h
(±0.2).
i
Approximate value, not able to populate limb because of increasing Km at acidic pH.
3.4.6

kcat/Km and kcat pH-profiles with E87L variant
The pH-dependences of the steady-state kinetic parameters kcat/Km and kcat were

determined with D-arginine in the E87L variant to investigate the role of E87 in amine oxidation.
The kcat pH profile of the E87L variant increased with increasing pH to reach a limiting value at
high pH, exhibiting three pH dependent terms (Figure 3.4). In contrast to the wild-type kcat/Km,
the E87L variant demonstrated the requirement for only a single unprotonated group for maximal
activity. Table 3.3 summarizes the apparent pKa values and the pH-independent, limiting values
of kcat/Km and kcat.
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Figure 3.4 pH-profiles of kcat and kcat/Km with PaDADH variants H48F (●) and E87L (○).
PaDADH activity was measured at varying concentrations of D-arginine and 1 mM PMS at 25
°C. Curves represent fits of the data to Eqs. (3)–(5).
3.4.7

kred pH-profile with D-leucine

D

The pH-dependence of the kinetic isotope effects on the rate constant for flavin reduction
at saturating substrate (kred) was determined with D-leucine to establish if the latter is a slow
substrate for PaDADH for which apparent and intrinsic pKa values are identical. Since the
reaction is too fast with D-arginine, it could not be studied in a stopped-flow spectrophotometer,
as previously reported.[6] Flavin reduction was followed at 446 nm upon mixing the enzyme
with varying concentrations of D-leucine in a stopped-flow spectrophotometer, yielding
monophasic traces (Figure 3.5 shows the case of pH 8.5, with pH 7.0 and 10.3 being similar).
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The Dkred values were computed from the ratio of the kred values with D-leucine and D-leucined10
determined by plotting the observed rate constants for flavin reduction as a function of substrate
concentration. As illustrated in Table 3.4, the Dkred had similar values in the pH range from 7.0 to
10.3.

Figure 3.5 Kinetic isotope effects on kred at pH 8.5 with D-leucine (black) and D-leucined10 in
(red).
Panel A shows representative time courses for the light and heavy substrate at 50 mM substrate
concentration; the traces were fit to Eq. (1). Panel B shows the concentration dependences of the
observed rate constants for flavin reduction at different substrate concentrations of protiated and
deuterated leucine.
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Table 3.4 pH effects on kinetic isotope effects with D-leucine.
D
pH
kred
a
7.0
4.6 (±0.9)
8.5b
5.2 (±0.4)
c
10.3
5.1 (±0.1)
Experimental conditions: 20 mM asodium
phosphate and bsodium pyrophosphate in H2O at
25 oC with between 0.5 to 50 mM D-leucine and
D-leucine-d10.
c
From Yuan et al.[7]

3.5

Discussion
The substrates of PaDADH, which displays broad specificity being able to oxidize most

of the D-amino acids except D-aspartate, D-glutamate, and glycine,[2] can be classified as
cationic or zwitterionic, depending on the presence of a charge on the side chain. In this study,
we have used D-arginine, D-lysine, D-methionine and D-leucine to investigate mechanistically
how cationic and zwitterionic substrates bind to and are oxidized by PaDADH. Insights on the
roles played by several functional groups in the active site of the enzyme have emerged from the
investigation of wild-type and selected active site variants of the enzyme, as discussed below.
The unprotonated side chain of E87 is important for binding cationic substrates through
an electrostatic interaction with the substrate side chain. This conclusion is supported by pH
profiles of the steady-state kinetic parameters, site-directed mutagenesis and previously
published X-ray structures of the enzyme in complex with the iminoarginine product.[2] While a
single unprotonated group is required to achieve maximal kcat/Km values at high pH with the
zwitterionic substrates D-methionine and D-leucine, two groups are seen in the kcat/Km pHprofiles with the cationic substrates D-arginine and D-lysine. The extra unprotonated group must
be involved in substrate binding rather than catalysis, since it is not seen in the kcat pH-profiles,
which show the requirement for a single unprotonated group for catalysis with both cationic and
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zwitterionic substrates. The kcat/Km pH-profile of the E87L mutant indicates only a single group
is required for maximal activity with D-arginine, providing unequivocal evidence that E87 is the
unprotonated group on the enzyme that binds cationic substrates. Further support for E87
interacting with the side chain of the cationic substrates comes from the X-ray structures of the
enzyme in complex with iminoarginine and one of the two alternate conformations of
iminohistidine,[2] showing the carboxylate chain of E87 at ≤2.8 Å away from the guanido and
ε-amino groups of the cationic products of the reaction. Interestingly, the pKa of E87 is perturbed
to a value ≥7.9, as suggested by the kcat/Km pH-profiles with the cationic substrates D-arginine
and D-lysine. This may be due to E87 being close to the hydrophobic side chains of M240 and
V242. Large upward perturbations of pKa values for aspartate and glutamate attributed to a
hydrophobic environment have been previously reported for bacteriorhodopsin and bacterial
thioredoxin, respectively.[15-18] Upward shifts in pKa values of anionic residues have also been
reported to occur when other negatively-charged residues are in close proximity to the group in
question, such as E72 in Bacillus circulans xylanase.[19] In the case of PaDADH, while there is
no other anionic group close to E87 a hydrogen bond interaction of the side chain of E87 with
the O atom of T50 may also contribute to the elevation of the pKa value, similar to human
thioredoxin, in which a hydrogen bond to a neighboring serine elevates the pKa of an aspartate
residue.[20] An intrinsic value for the pKa for E87 in the active site of PaDADH, however,
cannot be estimated because different pKa values were determined with D-arginine and D-lysine.
pKa values determined from kcat/Km pH-profiles refer to ionizations of the free enzyme or
substrate, but not of enzyme-substrate complexes.[21] Thus, the different values determined with
D-arginine and D-lysine reflect the stickiness of these substrates, i.e., the propensity of the
enzyme-substrate complex to catalyze amine oxidation rather than releasing the substrate to bulk
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solvent (k3/k2 in Scheme 3.2). Due to substrate stickiness perturbing apparent pKa values outward
in kcat/Km pH-profiles,[21] D-arginine, with a pKa value of 7.2, is stickier than D-lysine, with pKa
value of 7.9. However, no conclusion on the stickiness of D-lysine can be drawn with the data
available, preventing the determination of the intrinsic pKa value of E871. In the case of DAAO,
Denu and Fitzpatrick observed outward perturbation of the pKa values with D-alanine,
establishing it as a sticky substrate.[22]

An unprotonated group with an intrinsic pKa value of ~9.5, which is assigned to the -

NH3+ group of the amino acid substrate, is required for catalysis with both cationic and
zwitterionic substrates. Evidence for this conclusion comes from the pH profiles of the steadystate kinetic parameters and site-directed mutagenesis. The kcat and kcat/Km values increased to
limiting values with increasing pH with all substrates. This establishes the requirement for an
unprotonated group acting in the chemical step of amine oxidation rather than in substrate
binding, since kcat excludes binding steps because the enzyme is saturated with the substrate.[23]
The linear decrease with decreasing pH in both kcat and kcat/Km with all tested substrates is
consistent with the unprotonated group not acting as an electrostatic catalyst, in which case the
kinetic parameters would approach a limiting, lower value at low pH. The apparent pKa values
determined in the kcat and kcat/Km pH profiles with D-leucine approximate well the intrinsic pKa
value, since D-leucine is a slow, non-sticky substrate for PaDADH. This conclusion comes from
the pH-independence of the Dkred value for the reduction of the enzyme-bound flavin with Dleucine between pH 7.0 and 10.3, where both kcat and kcat/Km depend on pH, which establishes
that the enzyme-substrate complex is not committed to catalysis and that D-leucine is not a
Since E87 does not interact with the side chain of D-leucine, the perturbations of the apparent pKa of E87 and of
the unprotonated group participating in catalysis, which is instead common to all substrates oxidized by PaDADH,
are not the same. For this reason, while the ΔpKa values attributed to the chemical step of catalysis allows the
determination of the intrinsic pKa value on kcat (vide infra), the same cannot be done to establish the intrinsic pKa
value of E87.
1
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sticky substrate.[24] Independent support for D-leucine being a slow substrate is provided by the
comparison of the pKa of ~9.5 determined for kcat/Km with the pKa of 9.6 recently reported for the
kred pH-profile with D-leucine.[7] The active site of the enzyme has several side chains that could

potentially act as catalytic base for the deprotonation of the -NH3+ group of the amino acid
substrate, including H48, Y53, Y249 and, although less likely due to its location and
participation in binding the side chain of cationic substrate, E87. The pH profiles of the kcat and
kcat/Km values for the H48F variant with D-arginine still show the requirement for the
unprotonated group in the catalytic step, thereby eliminating H48 as being responsible for the
observed pKa value. A similar conclusion is drawn for E87, since the unprotonated group
involved in catalysis is still present in the pH profiles for the E87L variant. Previous site-directed
mutagenesis and rapid reaction studies established that neither Y53 nor Y249 is the catalytic
group required for flavin reduction.[25] Instead, Y53 may exert a similar role to the analogous
Y238 in DAAO from Rhodotorula gracilis by modulating the substrate entry and exit.[26] Thus,
despite the presence of several candidates in the active site of PaDADH the unprotonated group
required for catalysis cannot be attributed to any of the protein residues with potential to act as
base in the active site of the enzyme. Consequently, the pKa value of 9.5 for the unprotonated
group involved in catalysis is assigned to the -NH3+ group of the amino acid substrate.

D-Arginine is considerably stickier than D-leucine, followed by D-methionine and Dlysine, as suggested by the perturbations of the apparent pKa values in the kcat/Km pH-profiles
from the intrinsic value of ~9.5 determined with D-leucine. Substrate stickiness can be computed
by using eq 6, where ΔpKa is the difference between the apparent and intrinsic pKa values. As
expected from the kcat/Km of 106 M-1s-1, D-arginine is the stickiest substrate, with k3/k2 of ~200,
likely due to the optimization of the active site with key residues involved in binding, such as
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Y53, Y249, R222, R305 and, most importantly, E87. Interestingly, k3/k2 ratios of similar
magnitude are computed with D-methionine (~60) and D-lysine (~40), despite lack of interaction
of the side chain of methionine with E87, which instead is present with D-lysine. The stickiness
of D-methionine is possibly due to its S atom establishing S-π interactions[27] with the phenols
of either Y53, Y249 or both.
Δp

= log 1 +

(6)

The cationic side chains of the iminoarginine and iminolysine products contribute to their
stickiness compared to products lacking a positive charge. This conclusion is supported by the
pH-profiles of the kcat values, showing apparent pKa values with D-arginine and D-lysine ~3 pH
units lower than the intrinsic value of 9.5 determined with D-leucine. Perturbations of pKa values
in kcat pH-profiles are symptomatic of a kinetic step other than the chemical step of catalysis
being at least partially rate-determining for the overall turnover of an enzyme saturated with
substrates.[21] Since PaDADH operates through a Ping-Pong Bi-Bi kinetic mechanism in steadystate and previous studies established that the oxidative half-reaction with PMS as electron
acceptor is fast,[7] the only first-order kinetic step other than amine oxidation in the reductive
half-reaction of the enzyme is product release (k5 in Scheme 3.2). Most likely product stickiness
with cationic substrates is due to an interaction of the positive charge present on the side chain of
the ligand with the carboxylate of E87, as suggested by the structures of the enzyme in complex
with iminoarginine.[2] The similar pKa perturbations seen with D-arginine and D-lysine suggest
that the interaction of the carboxylate of E87 with the side chain of the ligand has similar effects
on the rate of turnover of PaDADH irrespective of the presence of an ε-amino or guanido group
on the product side chain. The increase in kcat from ~150 s-1 to ~550 s-1 seen in the pH-profile
with D-lysine above pH 9.2 is consistent with a difference in the rate-limiting kinetic step
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between the two substrates, potentially product release. Interestingly, iminomethionine is also
considerably stickier than iminoleucine, as suggested by the apparent pKa of 6.9 compared to the
intrinsic pKa ~9.5. Since both lack a cationic side chain, the stickiness of iminomethionine
cannot be due to electrostatic interactions with E87. Rather, potential S-π interactions of the
ligand S atom with the aromatic rings of Y53 or Y249 are likely responsible for the stickiness of
iminomethionine,[27] as also proposed for D-methionine.
Previous QM/MM computations and the pH profile of the Kd value determined in the
reductive half-reaction of wild-type PaDADH with D-leucine as substrate demonstrated that the
enzyme preferentially binds the zwitterionic form of the substrate rather than the anionic
form.[7] Solvent and substrate deuterium kinetic isotope effects on the rate constant for flavin
reduction with D-leucine further indicated that flavin reduction occurs through the asynchronous
cleavage of the substrate NH and CH bonds.[7] Thus, an accurate representation of the reductive
half-reaction that accounts for the effects of pH on the ionization state of the substrate is given

by Scheme 3.4, in which the substrate -amino group is either protonated or unprotonated before
binding to form the enzyme-substrate complex.

Scheme 3.4 Reductive half-reaction of PaDADH accounting for pH effects on substrate
ionization.
Cook et al. demonstrated earlier with creatine kinase that a “hollowed” pH profile is obtained
with sticky substrates when the equilibration of a proton within an enzyme-substrate complex is
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not rapid with respect to other relevant kinetic steps.[14] This yields three apparent pKa values,
which corresponds to the intrinsic pKa value for the ionization of the relevant group involved in
catalysis and two apparent pKa values from which the stickiness of both the substrate and the
proton with restricted movement can be extracted.[14] Alternatively, the hollow will not be
present when the proton rapidly equilibrates within the complex, as is the case for most
enzymatic reactions, or when the substrate/product is non-sticky.[14] With wild-type PaDADH
in turnover with cationic substrates the pH profile of the kcat value clearly demonstrates the
presence of a hollow with D-lysine, but not with D-arginine irrespective of temperature. Thus,
despite both substrates are sticky (see above) and share long, cationic side-chains that interact
with E87, they must have (slightly) different arrangements within their respective enzyme
complexes that result in different rates of proton release to the solvent. This may arise from a

sub-optimal orientation of the -NH3+ group of D-lysine as compared to D-arginine, which
would impair the unrestricted release of the proton to solvent within the active site of the
enzyme. In the three dimensional structure of the enzyme in complex with iminoarginine two
well-defined water molecules are present in the active site of the enzyme-product complex,
which are arranged to connect the -NH3+ group of the ligand with the side chain of H48 and

likely contribute to deprotonation of the substrate -NH3+ group in turnover. Such an optimal
arrangement may be missing in the complex with D-lysine and is likely to be disrupted upon
mutation of H48 or of the neighboring residue E87, as suggested by the appearance of hollowed
kcat pH profiles in the H48F and E87L variants with D-arginine as substrate. Lack of an

interaction between E87 and the side chain of D-methionine likely arranges the substrate -NH3+
group so that proton release to solvent is also unrestricted, resulting in a kcat pH profile not being
hollowed. Similarly, the kcat pH profile with D-leucine is not hollowed due to the latter being a
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non-sticky substrate (see above). In this context, previous results with tryptophan 2monooxygenase showed hollowed kcat/Km pH profiles with methionine or alanine, which were
associated with proton related isomerizations of the enzyme-substrate complex.[28, 29] Although
hollowed pH profiles were reported for the rate constant for anerobic flavin reduction of
Rhodotorula gracislis DAAO with alanine or asparagine as substrate, a different interpretation
was offered based on these substrates being nonsticky.[30]
In summary, we have used pH profiles, kinetic isotope effects, and site-directed
mutagenesis to investigate further the steady-state mechanism of amine oxidation in PaDADH
with a number of amino acid substrates. From a structural-functional standpoint, the results
presented herein have established the importance of E87 in the active site of the enzyme for
binding cationic substrates that carry a positive charge on the side chain, i.e., D-arginine and Dlysine. Despite the presence of several groups in the active site of the enzyme with the potential

to act as base, substrate deprotonation occurs through the direct release of the substrate -amino
proton to the solvent without involvement of protein residues. In this respect, PaDADH is similar
to other well-characterized flavoproteins that catalyze the oxidation of amino acids, i.e., L-amino
acid oxidase, DAAO, and monomeric sarcosine oxidase, which lack in their active sites catalytic
bases.[9, 30-32] From a mechanistic standpoint, D-arginine, D-lysine and D-methionine, as well
as their respective imino-products, are sticky, resulting in steady-state turnover being primarily
populated of enzyme complexes with substrates and products rather than the free enzyme.

Among the pool of sticky substrates, proton release from the substrate -amino group to solvent
is restricted with D-lysine as substrate due, most likely, to a non-optimal configuration of the
enzyme-substrate complex. The side chains of both H48 and E87 also contribute to optimal

orientation of the D-arginine substrate and its -amino group and the solvent in the active site of
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the enzyme. This study demonstrated restricted movements of protons that are relevant to

catalysis have been observed in a flavoenzyme that oxidizes -amino acids, both in the wild-type
species with a non-preferred substrate and in mutated variants with the physiological substrate.
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4

FUNCTIONAL ANNOTATION OF A PRESUMED NITRONATE

MONOOXYGENASE REVEALS A NEW CLASS OF NADH:QUINONE
REDUCTASES
(This chapter has been published verbatim in Ball J., Salvi F., and Gadda G., (2016), J Biol
Chem, 291(40), 21160-21170)
4.1

Abstract
The protein PA1024 from Pseudomonas aeruginosa PAO1 is currently classified as 2-

nitropropane dioxygenase, the previous name for nitronate monooxygenase in the GenBank TM
and PDB databases, but the enzyme was not kinetically characterized. In this study, PA1024 was
purified to high levels and the enzymatic activity was investigated by spectroscopic and
polarographic techniques. Purified PA1024 did not exhibit nitronate monooxygenase activity;
however, it displayed NADH:quinone reductase and a small NADH:oxidase activity. The
enzyme preferred NADH to NADPH as a reducing substrate. PA1024 could reduce a broad
spectrum of quinone substrates via a Ping Pong Bi-Bi steady-state kinetic mechanism, generating
the corresponding hydroquinones. The reductive half reaction with NADH showed a kred value of
24 s-1 and an apparent Kd value estimated in the low µM range. The enzyme was not able to
reduce the azo dye methyl red, routinely used in the kinetic characterization of azoreductases.
Finally, we revisited and modified the existing six conserved motifs of PA1024, which define a
new class of NADH:quinone reductases and are present in more than 490 hypothetical proteins
in the GenBankTM, the vast majority of which are currently misannotated as nitronate
monooxygenase.
4.2

Introduction
The discrepancy between the rapid increase in the number of sequenced genomes of
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prokaryotes and the slower experimental determination of protein function has resulted in the
presence of a large number of hypothetical proteins in the databases, with gene function
prediction oftentimes unreliable (1,2). One case of an enzyme family consisting mainly of
hypothetical proteins is represented by the nitronate monooxygenases (NMOs, E.C. 1.13.12.16),
which includes >5000 genes in the GenBankTM. NMOs are FMN-dependent enzymes that
catalyze the detoxification of propionate 3-nitronate (P3N), a metabolic poison produced by
plants and fungi as a defense mechanism against herbivores (3). The kinetic mechanism of NMO
has been investigated in previous studies on the fungal enzymes from Neurospora crassa (4)
and Cyberlindnera saturnus (previously known as Williopsis saturnus) (5). The recent structural
and kinetic characterization of the gene product PA4202 from Pseudomonas aeruginosa PAO1
as PaNMO identified four motifs that establish Class I NMO, with 500 sequences from bacteria,
fungi, one insect and one animal (6). Class I NMO oxidizes the anionic nitronate form of the
substrate, whereas Class II NMO can oxidize both the neutral and anionic forms of P3N (6). P.
aeruginosa PAO1 possesses two other genes coding for hypothetical NMOs, namely pa0660 and
pa1024; however, these proteins do not carry the four motifs characteristic of Class I NMO nor
any of the motifs signature of Class II NMO, raising the possibility that they code for enzymes
with different function. While there is no experimental evidence at transcript or protein levels for
the gene product PA0660, a crystal structure for the hypothetical protein PA1024 is available for
the enzyme in free form and in complex with 2-nitropropane (PDB codes 2GJL and 2GJN) at 2.0
and 2.3 Å resolution, respectively (7). The protein PA1024 is currently classified as 2nitropropane dioxygenase, a previous name for NMOs, based on the gene function prediction
(~32% sequence identity) and a qualitative enzymatic assay performed with 20 mM 2nitropropane at pH 6.5 (7). Nonetheless, the kinetic parameters with 2-nitropropane were not
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determined, and the physiological substrate P3N was not tested, because it was unknown at the
time of the study. The structural characterization of PA1024 previously highlighted six motifs
conserved in other hypothetical proteins similar to PA1024 (7), which are different from the four
motifs described for Class 1 NMO (6).
In the present study, we have cloned from genomic DNA the gene pa1024, purified the
His-tagged recombinant PA1024, and characterized the spectral and kinetic properties of the
enzyme. We demonstrated that purified PA1024 does not exhibit NMO activity. The enzyme
belongs to an operon that contains two acyl-CoA dehydrogenases, an acyl-CoA
hydratase/isomerase, a short chain dehydrogenase, and a porin (all hypothetical). All of these
enzymes together imply the operon plays a role in β-oxidation. Based on the genomic context of
PA1024, we hypothesized the enzyme oxidizes NAD(P)H to NAD(P) + to maintain a favorable
[NADH]/[NAD+] ratio, since it has been observed that a low ratio stimulates β-oxidation (8,9).
The connection between the [NADH]/[NAD+] ratio and β-oxidation is assumed to be due to the
cofactor requirement of NAD+ for 3-hydroxyacyl-CoA dehydrogenases, which catalyze the third
step in β-oxidation (10). We also hypothesized the reduced enzyme is oxidized by quinones
since they are prevalent redox agents in nature (11,12). To investigate this hypothesis, we
experimentally tested NADH, NADPH, and various quinones for catalytic activity. Furthermore,
we reanalyzed and modified the conserved motifs identified by Ha et al. in the protein sequence
of PA1024 (7), and showed that they are present in more than 490 sequences in the nonredundant protein database. The results reinforce the need for accurate experimental data on
select hypothetical proteins to work in concert with computational methods for improved gene
function prediction.
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4.3
4.3.1

Results
Protein purification
The gene pa1024 was cloned from the genomic DNA of P. aeruginosa PAO1 in the

expression vector pET20b(+), with the addition of a His-tag at the C terminus of the recombinant
protein. The recombinant protein PA1024 was expressed in Escherichia coli and purified to high
yield by affinity chromatography. The presence of 200 mM NaCl in a storage buffer composed
of 20 mM TRIS-Cl, pH 8.0, 10 % v/v glycerol, was necessary for the in vitro stability of purified
PA1024. SDS-PAGE analysis of the purified protein estimated a high level of purity.
4.3.2

Spectral properties
The UV-visible absorption spectrum of purified PA1024 shows maxima at 370 and 461

nm (Figure 4.1), which are consistent with the presence of FMN as a cofactor, as previously
demonstrated in the crystal structure of PA1024 (PDB code 2GJL) (7) (Figure 4.2). The flavin
cofactor extracted by heat denaturation was released to the bulk solvent, indicative of a noncovalent attachment of FMN to the protein, which is also in agreement with the crystal structure
of the enzyme. The molar ratio FMN/enzyme was ~0.9, consistent with a 1:1 stoichiometry per
monomer of protein. The enzyme-bound flavin emitted light at 545 nm when excited at 461 nm,
with an intensity equivalent to ~10% that of an equimolar concentration of FMN in solution
(Figure 4.1).
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Figure 4.1 UV-visible absorption spectrum of the gene product PA1024.
Inset, solid line, fluorescence emission spectrum when the low energy band of the FMN-bound
to PA1024 is excited; dashed line, fluorescence emission spectrum when the low energy band of
the free FMN is excited.
Buffer conditions: 20 mm Tris-Cl, pH 8.0, 200 mm NaCl, 10% v/v glycerol, at 25 °C.

Figure 4.2 Surface depiction and active site of PA1024.
A, surface depiction of the three-dimensional structure of PA1024. FMN is shown as yellow
sticks. Water molecules are represented by red circles. B, FMN locus of PA104 with select
residues.
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4.3.3

Lack of nitronate monooxygenase activity
Nitronate monooxygenase activity was tested at pH 7.5 and atmospheric oxygen, i.e. 230

µM, as previously described (5,6,13), to determine the validity of the previous classification of
PA1024 as an NMO. No enzymatic activity was detected with 1 mM P3N or 3-NPA. No
enzymatic activity was detected with 20 mM nitroethane, 1-nitropropane, 2-nitropropane, nor the
anionic forms ethylnitronate, propyl-1-nitronate, and propyl-2-nitronate. In the case of propyl-2nitronate and ethylnitronate, velocities of 16 and 5 µM oxygen consumed per minute were
detected, which would correspond to enzymatic rates of 1 and 0.5 s -1 with 180 nM enzyme.
However, the same velocities were detected by incubating propyl-2-nitronate or ethylnitronate in
the reaction buffer without PA1024, and they therefore represent non-enzymatic reactions. The
activity reported by Ha et al was thus likely due to the non-enzymatic reaction of propyl-2nitronate with oxygen.
4.3.4

Reducing substrate
The operon where PA1024 is found suggests that PA1024 could serve to regenerate

NAD(P)+ for use by fatty acid oxidizing enzyme(s) also found in the operon. To evaluate the
reduction of PA1024 by NAD(P)H, the reduction of the FMN cofactor was followed by
monitoring the decrease in absorbance at 461 nm under anaerobic conditions at pH 7.0 and 25
°C, with the use of a stopped-flow spectrophotometer. The enzyme was fully reduced with
NADH in a biphasic pattern (Figure 4.3).
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Figure 4.3 Reduction of PA1024 by NADH.
A, anaerobic reduction with 500 μm NADH of PA1024 in 20 mm potassium phosphate, 200 mm
NaCl, pH 7.0, at 25 °C. B, observed rate constants of the first phase as a function
Note the log time scale on the x axis. The dead-time of the instrument was 2.2 ms.
The fast phase, which accounts for more than 95% of the total change in absorbance at 461 nm,
was assigned to flavin reduction. A slow phase accounting for less than 5% of the total change in
absorbance at 461 nm was seen, with a substrate concentration-independent kobs value of 1 s-1.
The latter phase, which was considerably slower than the kcat values determined with various
quinone substrates (see below), could be due to a fraction of the enzyme being damaged. The fast
phase of flavin reduction was analyzed with Eq. 2, demonstrating that the enzyme was fully
saturated with NADH from 90 to 500 µM, with a kred value of 24 ± 1 s-1. An accurate Kd value
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was not determined because it was not possible to lower NADH below 90 µM in order to
maintain pseudo first-order conditions. However, the observation that the enzyme was fully
saturated with 90 µM NADH suggests a Kd value in the 5 µM range or lower. When the enzyme
was anaerobically mixed with 500 µM NADPH, there was slow reduction of the enzyme-bound
flavin over 10 min, with an estimated rate constant of 0.0074 ± 0.0006 s -1. Thus, NADH is the
preferred reducing substrate of PA1024.
4.3.5

Oxidizing substrates
Quinones were selected as potential oxidizing substrates based on their powerful

oxidizing ability and pervasive nature in the cell. Turnover of PA1024 was monitored with a
quinone as the oxidizing substrate and NADH as the reducing substrate at pH 7.0 and 25 °C.
PA1024 turned over with a number of different quinones and the apparent steady-state kinetic
parameters were determined at a fixed, saturating concentration of 100 µM NADH. As shown in
Table 4.1, benzoquinone and 5,8-dihydroxy-1,4-naphthoquinone were the best substrates for the
enzyme based on the kcat/Km value. Naphthoquinone substrates with hydroxyl groups on the
aromatic ring of the naphthoquinone showed the highest kcat/Km values for the bi-cyclic series.
The kcat/Km values plotted against the one-electron reduction potentials did not show a linear
relationship (data not shown).
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Table 4.1 Apparent steady-state kinetic parameters of PA1024 with various electron acceptors.
Electron acceptor
1,4-Naphthoquinones
5,8-dihydroxy5-hydroxy2-methyl-5-hydroxy2-methyl2-methoxy2-hydroxy-

app

kcat/Km (M-1 s-1)

1,500,000 ± 100,000
1,200,000 ± 100,000
920,000 ± 120,000
270,000 ± 10,000
30,000 ± 3,000
nda

app

kcat (s-1)

14 ± 1
17 ± 1
16 ± 1
16 ± 1
6±1
nda

app

Km (µM)

10 ± 1
14 ± 2
18 ± 3
60 ± 5
185 ± 40
nda

1,4-Benzoquinones
benzoquinone
1,900,000 ± 130,000
27 ± 1
15 ± 1
2-methyl-5,6-dimethoxy- (Q0)
350,000 ± 30,000
24 ± 1
70 ± 10
b
2,6-dimethoxy100,000 ± 20,000
nd
ndb
2,3,4,6-tetramethyl80,000 ± 10,000
28 ± 3
355 ± 75
The kinetic parameters were determined with 100 µM NADH in 20 mM potassium phosphate,
200 mM NaCl, pH 7.0, at 25 °C. aEnzymatic activity not detected; bkcat or Km not determined
because unable to saturate with substrate

4.3.6

Steady-state kinetic mechanism with 5-Hydroxy-1,4-naphthoquinone
The traditional approach to obtain the steady-state kinetic mechanism of varying both

NADH and quinone concentrations yielded overlapping lines in a double reciprocal plot (data
not shown), likely due to NADH being saturating at all concentrations used. Consequently, the
product inhibition pattern using NAD+ and 5-hydroxy-1,4-naphthoquinone as a substrate was
used to establish the steady-state kinetic mechanism of PA1024. 5-Hydroxy-1,4-naphthoquinone
was chosen for its occurrence and importance in nature (14), and because of its high kcat/Km value
(Table 1). A double reciprocal plot of the initial rate of reaction versus the substrate
concentration yielded lines converging on the y-axis (Figure 4.4), consistent with 5-hydroxy1,4-naphthoquinone and NAD+ binding to the same form of enzyme. This, in turn, is in line with
a Ping-Pong Bi-Bi steady-state kinetic mechanism, as illustrated in Scheme 4.1. The Kis for
NAD+ was determined to be 2.2 mM.
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Figure 4.4 Lineweaver-Burk plots of product inhibition of PA1024 by NAD+.
Buffer conditions: 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. NADH was
kept at a fixed, saturating concentration of 100 μ M, and 5-hydroxy-1,4-NQ varied from 2 to 17
μM. Each line represents a different concentration of NAD+: ●, 0 mM; ○, 0.4 mM; ▴, 1.2 mM; and
▵, 3 mM.

Scheme 4.1 Steady-state kinetic mechanism of PA1024 with 5-hydroxy-1,4-napthoquinone as
substrate.
4.3.7

Quinone mode of reduction
To assess if the reduction of the quinones catalyzed by PA1024 occurs through a single-

or two-electron transfer from the enzyme-bound flavin, the obligatory one-electron transferring
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protein Cyt c was employed as a reporter. A single-electron flux, as defined by Iyanagi (15), is
the coupled Cyt c reduction rate (v) divided by the doubled NADH oxidation rate (2v). The
single-electron flux can have a value of 1 or lower, depending upon whether the reaction of
PA1024 with the quinone occurs via a single- or a two-electron transfer. As shown in Figure 4.5,
all quinones tested had single-electron fluxes considerably lower than unity, ruling out a pure
single-electron reduction of the quinone being catalyzed by PA1024.

Figure 4.5 Single electron flux for quinone reduction by PA1024.
Values are expressed as the ratio of coupled Cyt c reduction rate divided by the doubled NADH
oxidation rate. The dashed line represents the theoretical limit for a one-electron quinone
reductase. Experiments were performed in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0,
at 25 °C. The concentration of each quinone was saturating (if possible), and NADH was held at
a fixed, saturating concentration of 100 μM. BQ, benzoquinone; NQ, naphthoquinone.
In an independent experiment, the initial rates of the coupled Cyt c reduction were
measured in the absence and presence of SOD, since in the latter case a roughly 50% decrease in
the rate of reaction would be expected if quinone reduction by PA1024 occurred through a
single-electron reaction. As illustrated in Table 4.2, in all cases except 2,6-dimethoxy-1,4-
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benzoquinone2, the initial rates for the coupled Cyt c reduction catalyzed by PA1024 were equal
or lower than 50% in the presence of SOD, further ruling out a single-electron reaction of
PA1024 with the quinone substrates.
Table 4.2 Rate constants for the coupled Cyt c reduction by PA1024 with various quinones in
the presence or absence of SOD.
Electron acceptor

1,4-Naphthoquinones
2-methyl-5-hydroxy5-hydroxy2-methyl5,8-dihydroxy2-methoxy-

Coupled Cyt c
reduction (s-1)

Coupled Cyt c reduction +
SOD (s-1)

20.0 ± 1.5
22.1 ± 1.1
13.0 ± 0.3
14.5 ± 0.3
4.6 ± 0.2

7.5 ± 0.3
11.1 ± 1.2
4.6 ± 0.1
7.0 ± 0.3
2.1 ± 0.1

1,4-Benzoquinones
benzoquinone
0.9 ± 0.1
nd
2,6-dimethoxy9.3 ± 0.9
6.7 ± 0.2
2-methyl-5,6-dimethoxy- (Q0)
3.8 ± 0.2
1.4 ± 0.1
2,3,5,6-tetramethyl0.9 ± 0.2
nd
nd: enzymatic activity not detected. The kinetic parameters were determined with 100 µM
NADH in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, 25 °C, at a saturating (if
possible) concentration of the quinone substrate with or without the addition of superoxide
dismutase.

4.3.8

NADH:oxidase activity
PA1024 displayed an NADH oxidase activity of ~1.0 s-1 at atmospheric oxygen, pH 7.0

and 25 °C. Addition of catalase to the reaction mixture decreased the rates of oxygen
consumption by half (data not shown), providing evidence for the production of hydrogen
peroxide, consistent with PA1024 displaying a small oxidase activity.
2

The product of this substrate may reduce Cyt c primarily through the hydroquinone form

of the product and the autoxidation products are a minor reduction pathway, thus SOD exerts less
of an inhibitory effect.
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4.3.9

Lack of azoreductase activity
In order to determine if PA1024 could perform azoreductase reactions, which is a

common activity shared among most quinone reductases, turnover of PA1024 was monitored
with the azo dye methyl red at saturating NADH concentration at pH 7.0, 25 °C. No significant
enzymatic reduction of methyl red was observed over 10 min, indicating PA1024 is not an
azoreductase.
4.3.10 Bioinformatics
In a previous study, Ha et al. identified six consensus motifs in the amino acid sequence
of PA1024 (7) and annotated PA1024 as 2-nitropropane dioxygenase, the former official name of
NMO. That study was carried out before the crystal structure of Pa-NMO (PA4202) was
available (6), which established Class I NMO. A reanalysis of the conserved motifs of PA1024
based on the comparison of the active site residues of the two enzymes, PA1024 and Pa-NMO, in
addition to a comprehensive PHI-BLAST search was carried out here, identifying small changes
in the six motifs originally reported (Table 4.3). A PHI-BLAST search of the six consensus
motifs of PA1024 recognized ~500 (erroneously annotated) hypothetical proteins that share these
motifs, the bulk of which come from bacterial sources and are currently annotated as NMOs. The
complete list of the genes and the PHI-BLAST search parameters can be found in the
supplemental data at http://www.jbc.org/content/291/40/21160/suppl/DC1.
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Table 4.3 Conserved motifs in the protein sequence of PA1024.
Motif

Consensus sequence

Ib

17

IIa

66

IIIb

121

IVb

144

P-[I/V]-h-Q-G-G-M-Q-W-[V/I]26

Vb
VIb
VII

T-D-[K/R]-P-F-G-V-N-L-T-h-[L/F]-P78
[V/I]-h-H-K-C-T-X-[V/I]-R-H-A131
I-D-G-F-E-C-[A/G]-G-H-P-G-E-X-D-X-[P/G/T]159

A-S-G-G-h-[A/G]-[D/E]-[A/G]-R-G-L-h-A-A-[L/F]-A-L-G-A-[D/E]-[G/A]-h-X-M-GT-R-F204
177

225
85

E-X-X-[T/S]-X-L-h-X-R-X-[L/M/W]-[R/H/K]-N-T-[S/A/V]-R-V241

Y-A-E-Y-R-X-[A/V]-I-[I/V]-E-X-G-h-X-[I/V]-V-E-T-A-G-X-X-P-X-[E/D]-H110

The numbering of the residues refers to the protein sequence of PA1024; the brackets identify
alternative residues that can be present in that position, h represents a position occupied by a
hydrophobic residue, while X represents a position where any amino acid is accepted. aMotif was
identified in a previous study by Ha et al. (7). bMotif was identified in a previous study by Ha et
al. (7) and modified in this study. The modifications to the consensus sequence are underlined.
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4.4

Discussion
Recent advances in the efficiency and speed of gene sequencing coupled to a

comparatively much slower pace of acquiring experimental evidence for protein function has
given rise to a large number of hypothetical or erroneously annotated proteins in the databases
(1,2). An example of a family of enzymes with a sizable amount of hypothetical proteins in the
database is the nitronate monooxygenases (NMOs), with over 5000 genes in the GenBank TM
currently annotated as NMO. The present study aimed to characterize PA1024, one of the three
genes encoding a hypothetical NMO in Pseudomonas aeruginosa PAO1. The current
classification of PA1024 is based on a 2006 study (7), but the enzyme does not carry the
consensus motifs characteristic of the recently defined Class I and Class II NMOs (6). The
biochemical and kinetic characterization of PA1024 presented herein show that the enzyme
indeed is not an NMO, as indicated by the lack of oxygen consumption with propionate-3nitronate and other nitronates. The enzyme, instead, uses NADH and quinones as reducing and
oxidizing substrates, respectively. Thus, PA1024 should be reclassified as an NADH:quinone
Reductase (E.C. 1.6.99.5), along with ~500 genes that contain the consensus motifs identified in
PA1024.
PA1024 efficiently uses NADH as a reducing substrate; the enzyme was fully reduced by
NADH with a kred value of 24 s-1 and a Kd value estimated in the low µM range (Figure 4.3).
PA1024 displayed a marked preference for NADH over NADPH, as indicated by the fact that
flavin reduction with 500 µM NADPH is ~3,500 times slower than with an equivalent
concentration of NADH. Preference for NADH as a substrate was previously reported for some
flavin-dependent monooxygenases (16), FMN-dependent quinone reductases in bacteria, such as
tryptophan [W] repressor-binding protein (WrbA) (17), and the FMN-dependent azoreductases
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AzoA (18), AcpD (19), and AzoR (20). In the case of PA1024, the structural determinants for
NADH specificity are currently unknown, and future crystallographic studies of the enzyme in
complex with the product NAD+ will be required for their elucidation.
PA1024 catalyzes the reduction of various quinone substrates as shown in Table 4.1. The
enzyme prefers benzoquinone, but naphthoquinones carrying hydroxyl groups in the 5 or 8
positions are also good substrates, as indicated by the large kcat/Km values determined with these
substrates. Addition of methyl groups on the benzoquinone ring or methoxy groups in the 2
position results in a significant decrease in the kcat/Km value, possibly due to increased steric
constraints for the formation of a catalytically competent enzyme-substrate complex.
Interestingly, PA1024 does not react when the hydroxyl group is in the 2 position of the
naphthoquinone substrate. Non-reactivity with 2-hydroxy-1,4-napthoquinone is in stark contrast
to Enterococcus cloacae nitroreductase, which shows a marked preference for this substrate (21).
PA1024 reduces quinones to the hydroquinone form through a two-electron mechanism.
Two lines of evidence support this conclusion. First, single-electron fluxes considerably smaller
than 1 were obtained with a number of quinone substrates when the obligatory one-electron
acceptor Cyt c was used in a coupled enzymatic assay (Figure 4.5). In this context, a singleelectron flux is the ratio of the rate constant for Cyt c reduction to the doubled rate constant for
NADH oxidation (15). The data rule out the alternative possibility of a single-electron reduction
of the quinones by the enzyme-bound flavin of PA1024, since if this were the case singleelectron fluxes of 1 would have been observed. The different single-electron fluxes determined
with the various quinone substrates tested can be reconciled with their autoxidation rates, which
were previously shown for naphthohydroquinones to follow the order of 5-hydroxy > 2-methoxy
> 2-methyl > unsubstituted hydroquinone (22). In essence, hydroquinones that are more prone to
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non-enzymatic autoxidation can indirectly reduce Cyt c at faster rates through the products of
autoxidation. The effect of SOD on the enzymatic activity of the enzyme in the Cyt c coupled
assay provides independent evidence for quinone reduction to the hydroquinone rather than the
semiquinone state. With all quinone substrates tested except 2,6-dimethoxy-1,4-benzoquinone,
the presence of SOD decreased the initial rates for the coupled Cyt c reduction catalyzed by
PA1024 by 50% or more (Table 4.2). In the presence of Cyt c, if a semiquinone radical were
produced in the quinone reduction catalyzed by PA1024 it would redox cycle without reducing
oxygen and bypass superoxide formation (23). This property explains the ability to significantly
inhibit the coupled Cyt c reduction by a 2-electron reductase with SOD, but not a 1-electron
reductase, and the latter phenomenon has been observed in studies with ferric reductase B from
Paracoccus denitrificans (23). Additional evidence of a two-electron reduction comes from the
kcat/Km values, which did not show a linear relationship with the one-electron reduction potentials
and were sensitive to the structure of the substrate. The last two features are common amongst
most two-electron quinone reductases (21,24).
The two-electron reduction of quinones by PA1024 occurs through a Ping-Pong Bi-Bi
steady-state kinetic mechanism, as demonstrated by the competitive inhibition pattern observed
between NAD+ and the quinone substrate (Figure 4.4). NAD+ must first leave the reduced
enzyme before the quinone can bind, and the napthoquinone and NAD+ compete for the reduced
free enzyme (Scheme 4.1). All known two-electron flavin-dependent NAD(P)H:quinone
reductases operate via a Ping-Pong Bi-Bi mechanism (25). This is likely due to the requirement
for both reducing and oxidizing substrates to alternately position close to the flavin for the
transfer of a hydride in the reductive and oxidative half-reactions catalyzed by NADH:quinone
reductases (26).
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With benzoquinones, flavin reduction is fully rate-limiting for the overall turnover of the
enzyme. Evidence for this conclusion comes from the comparison of the limiting rate constant
for flavin reduction (kred) and the kcat value that define turnover at saturating concentrations of
both substrates, showing similar values of 24-28 s -1. In contrast, with all naphthoquinones used,
flavin reduction is partially rate-limiting for the overall turnover of the enzyme, as indicated by
the kred value being significantly larger than the kcat values. This may reflect a slower rate
constant for the release of the product of the reaction for the bulkier naphthoquinones compared
to the smaller benzoquinones.
The Kis value for NAD+ of ~2 mM is at least 400 times larger than the Km value for
NADH. This substantial difference is consistent with an unfavorable interaction of the positively
charged NAD+ in the active site of the enzyme as compared to the neutral NADH. The
crystallographic structure of PA1024 (PDB 2GJL) shows the presence of the side chain of K124
at ~4 Å from the N1-C2 locus of the flavin (Figure 4.2B), allowing us to speculate that this
residue may be responsible for NAD+ binding being weaker than NADH due to electrostatic
repulsion.
PA1024 has a small NADH oxidase activity, with a turnover rate of ~1 s -1 at saturating
NADH concentration and atmospheric oxygen. This indicates that the NADH oxidase activity is
likely not the primary function of PA1024. Slow oxidase activity has been observed in the case
of NADH:quinone oxidoreductases (27), chromate reductase (28),

flavin-dependent

monooxygenases (uncoupling) (16), and old yellow enzyme (OYE) (29,30). In contrast to
PA1024, FAD-dependent NAD(P)H:quinone oxidoreductase 1 (NQO1) and the quinone
reductase Lot6p are not oxidized by molecular oxygen (25). In PA1024, the presence of a
positive charge near the N1-C2 locus of the flavin, i.e., on the side chain of K124, may
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contribute to the small oxidase activity observed, as in the case of several other flavin-dependent
oxidases (31).
The UV-visible absorption spectrum of purified PA1024 in Figure 4.1 displays the
characteristic flavin signature, but the low-energy band of the cofactor at 461 nm is significantly
red shifted compared to free FMN (450 nm) and to Pa-NMO (443 nm) (6). A large red shift in
the low-energy peak is a feature usually indicative of a more polar protein environment around a
flavin cofactor (32,33). Accordingly, in the crystal structure of PA1024 (7) there is a polar T75
located 3.8 Å from the N3 atom of FMN, while in the same position in Pa-NMO (PDB 4Q4K)
there is the hydrophobic F71 at 3.6 Å from N3 atom of FMN (6). Furthermore, the flavin in
PA1024 is exposed to the solvent (Figure 4.2B), which could contribute to additional hydrogen
bond interactions with water. The fluorescence emission peak of PA1024 upon exciting the
enzyme-bound flavin at 461 nm demonstrates a significant red shift to 543 nm and is only 10
times less fluorescent than FMN free in solution (Figure 4.1 inset).
Enzymes with NAD(P)H:quinone reductase activity were recently reported from bacteria
with the ability to detoxify azo dyes from the environment (34-36). Convergent evolution of
azoreductases and quinone reductases has been proposed based on similar reaction mechanisms
involving the flavin-mediated reduction of an organic molecule with NAD(P)H and substrate
scope (37,38). The lack of enzymatic activity with the azo dye methyl red indicates that PA1024
is not an azoreductase. Although there are several azoreductases from P. aeruginosa capable of
reducing quinones (38), WrbA is the only other two-electron NAD(P)H:quinone reductase
identified to date that does not possess azoreductase activity (39) beside PA1024.
PA1024 is a novel NADH:quinone reductase as illustrated below. The enzyme shares
little overall sequence similarity to the well-characterized human NQO1 and FAD-dependent
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NAD(P)H:quinone oxidoreductase 2 (NQO2), with only 20% and 19% identity in its amino acid
sequence, respectively. As shown in Figure 4.6, which compares the active sites of the three
enzymes, there are prominent differences in the active site frameworks of the three enzymes.

Figure 4.6 Comparison of the active sites of PA1024, NQO1, and NQO2.
FMN or FAD carbon atoms are in yellow sticks, and the side chain residue carbons are in cyan
sticks. A, PA1024 (PDB 2GJL). B, NQO1 (PDB 1QBG) (66). C, NQO2 (PDB 1QR2) (67).
A major difference is the presence of H152 above the flavin of PA1024 and S288 near the C7/C8
methyls of the flavin, both of which are absent in the NQOs. Also, K124 is located near the N1
of PA1024, as opposed to T148 residue in the NQOs. Notably a M23 is positioned behind the re
face of the flavin in PA1024, whereas a hydrophilic residue is present in NQO1 and NQO2.
Similarities include the presence of a tryptophan below the flavin, and hydrophilic residues near
the N1-C2(O) locus of the flavin. Besides the active site, PA1024 displays several differences
with respect to mammalian NQOs. First, PA1024 contains FMN while the mammalian NQOs
use FAD (7,25). Second, PA1024 has a clear preference for NADH, whereas NQO1 can utilize
both NADH and NADPH with similar efficacy, and NQO2 prefers modified derivatives of
NADH such as dihydronicotinamide riboside (40). Third, PA1024 is unable to reduce azo dyes,
which are substrates of NQO1 and NQO2 (41-44).
Comparison of PA1024 with other known NADH:quinone reductases indicates that the
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enzyme is distinct in sequence and structure from those enzymes as well. The overall fold of
PA1024 is a TIM-barrel, distinguishing it from the flavodoxin-like fold of most
NAD(P)H:quinone reductases characterized to date (25). As mentioned earlier, very few FMNdependent quinone reductases specific for NADH have been identified. Other FMN-dependent
quinone reductases, which however utilize both NADH and NADPH, have also been identified
in bacteria, fungi and plants, including Methanothermobacter marbergensis NQO (45), Lot6p
from Saccharomyces cerevisiae (46), YhdA (47), FQR1 (48) and NQR (49), among others. It is
worth noting that other flavin-dependent enzymes with known functions have been shown to
exhibit NAD(P)H:quinone reductase activity, for example bacterial nitroreductases and glucose
oxidase (50). Thus, the possibility that the primary function of PA1024 may be different from the
NADH:quinone reductase activity characterized in this study cannot be excluded.
The six consensus motifs identified in PA1024 contain critical differences to PaNMO that
discriminate the reactivity and substrate preference between the two enzymes.

Motif I and V

may aid in binding the cofactor and possibly modulating the redox potential. Motif II is most
likely related to the folding of the TIM barrel domain, yet a key difference being the presence of
T75 in PA1024 as opposed to F71 in PaNMO. Motif III is also a part of the TIM barrel fold since
all of the residues are not located near the active site, with the exception of the K124 which is
unique to the PA1024-like class of quinone reductases. Motif IV is located on the surface above
the active site cavity and may play a role in substrate preference. Motif VI is located in the
putative substrate binding domain and is completely absent in PaNMO. Most importantly, the
last part of motif II, motif III, and motif VI of PA1024 are the most helpful in identifying
significant differences in the two classes of enzymes represented by PA1024 and Pa-NMO.
NAD(P)H:quinone oxidoreductases have been implicated in the detoxification of
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quinones within intracellular pools, thereby exerting an antioxidant protective role. This is due to
the fact that upon a two-electron reduction of quinones to the hydroquinones, the highly reactive
semiquinones are bypassed, which in turn lowers free radical formation and consequent lipid
peroxidation, formation of protein adducts, and DNA modifications (51-53). This could be the
case for PA1024. However, when one considers that the operon containing pa1024 includes
hypothetical acyl-CoA dehydrogenases, a short chain dehydrogenase, an acyl-CoA
hydratase/isomerase, and a porin, an alternative speculation is that PA1024 may be required to
maintain an appropriate [NAD+]/[NADH] ratio for the catabolism of fatty acids in P. aeruginosa
PAO1. A link between a low [NAD+]/[NADH] ratio and the stimulation of β-oxidation was
observed previously (8,9). Furthermore, participation of an NADH:acceptor oxidoreductase as a
physiological

partner

of

a

butyryl-CoA

dehydrogenase

was

recently

proposed

in

Syntrophomonas wolfei, although the enzyme was not identified (54).
In summary, the results presented in this study remedy the annotations of close to five
hundred, mostly bacterial, hypothetical proteins in the databases, and define a new class of
FMN-dependent quinone reductases with a TIM-barrel fold. There appears to be a widening gap
between the benchtop and desktop that if left unchecked could potentially cause confusion,
raising the necessity for computational biochemists and experimentalists to cooperate more
closely in order to enhance gene function prediction. The results presented herein also highlight
the structural diversity among quinone reductases and their deeply rooted evolutionary
differences in nicotinamide preference and azoreductase activity. The biological significance of
an NADH:quinone reductase activity is possibly more complex than previously considered, and
the various effects of quinones and quinone reductases on the cellular setting have yet to be fully
unraveled.
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4.5
4.5.1

Experimental procedures
Materials
The enzymes XhoI, NdeI, DpnI, calf intestinal alkaline phosphatase (CIP), and T4 DNA

ligase were from New England BioLabs (Ipswich, MA), Pfu DNA polymerase from Stratagene
(La Jolla, CA), and oligonucleotides from Sigma Genosys (The Woodlands, TX). Escherichia
coli strain DH5α was purchased from Invitrogen Life Technologies (Grand Island, NY). E. coli
strain Rosetta(DE3)pLysS and the expression vector pET20b(+) were from Novagen (Madison,
WI), QIAprep Spin Miniprep kit, QIAquick PCR purification kit and QIAquick gel extraction kit
were from Qiagen (Valencia, CA). The genomic DNA of P. aeruginosa PAO1 was a kind gift
from Dr. Jim Spain, Georgia Institute of Technology, Atlanta, GA. HiTrapTM Chelating HP 5
mL affinity column was from GE Healthcare (Piscataway, NJ), and isopropyl-1-thio-β-Dgalactopyranoside (IPTG) was from Promega (Madison, WI). Cytochrome c from bovine heart,
superoxide dismutase, nitroalkanes and quinones were from Sigma-Aldrich (St. Louis, MO). All
other reagents used were of the highest purity commercially available.
4.5.2

Cloning
The gene pa1024 was amplified from the genomic DNA of P. aeruginosa PAO1 by PCR

in presence of 5% DMSO. The PCR protocol included an initial denaturation step at 95 °C, 20
cycles of denaturation for 45 s at 95 °C, annealing for 30 s at 56 °C (with the annealing
temperature progressively decreasing by 0.2 °C at each cycle), extension for 3 min at 72 °C, and
a final step for 10 min at 72 °C.
The pa1024 gene amplified by PCR was purified by agarose gel extraction with the
QIAquick gel extraction kit. The amplicon and the expression vector pET20b(+) were subjected
to double digestion with NdeI and XhoI and purified with the QIAquick PCR purification kit.
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After a dephosphorylation step with 0.5 units of calf intestinal alkaline phosphatase for 30 min at
37 °C the dephosphorylated vector was purified with the QIAquick PCR purification kit and
ligated to the insert with incubation for 15 h at 16 °C with T4 DNA ligase. A volume of 5 µL of
the ligation mixtures was used to transform E. coli strain DH5α. The resulting colonies grown at
37 °C on Luria-Bertani agar plates containing 50 μg/mL ampicillin were screened for the
presence of the desired insert by DNA sequencing at the Cell, Protein and DNA Core Facility at
Georgia State University. The DNA sequencing confirmed the correct insertion of the gene in the
plasmid vector and the absence of undesired mutations.
4.5.3

Recombinant expression and purification
E. coli expression strain Rosetta(DE3)pLysS transformed with the construct

pET20b(+)/pa1024 was used to inoculate 90 mL of Terrific Broth containing 50 µg/mL of
ampicillin and 34 µg/mL of chloramphenicol, which was incubated at 37 °C for 15 h. One
aliquot of 8 mL of this culture was used to inoculate 1 liter of Terrific Broth containing 50
µg/mL of ampicillin and 34 µg/mL of chloramphenicol, which was incubated at 37 °C until it
reached an optical density at 600 nm of 0.8. IPTG was then added to a final concentration of 200
µM and the culture was incubated at 18 °C for 20 h. The wet cell paste of 8.5 g, recovered by
centrifugation, was resuspended in 40 mL of lysis buffer containing 10 mM imidazole, 300 mM
NaCl, 10% v/v glycerol, 1 mM phenylmethylsulfonyl fluoride, 5 mM MgCl 2, 2 mg/mL
lysozyme, 5 μg/mL DNase, 5 μg/mL RNase, and 20 mM sodium phosphate, pH 7.4. The
resuspended cells were subjected to several cycles of sonication. The cell free extract obtained
after centrifugation at 12000 g for 20 min was loaded onto a HiTrapTM Chelating HP 5 mL
affinity column equilibrated with 10 mM imidazole, 300 mM NaCl, 10% v/v glycerol, and 20
mM sodium phosphate, pH 7.4. After washing with 10 column volumes of equilibrating buffer,
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the column was treated with four intermediate steps at 50, 100, 150 and 250 mM imidazole in
equilibration buffer to remove possible contaminants. PA1024 was eluted with 500 mM
imidazole in equilibration buffer. The purest fractions based on SDS-PAGE analysis were
pooled, dialyzed against 20 mM Tris-Cl, pH 8.0, 200 mM NaCl, 10 % glycerol and stored at -20
°C.
4.5.4

Spectroscopic studies
UV-visible absorbance was recorded with an Agilent Technologies diode-array

spectrophotometer Model HP 8453 PC (Santa Clara, CA) equipped with a thermostated water
bath in 20 mM TRIS-Cl, pH 8.0, 200 mM NaCl, plus 10 % glycerol at 25 °C. The extinction
coefficient of purified PA1024 was determined by extracting the FMN cofactor by heat
denaturation of the enzyme. After removing the denatured protein by centrifugation, the
concentration of free FMN was determined spectroscopically by using ε 450 = 12,500 M-1 cm-1
(55). The concentration of flavin-bound active enzyme was determined by using the
experimentally determined extinction coefficient ε461 of 12,400 M-1 cm-1 (this study). The total
protein concentration was determined using the Bradford method with bovine serum albumin as
standard (56). Initial rates of enzymatic reaction were normalized for the concentration of
enzyme-bound flavin.
Fluorescence emission spectra were recorded in 20 mM TRIS-Cl, pH 8.0, 200 mM NaCl,
10 % glycerol, at 25 °C, with a Shimadzu model RF-5301 PC spectrofluorometer (Kyoto, Japan)
using a 1 cm path length quartz cuvette. All fluorescence spectra were corrected with the
corresponding blanks for Rayleigh and Raman scatterings. For flavin fluorescence, the sample at
an FMN concentration of 3.2 μM was excited at 461 nm (447 nm for free FMN) and the
emission scan was determined from 480 to 680 nm. Free FMN was obtained by boiling the

128

native enzyme followed by centrifugation.
4.5.5

Enzymatic assays
Reduction of the enzyme-bound flavin with NAD(P)H was carried out anaerobically with

an SF-61DX2 Hi-Tech KinetAsyst high-performance stopped-flow spectrophotometer
(Bradford-on-Avon, U.K.), thermostated at 25 ºC. Anaerobiosis of the instrument was obtained
by overnight incubation with glucose (5 mM)/glucose oxidase (1 µM) in sodium pyrophosphate,
pH 6.0. The enzyme was passed through a desalting PD-10 column equilibrated with 20 mM
potassium phosphate, pH 7.0, 200 mM NaCl, transferred in a tonometer and subjected to 20
cycles of degassing by applying vacuum and flushing with argon. The syringes containing 20
mM potassium phosphate, pH 7.0, 200 mM NaCl, as buffer, or the substrate NAD(P)H dissolved
in buffer were flushed for 30 min with ultrapure argon before mounting onto the stopped-flow
spectrophotometer. To ensure complete removal of traces of oxygen, glucose (2 mM) and
glucose oxidase (0.5 µM) were present in the buffer, enzyme and substrate solutions. The
concentration of the substrate NAD(P)H was determined spectrophotometrically at 340 nm with
the extinction coefficient 6,220 M-1 cm-1 (57). The concentration of the enzyme after mixing was
15 µM and of NAD(P)H ranged from 90 to 500 µM to maintain pseudo first order conditions.
Turnover of PA1024 with NADH was monitored with a suitable quinone in 20 mM
potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. NADH was kept at a constant, saturating
concentration of 100 µM. Stock solutions of quinones were prepared in 100% ethanol, except
2,6-dimethoxy-1,4-benzoquinone, which was dissolved in DMSO. The final ethanol or DMSO
concentration in all reaction mixtures was kept fixed at 1% to minimize possible effects on
enzymatic activity. Reaction rates were measured by following NADH consumption at 340 nm,
using ε340 = 6,220 M-1 cm-1 (58). In the case of 2-methyl-1,4-naphthoquinone, 343 nm was
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followed instead, since its oxidized and reduced forms are isosbestic at this wavelength. The
coupled Cyt c reduction was monitored by measuring the increase of absorbance at 550 nm using
an ε550 = 29,500 M-1 cm-1 in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. The
final concentrations of NADH and Cyt c were saturating at 100 µM and 8.4 µM, respectively.
For the experiments that compared the NADH oxidation versus the coupled Cyt c reduction,
assays were done in triplicate in the presence and absence of 330 units of superoxide dismutase
(SOD). Control reactions were run in the absence of the enzyme for all experiments.
NADH oxidase activity was monitored on an Oxy-32 oxygen-monitoring system at
atmospheric oxygen in 20 mM potassium phosphate, 200 mM NaCl, pH 7.0 and 25 oC, by
following the initial rate of oxygen consumption. Final concentrations of NADH and the enzyme
were 100 µM and 0.14 µM, respectively. To test whether hydrogen peroxide was produced
during enzymatic turnover, the rate of oxygen consumption was measured at a fixed substrate
concentration in the presence and absence of 170 units of catalase.
The NMO activity assay was performed as previously described (5,6,13,59), following
the initial rate of oxygen consumption with a Hansatech Instruments computer-interfaced Oxy32 oxygen-monitoring system at atmospheric oxygen, i.e., 230 µM oxygen, and 30 °C. Stock
solutions of nitronates and nitroalkanes were prepared as previously described (5,13). Enzyme
concentration was 180 nM and substrate concentration was 1 mM for P3N or 3-NPA, and 20
mM for 2-nitropropane, propyl-2-nitronate, nitroethane, or ethylnitronate. A positive control for
nitronate monooxygenase activity was performed in parallel with purified Pa-NMO to a final
concentration of 1.4 nM and 1 mM P3N as previously described (6).
The azoreductase activity of PA1024 was tested as previously described (19,60), by
monitoring the reduction of methyl red at 430 nm, using ε430 = 23,360 M-1 cm-1, in 20 mM
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potassium phosphate, 200 mM NaCl, pH 7.0, at 25 °C. The final concentrations of NADH,
methyl red and enzyme were 100 µM, 25 µM, and 0.20 µM. The control reaction run in the
absence of the enzyme was negligible, consistent with the non-enzymatic reaction between
NADH and methyl red occurring only at low pH (61).
4.5.6

Product inhibition of PA1024 with NAD+
Product inhibition of PA1024 was carried out using NAD+ as the inhibitor with NADH

and 5-hydroxy-1,4-naphthoquinone as substrates in 20 mM potassium phosphate, 200 mM NaCl,
pH 7.0, at 25 °C. The final concentration of NADH was held fixed at 100 µM, whereas 5hydroxy-1,4-naphthoquinone concentrations ranged from 2 µM to 17 µM. The concentration of
NAD+ was kept fixed at 0.4, 1.2, and 3 mM and a set in the absence of NAD + was included.
4.5.6.1 Data analysis
The steady-state kinetic parameters for the enzymatic assays were obtained from the
fitting of the experimental points to the Michaelis-Menten equation for one substrate using
KaleidaGraph software (Synergy Software, Reading, PA). Double reciprocal plots were
constructed for product inhibition patterns using KaleidaGraph, and global analysis was carried
out using Enzfitter software (Biosoft, Cambridge, U.K.). Stopped-flow traces were fit with the
software KinetAsyst 3 (TgK-Scientific, Bradford-on-Avon, U.K.) to Equation 1, which
represents a double-exponential process. A represents the absorbance at 461 nm at time t, B1 and
B2 are the amplitudes of the decrease in absorbance, kobs1 and kobs2 represent the observed rate
constants for the change in absorbance, and C is an offset value accounting for the nonzero
absorbance of the enzyme-bound reduced flavin at infinite time.
A = B1– kobs1t + B2– kobs2t + C

Eq. 1
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Concentration dependence of the observed rate constants for flavin reduction was
analyzed with Equation 2, where S represents the concentration of organic substrate, kred is the
rate constant for flavin reduction at saturating substrate concentration, and Kd is the apparent
dissociation constant for substrate binding.

=

4.5.7

Eq. 2

Bioinformatic analysis
The analysis of the protein sequence of PA1024 was performed with BlastP

(62),

selecting the non-redundant protein sequence database. Multiple sequence alignments were also
created with Clustal Omega (63) and Jalview 2.8 (64). To find hypothetical proteins sharing the
6 motifs of PA1024, the PHI-BLAST (65) feature was utilized. The modifications to the
conserved motifs were designed manually based on the multiple sequence alignment generated
by BlastP, analysis of potential critical residues, and multiple PHI-BLAST reiterations of varying
patterns.
4.6
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5

PH EFFECTS DEMONSTRATE TWO CATALYTIC REGIMES IN A FLAVINDEPENDENT NADH:QUINONE OXIDOREDUCTASE

5.1

Abstract
NAD(P)H:quinone oxidoreductases (NQOs) catalyze the flavin-mediated two electron

reduction of quinones to hydroquinones using NAD(P)H as an electron donor. NQOs are
proposed to detoxify quinones by preventing one-electron reductases from reducing the quinone
to the semiquinone, the latter of which wreaks cellular havoc though chain radical reactions
resulting in superoxide generation. PA1024 is a recently discovered NQO from Pseudomonas
aeruginosa with proposed roles in quinone detoxification and maintenance of the cellular
[NAD+]/[NADH] balance. The present study utilizes pH and viscosity effects on the reductive
half-reaction and steady-state kinetics of PA1024 to gain additional mechanistic clues on the
general NQO reaction. The results revealed that PA1024 has two competent, catalytic regimes of
activity at low and high pH modulated by a separate deprotonation event with pKa ~6. The slow
and fast regimes of activity may have implications in the P. aeruginosa pH-influenced metabolic
stress response.
5.2

Introduction
The NASA spacecraft STARDUST collected interstellar dust particles in 2004 and

determined the main class of compounds present were quinone-type molecules, suggesting they
are some of the most ancient organic molecules in the universe.1 Quinones are cyclic unsaturated
compounds containing two carbonyl groups either adjacent or separated by a vinylene group in a
six-membered ring.2 Found in all domains of life from Bacteria to Archaea to Eurkarya3,
quinones are essential to biological processes such as electron transfer and oxidative
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phosphorylation4, which utilize ubiquinone (Coenzyme Q10) or some variation of it to carry out
redox reactions. Quinones can participate in a wide array of chemistry in addition to redox
catalysis including cycloadditions, halogenations, and radical reactions. 5
NAD(P)H:quinone oxidoreductases (NQOs) catalyze the flavin-mediated two-electron
reduction of quinones via the oxidation of NAD(P)H. The most well studied member of these
enzymes is NAD(P)H:quinone oxidoreductase 1 (NQO1). The consensus among the majority of
the scientific community is the enzyme serves to detoxify quinones through the two electron
reduction to the hydroquinone, thereby preventing one electron reductases such as cytochrome
p450 reductase that act on the quinone to produce toxic semiquinone radicals. 6-9 On the other
hand, several quinone-containing drugs are activated upon NQO1 action to become cytotoxic
such as β-lapachome and mitomycin C.6, 8, 10 The bioactivation of specific quinones by NQO1
has prompted the development of antitumor and chemotherapeutic compounds incorporating
quinone moieties.
An alternative role for these enzymes could entail maintenance of the [NADH]/[NAD +]
ratio in the cell. The [NADH]/[NAD+] ratio has a significant impact on the ability to break down
fatty acids, as a low ratio stimulates β-oxidation.11 This role was speculated for a newly
discovered NQO in Pseudomonas aeruginosa, PA1024, based on the genomic context and
kinetic specificity for NADH. The operon PA1024 belongs to consists of probable acyl-CoA
dehydrogenases, a β-hydroxylacyl CoA dehydrogenase, an enoyl-CoA hydratase/isomerase, a
short chain dehydrogenase, and a porin,12, 13 all of which are proteins typically involved in βoxidation. The requirement for NAD+ in β-oxidation stems from the enzyme β-hydroxylacyl
CoA dehydrogenase.14
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PA1024 was originally annotated in the GenBankTM and PDB databases as a nitronate
monooxygenase (NMO), and the highest levels of sequence identity are shared with P.
aeruginosa NMO and Streptococcus pneumoniae enoyl-acyl carrier protein reductase (FabK) at
32% and 31%, respectively. Despite the considerable levels of sequence identity and structural
overlap, subsequent kinetic studies demonstrated PA1024 does not possess NMO nor enoyl-acyl
carrier protein reductase activity15,

16

, but instead the enzyme catalyzes the FMN-dependent

oxidation of NADH utilizing quinones as electron acceptors (Scheme 5.1)15. Closer inspection of
PA1024 revealed the active sites of NMO and FabK contain key differences from PA1024 and
that may explain the divergence in catalytic function.15, 17

Scheme 5.1 Reaction catalyzed by PA1024
PA1024 shares little sequence similarity (< 25 %) to known flavin-dependent NQOs such
as eukaryotic NQO118,

19

, eukaryotic N-ribosyldihydronicotinamide:quinone reductase 2

(NQO2)20, lot6p from Saccharomyces cerevisiae7, tryptophan repressor binding protein from
Escherichia coli (WrbA)9, 21, 22, or Pst2p (protoplasts-secreted 2).23 PA1024 demonstrates a strict
specificity for NADH with virtually no reactivity with NADPH, and the best quinone substrates
for the enzyme based on the second order rate constant kcat/Km are 1,4-benzoquinone, 5,8dihydroxy-1,4-naphthoquinone and 5-hydroxy-1,4-naphthoquinone. 15 The TIM-barrel fold of the
34 kDa monomer of PA102424 is in contrast to most NAD(P)H quinone oxidoreductases reported
to date which are typically a dimer in a flavodoxin-like fold. 25
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In the present study we sought to gain insights on the catalytic mechanism through a
detailed investigation into the effect of pH on the reductive half-reaction and pH and viscosity on
the steady-state kinetics of PA1024. The pH effects reveal two regimes of catalytic activity for
the enzyme dictated by a deprotonation event with pKa ~6. The two catalytic regimes are
discussed in the context of the pH effect on P. aeruginosa virulence.
5.3
5.3.1

Materials and Methods
Materials
Nicotinoamide adenine dinucleotide reduced (NADH) was from VWR (Randor, PA).

1,4-benzoquinone, 5-hydroxy-1,4-naphthoquinone, sucrose, glucose, glucose oxidase, and
piperazine were from Sigma-Aldrich (St. Louis, MO). Sodium chloride, sodium phosphate and
sodium pyrophosphate were from Fischer Scientific (Fairlawn, NJ). PA1024 was prepared as
described previously.15 All other reagents used were of the highest purity commercially
available.
5.3.2

Enzymatic Assays
All assays were conducted in buffer consisting of 20 mM sodium phosphate, sodium

pyrophosphate, or piperazine (depending on the pH) and 200 mM sodium chloride at 25 oC. The
reduction of enzyme-bound FMN by NADH was monitored at 461 nm on a SF-61DX2 Hi-Tech
KinetAsyst high-performance stopped-flow spectrophotometer (Bradford-on-Avon, U.K.),
thermostatted at 25 ºC. Anaerobiosis of the instrument and all buffers, substrate, and enzyme
solutions was achieved according to published procedures. 15 The concentration of the substrate
NADH was determined using the extinction coefficient at 340 nm of 6,220 M -1 cm-1.26 The
concentration of the enzyme after mixing was 15 µM and of NADH ranged from 90 to 500 µM
to maintain pseudo first order conditions.
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The steady-state kinetic parameters of PA1024 were monitored on an Agilent
Technologies UV-visible Spectrophotometer (Santa Clara, CA) thermostatted at 25 oC in 20 mM
sodium phosphate, sodium pyrophosphate, or piperazine (depending on the pH) and 200 mM
sodium chloride. The reducing substrate was NADH and the electron acceptor was either 1,4benzoquinone or 5-hydroxy-1,4-naphthoquinone. Initially, a fixed concentration of 100 µM
NADH was used across the pH range of 5-11 and variable quinone concentrations ranging from
4 µM to 200 µM for 1,4-benzoquinone and 12.5 µM to 200 µM for 5-hydroxy-1,4naphthoquinone. Because of the requirement for steady-state kinetics where the [S] » [E],
accurate Km values lower than roughly 10 µM concentration were not measureable. The Km of
1,4-benzoquinone could only be measured at pHs 5-7.5, and 10-11. The Km for each of these pH
values for 1,4-benzoquinone was less than 20 µM (data not shown). Because of these
complications, very little emphasis is put on the Km and kcat/Km values of the quinone substrates.
To ensure NADH was saturating at all pH values, the steady-state kinetic values were measured
at varying concentrations of NADH and a saturating concentration for each quinone at the pH
extremes of 5 and 11. The kinetics at pH 5 demonstrated no dependence on the concentration of
NADH. Upon determining 100 µM was not sufficient to fully saturate at pH 11, which yielded a
Km value for NADH of 80 µM, pHs 10.5, 10, 9.5 and 8.5 were assayed at variable NADH
concentrations and a fixed, saturating quinone concentration of 200 µM to obtain a Km value for
NADH and an close estimate of the true kcat values. A limiting value of 30 µM was calculated for
the Km of NADH at low pH. Consequently, when the apparent steady-state kinetic parameters
were determined at a fixed concentration of 100 µM NADH and variable quinone concentration
from pH 5 to 8.5, they approximate about 80% of the true kcat values. Since the values are plotted
on a log scale, the overall pKa’s and limiting values would be similar if 100% saturation was
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achieved. Stock solutions of quinones were prepared in 100% ethanol. The final ethanol
concentration in all reaction mixtures was kept fixed at 1% to minimize possible effects on
enzymatic activity. Reaction rates were measured by following the disappearance of NADH
absorption at 340 nm, using ε340 = 6,220 M-1 cm-1.26 Final enzyme concentrations ranged from
100-200 nM. All steady-state kinetic assays were initiated by the addition of NADH.
Solvent viscosity effects on steady-state kinetic parameters were measured in 20 mM
sodium pyrophosphate, 200 mM NaCl at pH 6.0 and 8.5. Glucose and sucrose were investigated
independently as viscosigens at both pH 6.0 and 8.5. The relative viscosity values at 25 °C were
calculated according to the reference values at 20 °C from Lide.27 For each set of viscosigen
concentration, NADH was held constant at 100 µM and 5-hydroxy-1,4-naphthoquinone was
varied from 10-140 µM. The final enzyme concentration was 140 nM.
5.3.3

Data Analysis
The steady-state kinetic parameters were obtained from the fitting of the experimental

points of the enzymatic assays to the Michaelis-Menten equation for one substrate using
KaleidaGraph software (Synergy Software, Reading, PA). The pH profiles of the kred values for
NADH were fit to eq 1, which describes a curve that plateaus to a limiting value (CL) at low pH
and increases with increasing pH with slope of +1 and plateaus to a limiting value (CH) at high
pH. The pH profiles of the kcat values for 1,4-benzoquinone and kcat and kcat/Km values for 5hydroxy-1,4-naphthoquinone were fit to eq 2, which describes a curve that plateaus to a limiting
value (CL) at low pH and increases with increasing pH with slope of +1 and plateaus to a limiting
value (CH) at pH 8-9 to decrease at pH 10-12 with a slope of -1. Eq 2 is also known as a bellshaped dependence with an offset at low pH.
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C H  C L (10( pKa pH ) )
log(k red )  log
1  10( pKa pH )

Eq. 1

 C H  CL (10( pKa1 pH ) ) 

log(kcat , kcat / K m )  log
( pKa1 pH )
( pH  pKa 2 ) 
 10
 1  10


Eq. 2

Stopped-flow traces were fit using the software KinetAsyst 3 (TgK-Scientific, Bradfordon-Avon, U.K.) to eq 3, which defines a double-exponential process. A represents the absorbance
at 461 nm at time t, B1 and B2 are the amplitudes of the decrease in absorbance, kobs1 and kobs2
represent the observed rate constants for the change in absorbance, and C is an offset value
accounting for the nonzero absorbance of the enzyme-bound reduced flavin at infinite time. For
the stopped-flow traces that were triphasic, eq 4 was used, which is similar to eq 3, except an
additional B3 amplitude and kobs3 are included for the third phase. Concentration dependence of
the observed rate constants for flavin reduction was analyzed with eq 5, where S represents the
concentration of substrate, kred is the rate constant for flavin reduction at saturating concentration
of substrate, and Kd is the apparent dissociation constant for substrate binding. Viscosity effects
on the kcat values were fit to eq 6; those on the kcat/Km values were fit to eq 7. In these equations
(k)o and (k)η are the kinetic parameters in the absence and presence of viscosigen, respectively, Ѕ
is the degree of viscosity dependence, ηrel is the relative viscosity of the aqueous buffered
solution, and YH is the limiting value of the steady-state kinetic parameter of interest at high
concentration of viscosigen. Sequence identities reported in the introduction were performed
with ClustalOmega.28

149

A = B1– kobs1t + B2– kobs2t + C

Eq. 3

A = B1– kobs1t + B2– kobs2t + B3– kobs3t + C

Eq. 4

=

( )

= Ѕ(η

( )

=

( )

( )

5.4
5.4.1

Eq. 5

− 1) + 1

Eq. 6

Eq. 7

Results
Reductive half-reaction at pH 8.0
To evaluate the oxidation of NADH by PA1024, the reduction of the enzyme-bound

FMN was followed by monitoring the decrease at 461 nm under anaerobic conditions at pH 8.0
and 25 oC with the use of a stopped-flow spectrophotometer. The stopped-flow traces and
concentration dependence of NADH for the observed rate constant of flavin reduction, kobs, are
shown in Figure 5.1 as an example. The enzyme was fully reduced in a triphasic manner with
the fast phase accounting for 93% of the amplitude change. The slow phases accounted for a
combined 7 % of the total amplitude change and could be the result of a fraction of damaged
enzyme. Stopped-flow traces were analyzed with eq 3, and the resulting parameters were fit to eq
5, demonstrating the enzyme was fully saturated from 90-500 µM NADH, with a kred value of 38
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± 1 s-1. The Kd value was not measurable because 90 µM was the lowest concentration of NADH
possible without compromising pseudo-first order conditions; however, the fact that the enzyme
was fully saturated with 90 µM suggests a Kd value equal to or less than 10 µM.

Figure 5.1 Anaerobic reduction of PA1024 by NADH at pH 8.0.
(A) Anaerobic reduction with 90-500 µM NADH of PA1024 at 8.0 and 25 oC. (B) Observed rate
constants of flavin reduction as a function of NADH concentration
Note the log time scale on the x axis. The dead time of the instrument was 2.2 ms. 20 mM
sodium phosphate and 200 mM NaCl were the buffer conditions.
5.4.2

Effect of pH on the reductive half-reaction
The pH dependence of the rate constant of flavin reduction, kred, was determined to

establish relevant ionizations involved in the reductive half-reaction (Figure 5.2). The kred values
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were determined over a pH range of 6-11 on a stopped-flow spectrophotometer by measuring the
decrease in FMN absorbance at 461 upon reduction by NADH. The concentration of NADH was
varied from 90-500 µM at all pHs. Biphasic stopped-flow traces were analyzed with eq 3 and
triphasic traces were analyzed with eq 4. The resulting parameters were fit to eq 5 to give a kred
and Kd value. All pH values were biphasic or triphasic in nature with the fast phase accounting
for more than 90% of the total amplitude change and the NADH Kd was below 90 uM for all pH
values except pH 11, which gave a measureable Kd value of 140 ± 25 µM. An accurate yintercept of zero could be obtained for pH 11, indicating that flavin reduction is irreversible. The
other pH values may be irreversible as well, but it is not possible to verify since accurate yintercepts could not be calculated.
As shown in Figure 5.2, the kred values showed an offset at low pH and increased with
increasing pH to a limiting value at high pH. The two catalytic regimes are modulated by a group
with a pKa value of 6.3 ± 0.2, which is required to be deprotonated for maximal kred. The kred pH
profile values are listed in the top of Table 1. At all concentrations of NADH in all pHs tested,
there was no accumulation of a charge transfer band between 500-700 nm, the absence of which
indicates no detectable formation of a Ered-NAD+ complex29 (data not shown).
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Figure 5.2 Effect of pH on the kred and kcat of PA1024.
(A and B - blue open circles) effect of pH on the kred and (A – solid black circles) effect of pH on
the kcat of PA1024 with 1,4-benzoquinone and (B - solid black circles) effect of pH on the kcat
with 5-hydroxy-1,4-naphthoquinone.
Assays were carried out in 20 mM sodium phosphate or sodium pyrophosphate (depending on
the pH) and 200 mM sodium chloride at 25 oC. NADH was varied from 90 µM to 500 µM.
Curves with open blue circles were fit to eq 1. Curves with solid black circles were fit to eq 2.
5.4.3

Effect of pH on the steady-state kinetics
The pH-dependences of the steady-state kinetic parameters kcat and kcat/Km were

determined with 1,4-benzoquinone and 5-hydroxy-1,4-naphthoquinone as substrates to establish
relevant ionizations of groups involved in the overall catalytic cycle. The kcat and kcat/Km values
were obtained over a pH range of 5-11 by measuring the decrease in absorbance at 340 nm,
indicating the oxidation of NADH to NAD+. NADH was held at a constant 100 µM and the
quinone was varied for the pH range of 5-8.0. NADH was varied and the quinone was held at a
saturating concentration for the pH range of 8.5-11 (See materials and methods for explanation).
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All of the pKa values and limiting values for the steady-state kinetics are listed in the bottom of
Table 5.1. As shown in Figure 5.2, the kcat pH-profile with 1,4-benzoquinone was different from
the kred pH profile, in that it contained an additional group at high pH required to be protonated
for maximal kcat. The two groups are distinct as the number of pH unit separation between the
pair is greater than 2. The group at 6.4 is required to be deprotonated for maximal kcat, whereas
the group at is 11.0 required to be protonated for maximal kcat, defining an optimal pH of 8.5 for
the NADH:benzoquinone reductase activity.
The kcat pH-profile with 5-hydroxy-1,4-naphthoquinone in Figure 5.2B demonstrated a
bell-shape dependence with an offset at low pH, defining two separate pKas with an optimal pH
of 8.4. The second pKa seen in both kcat profiles of the quinone substrates was absent in the kred
pH profile, indicating the second pKa occurs in the oxidative half-reaction; however, the second
pKa of 11 is not well defined since the highest pH tested was pH 11, thus we cannot definitively
conclude this pKa is real and cannot elaborate further on the significance of this pKa. The kcat/Km
pH profile for 5-hydroxy-1,4-NQ shown in Figure S2 of the supplemental information was
qualitatively similar to the kcat pH profile but displayed large errors due to the barely
measureable, low µM KM values for the quinone substrate. 4 µM was the lowest quinone
concentration possible without violating the first requirement of steady-state kinetics, ie; [S] »
[E]. The fact that the kcat and kcat/Km pH profiles have almost identical shapes establishes these
two pKas are purely catalytic and not related to any binding event.
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Table 5.1 pH effects on the kred and kcat of PA1024.
Substrate
NADH

pKa
7.3e
c

kred (s-1)

(kred)La
11f

(kred)Hb
44f

kcat (s-1)
Substrate*
pKa2d
(kcat)La
(kcat)H b
5-H-1,4-NQ 6.4
11.0e
3f
25f
e
e
f
1,4-BQ
6.9
11.0
9
31f
1,4-BQ: 1,4-benzoquinone; 5-H-1,4-NQ: 5-hydroxy-1,4-naphthoquinone
a
pH-independent limiting value at low pH
b
pH-independent limiting value at high pH
c
Determined by using eq 1
d
Determined by using eq 2
e
(± 0.1)
f
(± 1)
*NADH was used as the reducing substrate
pKa1d
e

5.4.4

Effect of viscosity on the steady-state kinetics
The effect of viscosity on the kinetic parameters of PA1024 with 5-hydroxy-1,4-

napthoquinone at pH 8.5 was carried out to assess the presence or absence of diffusioncontrolled events during the catalytic cycle. The kcat and kcat/Km values were determined at
different concentrations of viscosigen on a UV-Visible spectrophotometer by measuring the
decrease in NADH absorbance at 340 nm. NADH was fixed at 100 µM and the quinone was
varied. As shown in Figure 5.3A, the effect of glucose on kcat at pH 8.5 was linear with a slope
of 34 ± 3 %, demonstrating the presence of a diffusion-controlled event in kcat.
Because the Km for 5-hydroxy-1,4-naphthoquinone was not measurable at pH 8.5 at
increased relative viscosities, accurate kcat/Km values could not be obtained at different relative
viscosities for pH 8.5. Thus, the pH was lowered to 6.0 and the effect of glucose was performed.
For the kcat value, glucose gave a value of 20 ± 2 % (Figure 5.3B). For the kcat/Km value, glucose
(Figure 5.3C) gave an inverse solvent effect of 77 ± 11 %. The effect of viscosity at pH 11 could
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not be measured due to an apparent side reaction between glucose with the quinone substrate that
prevented accurate determination of initial rates.

Figure 5.3 Effect of viscosity on kcat and kcat/Km of PA1024.
(A) Effect of viscosity on the kcat of PA1024 at pH 8.5 and 25 oC. (B) Effect of viscosity on the
kcat of PA1024 at pH 6.0 and 25 oC. Panel C. Effect of viscosity on the kcat/Km of PA1024 at pH
6.0 and 25 oC.
PA1024 activity was measured at varying concentrations of 5-hydroxy-1,4-naphthoquinone and
100 µM NADH at different concentrations of glucose. The buffer consisted of 20 mM sodium
phosphate and 200 mM NaCl. The normalized kcat or kcat/Km values are shown as a function of
relative viscosity. Panels A and B were fit to eq 6. Panel C was fit to eq 7. The dashed line with a
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slope of 1 represents the theoretical limit for a fully diffusion controlled process, whereas the
dashed line with a slope of 0 represents a process that lacks diffusion control.
5.5

Discussion
The present study aimed to examine to the effect of pH and viscosity on the kinetic

parameters of PA1024 to gain mechanistic insights on the catalytic cycle. The results indicate
there are two active states of the enzyme, a slow regime at low pH and a fast regime at high pH,
which are controlled by the depronation of an enzymatic group with pKa ~7. The two regimes
could have implications in the P. aeruginosa pH-influenced stress response. An additional group
with pKa ~11 is required to be protonated, indicating the oxidative half-reaction concludes with
protonation of the hydroquinolate, which has been proposed for the prototypical eukaryotic
NQO1.30 Viscosity effects on the kinetics of PA1024 have been employed to gain additional
mechanistic clues. The details are discussed below.
5.5.1

PA1024 possesses two competent pH regimes of catalytic activity
PA1024 operates over a broad pH range with two catalytic regimes of activity that are

modulated by the deprotonation of an enzymatic group (Figure 5.2). Evidence of this conclusion
stems from the effect of pH on the kred and kcat values. The fast regime at basic pH is four fold
faster than the slow regime at acidic pH. Although this may seem like a small fold increase, even
small fluctuations in the [NADH]/[NAD+] ratio can have significant effects on various metabolic
processes.31, 32
The pH-driven change in the catalytic rate of PA0124 may have implications in P.
aeruginosa antibiotic resistance and metabolic versatility. The airway surface liquid (ASL) of
the lungs have been shown to be acidified in cystic fibrosis (CF) patients, which is a disease that
primarily afflicts the lungs and dramatically increases susceptibility of P. aeruginosa infection.33,
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The acidification of the ASL results from the impairment of bicarbonate ion transport in CF

patients.35 Studies have demonstrated that the antimicrobial compounds present in the ASL,
which are critical components of the host defense mechanism, and various commercial
antibiotics are rendered ineffective at acidic pH, allowing P. aeruginosa to thrive in acidic
environments.36-38 Another study demonstrated that biofilm production is enhanced at high pH,
representing yet another important pH-influenced mechanism by which the bacterium increases
survival chances.39 We speculate that perhaps at acidic pHs, PA1024 and the bacterium are in a
resting state, therefore only the slow catalytic regime is required to maintain the
[NADH]/[NAD+] balance. But as the pH increases to neutral or slightly higher than neutral pHs,
the bacterium faces more metabolic stress, therefore the fast catalytic regime is employed to
quickly produce NAD+ in order to upregulate β-oxidation pathways for increased virulence and
survival.
5.5.2

Rate-limiting contributions are altered as pH changes
Comparison of the rate of flavin reduction to the kcat value (Figure 2) indicates flavin

reduction is the principal rate-limiting step for the overall turnover from pHs 6-7. (Ref lot6p
paper for comparison) After the deprotonation of group with pKa ~7.3, another step becomes rate
limiting based on the comparison of kcat and kred values in Figure 5.2. The results of the viscosity
effects on kcat are consistent with a partially rate-limiting unimolecular step contributing to
overall turnover, such as the release of the hydroquinone or NAD+. Evidence of this conclusion
comes from the effect of solvent viscosity on kcat at pH 6.0 and 8.5, which are 20% and 35%
diffusion controlled, respectively, based on the slopes of the linear plots (Figure 3). However, a
slow release of the NAD+ is a less likely possibility because there was no accumulation of the
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Ered-NAD+ complex over 60 secs with excess of NADH, which typically generates a charge
transfer band in the 500-700 nm region of the visible spectrum. 29
5.5.3

A conformational change may be required to bind the quinone
A conformational change of the reduced PA1024 may be required to efficiently bind the

quinone. This conclusion was drawn based on the observation of inverse viscosity effects on the
kcat/Km values with 5-hydroxy-1,4-naphthoquinone (Figure 5.3C). Inverse viscosity effects have
been reported for the NAD-malic enzyme, which were accredited to an enzyme conformational
change that may involve small motions or rotations. 40 In the case of choline oxidase, the inverse
viscosity effects observed were attributed to the movement of a phenylalanine residue acting as
an oxygen gate. 41 The inverse effect reported here could be the result of a minor conformational
change to a configuration that favors quinone binding.
5.5.4

Conclusions
To summarize, we have employed pH and viscosity effects to elucidate key features of

the overall catalytic mechanism of PA1024. The overall turnover is principally limited by flavin
reduction and, to a lesser extent, the release of the hydroquinone product for pHs 5-9, however at
higher pHs 10-11, presumably the release of the hydroquinone product becomes more rate
limiting based on the comparison of the reductive half-reaction and steady-state kinetics. The
enzyme functions with two catalytic regimes that are dictated by the deprotonation of a group on
the enzyme with pKa ~6 that elicits the fast regime.
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6

STERIC HINDRANCE CONTROLS THE PYRIDINE NUCLEOTIDE SPECIFICTY
OF A FLAVIN-DEPENDENT NADH:QUINONE OXIDOREDUCTASE

6.1

Abstract

The crystal structure of the NADH:quinone oxidoreductase PA1024 has been solved in complex
with the reaction product NAD+. The nicotinamide C4 is located 3.6 Å from the FMN N5 atom,
representing a suitable separation and conformation for hydride transfer. NAD + is bound at the
interface of the TIM-barrel domain and the extended domain of the enzyme in a folded
conformation, with the two ribose groups close to each other. The steric hindrance of the ribose
of NAD+ and a nearby P78 controls the strict coenzyme specificity for NADH in PA1024. The
comparison of the structure with that of the ligand-free enzyme revealed a different conformation
of a short loop (75-86) that retains the NAD+ bound and an unusual interrupted helix that binds
the pyrophosphate moiety of NAD+. The structure of the PA1024-NAD+ complex contributes to
ongoing efforts to understand pyridine nucleotide specificity, NAD+ conformational diversity,
and enzyme active site gates.
6.2

Statement of importance
Understanding the coenzyme specificity of nicotinamide-dependent enzymes is crucial to

the advancement of protein engineering efforts. NADH is a far less expensive than NADPH, and
many efforts by various research groups are currently underway to alter coenzyme specificity
towards NADH. The coenzyme specificity in enzymes commonly relies on electrostatics, but
rarely on steric hindrance as we have reported here for the NAD+-PA1024 complex. The steric
hindrance of the ribose groups of NAD+ and a nearby P78 in the putative 2’phosphate-binding
region of NADP+ in the model controls the strict substrate specificity for NADH in PA1024.
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6.3

Introduction
Pyridine nucleotides are ubiquitous and important biological molecules that are vital to

the function of living cells.1 The two primary forms, reduced nicotinamide adenine dinucleotide
(NADH) and reduced nicotinamide adenine dinucleotide phosphate (NADPH), along with their
oxidized counterparts NAD+ and NADP+, participate in numerous biological processes,
including among others cellular energy production, mitochondrial functions, calcium regulation,
oxidative stress, gene expression, immune functions, the aging process, and cell death. 2 The
chemical structures of NADH and NADPH differ only by the presence of an extra phosphate
group on the 2’hydroxyl of the adenine ribose moiety. NADH is commonly involved in catabolic
pathways, whereas NADPH serves in anabolic pathways. 3 The small structural difference
between the two molecules of a phosphate versus a hydroxyl group is responsible for eliciting
different roles for each molecule and the enzymes that catalyze these reactions.
A plethora of enzymes with varying functions employ pyridine nucleotides as substrates
or, more seldom, cofactors. Major classes include, but are not limited to, oxidoreductases, such
as NAD(P)H quinone oxidoreductases4 (NQOs) and azoreductases;5 reductases, such as
cytochrome P450 reductases6 and glutathione reductase;7 and dehydrogenases, such as lactate
dehydrogenase8 and glutamate dehydrogenase.9 These enzymes often show a preference for
NADH or NADPH; however, among the NQOs, lot6p and NQO1 can utilize both NADH and
NADPH.10,

11

YhdA from Bacillus subtilis and PA1225 from Pseudomonas aeruginosa are

NQOs specific for NADPH,12,

13

while AzoA from Enterococcus faecalis and tryptophan

repressor binding protein (WrbA) are specific for NADH. 14, 15
The most common fold that binds pyridine nucleotides is the βαβαβ motif, also known as
the Rossmann fold,16,

17

yet other folds have been discovered to bind NAD(P)H, such as the
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TIM-barrel fold18 and the flavodoxin-like fold.4 The pyridine nucleotide is usually bound to the
protein in an extended conformation.16 The adenine portion of NAD(P)H typically binds a
mostly hydrophobic pocket, whereas the pyrophosphate portion binds to the backbone amide
groups of glycine residues positioned on α-helices or loops. NADPH-specific enzymes
frequently have insertions of basic residues within the nicotinamide-binding region to bind the
extra phosphate group, while NADH-specific enzymes have acidic residues positioned to repel
the additional phosphate on NADPH. Numerous reports describe alteration or switching of the
specificity of NADPH- and NADH-dependent enzymes through site-directed mutagenesis. 19-25
Despite the wealth of knowledge accumulated, the structural rules governing pyridine
nucleotides specificity have yet to be fully elucidated.
PA1024 is a recently characterized FMN-dependent NADH:quinone oxidoreductase that
demonstrates a strict specificity for NADH.26 The rate of flavin reduction at pH 7.0 with 500 µM
NADH is 22 s-1, whereas the reaction with an equivalent concentration of NADPH is 3,500 times
slower.26 A previous study determined the ligand-free structure of PA1024, indicating the overall
fold of the enzyme is a TIM-barrel fold.27 In the present study, we have solved the crystal
structure to 2.2 Å resolution of PA1024 in complex with the reaction product NAD + at pH 7.0.
The complex reveals the structural basis for the strict NADH specificity of the enzyme and its
lack of reactivity with NADPH. The results also reveal an active site gate that assumes a
different conformation in the PA1024-NAD+ complex as compared to the ligand-free enzyme
structure and an unusual “interrupted helix” that binds the pyrophosphate moiety of NAD +. The
findings of this study contribute to the overall understanding of nicotinamide coenzyme
specificity and aid in protein engineering efforts with related enzymes.
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6.4
6.4.1

Results and Discussion
Overall structure of the PA1024-NAD+ complex
PA1024 was co-crystallized with NAD+. The structure was solved in the trigonal space

group P3121 with one molecule per asymmetric unit by molecular replacement using the
coordinates of the ligand-free form of PA1024 as the initial search model. The structure was
refined to Rwork and Rfree values of 15.6% and 20.3%, respectively, to 2.2 Å resolution. The

resolution cutoff was determined by combining several criteria including CC 1/2, 〈I/σ(I)〉, and
completeness, but not the Rmerge values because they are poorly suited for determining highresolution limits.28 The crystallographic data and refinement statistics are summarized in Table
6.1. The final model of PA1024 in complex with NAD + (Protein Data Bank - PDB code 6E2A)
accounts for one polypeptide chain containing 326 residues from G2 to G327, 150 solvent sites
treated as water oxygens, one FMN molecule, one NAD+ molecule and two glycerol molecules
in the asymmetric unit. The N-terminal residue M 1 and the C-terminal residue V328, as well as the
C-terminal polyhistidine-tag, were excluded from the final structure due to lack of observable
electron density.
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Table 6.1 X-ray diffraction data collection and refinement statistics.
Data collection
Space group
P3121
a, b, c (Å)
93.38, 93.38, 80.76
α, β, γ (°)
90, 90, 120
Mosaicity (°)
0.64
Resolution range (Å)
80.76 – 2.20 (2.27-2.20)
Total No. of observed reflections
133527 (11413)
No. of unique reflections
21045 (1789)
Completeness (%)
99.9 (100)
Redundancy
6.3 (6.4)
CC1/2
0.995 (0.684)
9.6 (2.3)
〈 I/σ(I)〉
Rmerge
0.137 (0.952)
2
Overall B factor from Wilson plot (Å )
24.1
Refinement
Refinement resolution range (Å)
40.44 – 2.20 (2.27-2.20)
Rwork
0.156
Rfree
0.203
RMS deviations from ideality
Bonds lengths (Å)
0.007
Angles (°)
0.830
Number of atoms
Protein
2427
Water
150
FMN
31
NAD+
44
Glycerol
12
Average B factors (Å2)
Protein
33.7
Water
38.4
FMN
26.3
NAD
55.2
Glycerol
46.1
Ramachandran analyses
Most favoured (%)
97
Allowed (%)
3
Values for the outer shell are given in parentheses.
The monomeric enzyme consists of two domains, a TIM-barrel domain and an inserted
domain, which are connected by two loops. The TIM-barrel domain (M 1 – P211 and E299 – V328)
consists of eight α-helices and eight parallel β-strands, with the FMN and substrate binding sites
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capping the barrel. In the PA1024
PA1024-NAD+ complex, the FMN-binding
binding site is practically identical
to the ligand-free
free structure of the enzyme previously reported. The overall structure of PA1024
in complex with NAD+ is highly similar to the lig
ligand-free
free structure determined by Ha et al. with
an RMSD value of 0.13 Å on 326 equivalent C
Cα atoms (Figure 6.1).27

Figure 6.1 Superimposition of the ligand
ligand-free and NAD+-complex
complex structures of PA1024.
The overall structure of the ligand
ligand-free
free form of PA1024 (PDB ID: 2GJL) is in blue and the
PA1024- NAD+ complex (PDB ID: 6E2A) is in grey. The loop residues 75
75-86
86 are highlighted in
red (ligand-free
free form) and green (PA1024
(PA1024-NAD+ complex). The FMN carbons are in yellow
sticks and the NAD+ carbons are in cyan. The dashed line represents the distance between the
position of the C atom of Q80 in the ligand
ligand-free and NAD+-complex
complex structures.
Comparison of the structure of the PA1024
PA1024-NAD+ complex to the ligand-free
ligand
structure of
PA1024 indicates a conformational change occurs at a loop comprised of residues 75-86
75
(Figure
6.1). The loop residues P78,, P82, and P84, which are fully conserved
onserved in over 500 sequences that
share high identity and similarity with PA1024,, are likely necessary to provide internal rigidity
to the loop. Q80 on the loop shows the greatest variability from the ligand
ligand-free
free conformation, as
it moves 5.5 Å to form a hydrogen bond with the side chain of Y261 (2.9 Å) and latches
l
an
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apparent active site “gate” to secure the NAD+ (Figure 6.2). Q80 is highly conserved, but
isoleucine or leucine occurs at this position in some cases, suggesting that a long side-chain
side
is
required to physically block the active site entrance and contain the NADH. Active site gates or
“lids” at the entrance of the active site have also been observed in D
D-amino
amino acid oxidase from
pig kidney29 and human30, Pseudomonas aeruginosa D-arginine dehydrogenase,
ogenase,31 choline
oxidase,32 dihydrofolate reductase,33 RNA polymerase,34 and
d many more enzymes.35

Figure 6.2 Surface depiction of ligand
ligand-free structure (left) and the PA1024-NAD+
NAD+ complex
structure (right).
The TIM-barrel
barrel domain is in grey surface and the inserted domain is in blue surface. Q80 is in
green surface and Y261 is in orange surface. The NAD + carbons are
re in cyan sticks and the FMN
carbons are in yellow sticks.
The NAD+ molecule is bound to the si-face of the FMN. The re-face
face of the cofactor
instead is buried in the protein environment, making it impossible for the NAD + to access.
NQO1 and NQO2 are similar
imilar to PA1024 in this regard, as the re-face
face of FAD is buried in these
proteins and the pyridine nucleotide substrate binds to the si-face.36, 37 In contrast to PA1024,
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which is FMN-dependent and has TIM-barrel fold, NQO1 and NQO1 utilize FAD as a cofactor
and adopt a flavodoxin-like fold.

6.4.2

“Folded” conformation of NAD+ bound to PA1024
The electron density of the NAD+ bound to PA1024 is well defined (Figure 6.3) and the

occupancy is ~80%. The average B-factor for 44 NAD+ atoms is 55 Å2, which is higher than the
average value for the protein atoms, 34 Å2, and the protein residues in the NAD+-binding site, 40
Å2. The high B-factor suggests some degree of flexibility of the NAD+, which agrees well with
the observation that the NAD+-binding site is between the TIM-barrel domain and the inserted
domain and includes a mobile loop (Figure 6.1). NAD+ is bound to the enzyme in a “folded”
fashion (Figure 6.4), rather than in an extended conformation. The nicotinamide ring binds close
to the FMN, whereas the adenine ring resides close to the enzyme surface (Fig. 2). Variations of
the folded binding mode of NAD+ have been observed in other FMN-dependent enzymes, such
as the NADH:quinone oxidoreductase WrbA38 and flavin reductase P.39 It is worth noting that
NAD+ is an inhibitor of flavin reductase P and that the conformation of NAD + in WrbA does not
appear to be catalytically relevant because the nicotinamide C4 atom is located away from the
flavin. A folded binding mode has also been observed in both the NAD+ and NADP+ complex
with the short-chain flavin reductase HpaC from Sulfolobus tokodaii strain 740 and the NADP+
complex with catalase from beef liver.41 In contrast, FMN-dependent enzymes that have been cocrystallized with NAD+/NADH in the extended conformation include pentaerythritol tetranitrate
reductase,42 PfaD from Shewanella oneidensis, and the hydrophilic domain of respiratory
complex I from Thermus thermophilus.43
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Figure 6.3 Binding mode of NAD+ to PA1024.
σA-weighted 2Fo-Fc electron density map countered at 1 σ level (where σ is the root mean square
value of the electron density) is shown for FMN and NAD+. The NAD+ carbons are in cyan
sticks and the FMN carbons are in yellow sticks. The dashed line indicates the distance between
the C4 atom of the nicotinamide and the N5 atom of the FMN and the angle between the N10
and N5 atoms of the FMN and C4 atom of the nicotin
nicotinamide.
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Figure 6.4 Interactions of PA1024 residues with NAD+.
A) Residues that participate in the binding of NAD. FMN carbons are in yellow sticks, NAD +
carbons are in cyan sticks, and PA1024 residue carbons are in grey. B) Schematic representation
of the interactions of NAD+ with PA1024. The dashed lines represent distances between the
heavy atoms of the protein and the FMN cofactor.
6.4.3

Interactions of NAD+ with PA1024

Nicotinamide moiety
The nicotinamide NH2 moiety of NAD+ forms hydrogen bonds with the N10 atom of
FMN (3.4 Å) and the side-chain
chain hydroxyl of S288 (3.3 Å) ((Figure 6.4).
). Two van der Waals
contacts are made by the β- and γγ-carbons of Q24 with the nicotinamide ring of NAD+ (3.4 and
3.7 Å, respectively). As shown in Figure 3, the nicotinamide C4 of NAD+ is 3.6 Å from the N5
of FMN with a donor/acceptor angle of 110.6° for the atoms involved in the hydride transfer
reaction. Thus, the combination of the proximity and appropriate angle seen in the structure of
the PA1024-NAD+ complex represent a binding mode relevant for facile hydride transfer from
the nicotinamide of the NAD+ to the N5 atom of the FMN. The nicotinamide ring of the NAD+
does not appear to directly π-π
π stack with the pyrazine ring of FMN. A conformation similar to
that seen here was described in the ccrystal structure of PfaD from Shewanella oneidensis in
complex with NAD+ (PDB ID: 4Z9R). In contrast, complexes of 1,4,5,6-tetrahydro
tetrahydro-NADH in
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pentaerythritol tetranitrate reductase and NADH in the hydrophilic domain of respiratory
complex I from Thermus thermophilus showed the nicotinamide ring π-π stacked with the
pyrazine of FMN, but the carboxamide portion of the nicotinamide ring is tilted and aligns with
the O4 and N3 atoms on the pyrimidine ring of FMN. 42, 43
Ribose moieties
The 2’hydroxyl of the adenine ribose establishes a hydrogen bond with the backbone
C=O of P78 (3.1 Å). The 3’hydroxyl of the adenine ribose forms a hydrogen bond with the side
chain of H152 (3.5 Å). The ring O atom of the adenine ribose engages in a hydrogen bond with
the side-chain hydroxyl of Y261 (3.1 Å) (Figure 6.4). The nicotinamide ribose instead is not
well defined in the electron density map (Figure 6.3), thereby preventing a clear depiction of its
interactions with the protein.
Pyrophosphate moiety
The O5 phosphate atom of the pyrophosphate moiety of NAD+ is close to the NH group
on the side-chain of Q24 (3.7 Å) (Figure 6.4). The O1 and O2 atoms of the adenine phosphate
form hydrogen bonds with the backbone amides of G270 (3.1 Å) and Q80 (3.4 Å). G270 resides
on a short loop (268VSG270) that is connected to two α-helices in what can be described as an
interrupted helix (Figure 6.5). The interrupted helix is part of the inserted domain of PA1024
and appears to be a single helix that has been slightly unwound. Y261 anchors the helix by
stacking on the adenine of NAD+ and Q80 interacts with Y261. G270 is fully conserved in the
500 sequences that share high identity with PA1024; therefore, G270 is likely essential to
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provide the necessary space to bind the pyrophosphat
pyrophosphate of NAD+. Residues S271 and V272 are
likely required to have unbulky side
side-chains to accommodate the pyrophosphate of NAD+.

Figure 6.5 Pyrophosphate binding pocket of NAD + in PA1024.
The two α-helices in green are connected by a short loop composed of V268, S269, and G270
that form an “interrupted helix”. The NAD+ carbons are in cyan sticks and the FMN carbons are
in yellow sticks. The dashed lines represent distances.
Adenine ring moiety
The N3 atom of the
he adenine moiety of NAD+ forms a hydrogen bond with the side chain
C=O of N237 (3.1 Å). The adenine moiety of NAD + appears to π-π
π stack with Y261 (Fig.
(
5).
Comparison of 500 proteins sharing similar amino acid sequences to PA1024 indicates Y261 is
highly conserved as either a tyrosine or phenylalanine, and in a few cases (<5%), an isoleucine.
The important structural feature at position 261 for binding the pyridine nucleotide appears to be
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an aromatic residue capable of π-π stacking interactions with the adenine moiety. A similar π-π
stacking interaction with the adenine of ADP is well established in the aminoglycoside
phosphotransferase class of enzymes.44 In contrast, intramolecular π-π stacking of the adenine
and nicotinamide has been observed in complexes with both NAD+ and NADP+ in the shortchain flavin reductase HpaC from Sulfolobus tokodaii strain 7.40

6.4.4

Structural features responsible for coenzyme specificity
The folded binding mode of the pyridine nucleotide would position the 2’phosphate on

the adenine ribose of NADP+ ~2 Å from the 2’hydroxyl on the nicotinamide ribose of NADP +,
creating a steric clash that likely prevents NADP+ from binding to the enzyme (Figure 6.6). The
2’phosphate of the adenine ribose of NADP+ also would likely clash with P78 of PA1024 at a
distance of 1.9 Å (Figure 6.6). We propose that the steric constraint imposed by the folded
conformation of the NAD+ and P78 confer the strict specificity for NADH to PA1024.
Intriguingly, charged residues do not appear to play a role in the coenzyme specificity of
PA1024.
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Figure 6.6 Model of the PA1024
PA1024-NADP+ complex.
Different conformations of the phosphate group in the NADP + were modeled. The NADP+
carbons are in green, cyan and pink sticks, and the P78 and Q80 carbons and nearby loops of
PA1024 are in grey. The red circles represent steric clashes.
The majority of the structure
structure-function
function investigations on enzymes that utilize pyridine
nucleotides attributes their specificity to electrostatic
electrostatics.
s. An aspartate residue located in the
2’phosphate-binding
binding region has commonly been shown to discriminate between NADH-NADPH
NADH
in NADH-specific
specific enzymes. Examples include D175 in Lactobacillus bulgarius D-lactate
dehydrogenase, D53 in Bacillus stearothermophilus L-lactate
lactate dehydrogenase, and D223 in yeast
alcohol dehydrogenase.45 A recent study describes a variant of Lactibacillus delbrueckii 11842
D-lactate
lactate dehydrogenase with three point mutations (D176S/I177R/F178T) that displayed
displ
significantly improved catalytic activity on both NADH and NADPH. 21 In Type II NADH
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dehydrogenase, a relatively NADH-specific enzyme, a variant of E203Q granted the enzyme the
ability to oxidize NADH and NADPH with similar efficiency.46
The presence of arginine or lysine is typically observed in the 2’phosphate-binding region
of NADP+-specific enzymes. 4-hydroxyacetophenone monooxygenase exhibits a 700-fold
preference for NADPH over NADH, and makes use of three basic residues (R339, K439, and
R440) to dictate coenzyme specificity.47 Crystallographic studies on 6-phosphogluconate
dehydrogenase attribute the NADP+ specificity to an interaction between the 2’-phosphate of
NADP+ and R33, since without that interaction there is no cleft for binding the adenine of
NADH.48 In the crystal structure of NADP+ bound to NQO1, which can oxidize both NADH and
NADPH, the backbone amide N atom of F232 interacts with one of the O atoms of the phosphate
group on the adenine ribose of NADP+.36 This additional hydrogen bond is not present with
NADH as substrate and may explain the differences in affinity between NADH and NADPH in
NQO1, but the absence of fully charged side-chains interacting with the extra phosphate on the
adenine ribose may grant NQO1 its dual specificity.
Only a few studies have described a steric factor as controlling specificity in pyridine
nucleotide-dependent enzymes, as in the case reported here for PA1024. Homology modeling
and docking analysis with NADPH of the bifunctional alcohol/aldehyde dehydrogenase from
Clostridium thermocellum suggested the extra phosphate of NADPH would encounter
electrostatic repulsion and steric hindrance with D494.49 A variant of the enzyme with the
mutation D494G increased the specificity with NADPH in C. thermocellum bifunctional
alcohol/aldehyde dehydrogenase. A study on cytochrome P450 nitric oxide reductase, which
prefers NADH but can oxidize NADPH at 20% the relative activity of NADH, attributed the
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preference for NADH to steric clash of a serine residue (S75) with the 2’-phosphate moiety of
NADPH.50
6.5

Conclusions
We have determined the crystal structure of the FMN-dependent NADH:quinone

oxidoreductase PA1024 in complex with the reaction product NAD +. The results have uncovered
a different conformation of a short loop composed of residues 75-86 covering the nicotinamidebinding site in the structure of the PA1024-NAD+ complex as compared to the ligand-free
enzyme. P78, P82, and P84 provide internal rigidity to the loop. Q80 serves as an active site
latch that secures the NAD+ within the binding pocket. An interrupted helix that consists of two
α-helices connected by a small three-residue loop serves to bind the pyrophosphate of NAD +.
Furthermore, the structural factors governing the strict coenzyme specificity of PA1204 for
NADH have been determined. The NADP+ likely cannot bind due to a steric clash of its
2’phosphate with P78. The availability of the structure of the PA1024-NAD + complex provides a
firm framework for future structure-function studies aimed at the characterization of the FMNdependent NADH:quinone oxidoreductase PA1024.
6.6
6.6.1

Materials and Methods
Protein production and crystallization
Recombinant PA1024 from P. aeruginosa was obtained through expression and

purification methods previously described.26 The recombinant PA1024 was dialyzed against 20
mM Tris-Cl, pH 8 (25°C), 200 mM NaCl and 10% glycerol. The purified enzyme was
concentrated to 5 mg mL-1, mixed with 2 mM NAD+ (oxidized form of nicotinamide adenine
dinucleotide) and incubated for 30 minutes at 4° C. The enzyme concentration was estimated
based on the molar extinction coefficient of enzyme-bound FMN. 26 Crystallization was
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performed by the hanging drop vapor diffusion method at room temperature in 4 µL drops of a
1:1 ratio of protein previously incubated with NAD+ and the reservoir solution. Yellow crystals
were obtained within a day in presence of 0.1 M HEPES at pH 7.0, 4% (v/v) tacsimate at pH 7.0,
and 15% (w/v) poly-ethylene glycol methyl ether 5000 as previously described. 27 Prior to
crystallization, PA1024 activity was determined by monitoring the NADH consumption in the
presence of different quinones.26
6.6.2

Data collection and processing
The crystals were cryo-cooled in the mother liquor with 25% (v/v) glycerol and flash

frozen immediately in liquid nitrogen. X-ray diffraction data were collected at 100 K on
beamline 22-ID with detector Eiger 16M of the Southeast Regional Collaborative Access Team
(SER-CAT) at the Advanced Photon Source, Argonne National Laboratory. 180 images of 1°
oscillation per frame were collected with a 200 mm crystal-to-detector distance and an exposure
time of 1 s per image. Data integration and analysis were carried out using iMOSFLM 51 and
AIMLESS52 in the CCP4 suite.53 The resolution cutoff was determined by combining several

criteria including CC1/2 of > 0.5 for the highest resolution shell, 〈I/σ(I)〉 > 2 and completeness.
The data collection and processing statistics are summarized in Table 1.
6.6.3

Structure determination
The structure of the complex PA1024 with NAD+ was solved by molecular replacement

performed using the coordinates of the holo-form of PA1024 as the initial search model (PDB
ID: 2GJL) (REF 2GJL). A unique solution was found by PhaserMR 54, 55 in the trigonal space
group P3121 with unit cell dimensions of a = 93.38, b = 93.38, c = 80.76 Å. The Matthews
coefficient calculated with the CCP4i suite53 suggested one monomer in the asymmetric unit.
The model was subjected to several rounds of refinement using Phenix.refine. 56 Electron density
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and difference map were inspected, and modifications to the model were made with COOT. 57
The refinement ended when inspection of the maps suggested no more changes were justified,
and no significant changes in the Rfree and Rwork were observed. Solvent molecules were inserted
at stereochemically reasonable positions in peaks of 2Fo-Fc and Fo-Fc maps contoured at 1 and 3
sigma (σ) levels, respectively. Ligand restraint files were generated with phenix.elbow.58 The
final Rwork and Rfree values were 15.6% and 20.3% for the refined structure. The quality of the
model was regularly checked for steric clashes, incorrect stereochemistry and rotamer outliers
using MolProbity.59 All structural figures were produced using PyMol (www.pymol.org).
Refined atomic coordinates and experimental structure factors have been deposited in the Protein
Data Bank (PDB entry 6E2A). Refinement statistics are given in Table 1.
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7

GENERAL DISCUSSION AND CONCLUSIONS

PaDADH has been studied in this dissertation by a combined approach of mutagenesis and
pH kinetic effects. The mutagenesis was initially carried out in hopes of identifying the catalytic
base that deprotonates the substrate α-amino group. However, the pH profiles of variants
targeting H48, E87, Y53 and Y254 indicated the deprotonation was still occurring in the
mechanism. This finding was taken as evidence that there is no catalytic base functioning in the
mechanism, since all the potential bases were ruled out by mutagenesis, and consequently it was
proposed that the pKa belongs to the substrate α-amine that loses its proton to solvent possibly
with the aid of enzymatic residues. H48 may be involving in transferring the proton to the bulk
solvent, suggested by the hollowed pH profiles of the H48F variant. Hollowed pH profiles are
indicative of a disruption in the fast equilibration of the proton on the ES complex.
Comparison of the the pH profiles of the E87L variant to the wild-type demonstrated the
requirement of E87 to be depronated for tight binding of cationic substrates, as the binding pKa
seen in the kcat/Km pH profiles disappeared in the E87L variant. D-arginine and D-lysine most
likely form strong electrostatic interactions with E87, and this residue is the principle factor
controlling substrate specificity in PaDADH.
In the second part of this dissertation, we demonstrated that PA1024 is not a nitronate
monooxygenase, as it was annotated in the databanks. Instead, the enzyme exhibits an
NADH:quinone reductase activity with a strict preference for NADH. The NADH specificity
could have major implications in the physiological function of the enzyme, as NADH and
NADPH often play very distinct roles within metabolic pathways. The biochemical
characterization and bioinformatics anaylsis carried out established PA1024 as the founding
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member of a new class of FMN-dependent NQRs with a TIM-barrel fold. All of the NQRs
identified to date are a flavodoxin-like fold, making this the first TIM-barrel fold enzyme with
demonstrated NQO activity.
The kinetic characterization in combination with the structural analysis led to the
identification of structural motfis unique to the catalytic function of this class of NQRs. These
motifs were then used in a PHI-BLAST to identify close to 500 hypothetical proteins that belong
to this class of NQRs. The method utilized in this study of implementing both experimental and
computational approaches to identify structural motifs that define the catalytic function could be
used to enhance gene function prediction of hypothetical proteins from other enzyme familes,
instead of the current annotation method which relies solely on overall amino acid sequence
similarity. Key hypothetical proteins could be selected and characterized, and PHI-BLAST could
be used to identify other enzymes with similar function.
The enzyme has a strict preference for NADH over NADPH. The structure of the enzyme
in complex with NAD+ has been solved, leading to the structural basis for the strict NADH
specificity. P78 and Q80 are positioned in the NAD+-complex to sterically clash with putative
binding spot of the 2’-phosphate of NADP+. In addition, Q80 assumes two distinct
conformations in the ligand-free and NAD+-complex structures, revealing a conformational
gating mechanism of Q80 to secure the NAD+ within the binding pocket. Lastly, an unusual
interrupted helix that consists of (268VSG270) serves to bind the pyrophosphate of NAD+ is
observed in the structure of the NAD+-complex. This interrupted helix could potentially be a
novel structural motif to bind the pyrophosphate moieties in TIM-barrel enzymes.
The rate-limiting contributions of PA1024 are shifted as the pH increases. Product release
becomes progressively more rate-limiting at high pH, whereas flavin reduction is principal rate
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liming step at low pH. Kinetic solvent viscosity effects (KSVE) provided further evidence in
favor of product release being partially rate-liming in the reaction catalyzed by PA1024. KSVE
on the kcat/Km values with PA1024 suggested a conformational change may be required to bind
the quinone. However, whether the release of the NAD+ or hydroquinone or a combination of
both product release is responsible for the observed KSVE requires additional experiments.
The in vivo deletion mutant of PA1024 could provide the necessary information to better
determine to physiological role of the enzyme. The enzyme almost certainly oxidizes NADH to
NAD+ in vivo, but if quinones are the true physiological electron acceptors is still debatable. But
given their high kcat/Km values and widespread occurrence in nature, it is conceivable they could
possibly be the natural substrates of the enzyme. The operon to which PA1024 belongs to
consists of enzymes typically involved the β-oxidation of fatty acids. This operon could
potentially be a novel β-oxidation pathway yet to be characterized in P. aeruginosa. Another
study on Syntropos wolfei provided evidence that an NADH:acceptor reductase was the possible
physiological partner of a butyrl-Coa reductase, as the NADH:acceptor reductase was copurified
with the butyrl-Coa reductase. That same study also demonstrated that known NQO1 inhibitors
decreased the rate of β-oxidation, consistent with a biochemical link between NADH:quinone
reductases and β-oxidation. We propose that PA1024 plays a pivotal role in the maintenance of
the [NADH]/[NAD+] ratio in the cell, and consequently the ability of P. aeruginosa to perform
the β-oxidation of fatty acids through this hypothetical pathway. In order to verify this proposal,
in vivo experiments targeting PA1024 and this operon would be necessary.

